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According to Centers of Disease Control (CDC), 25.8 million Americans were diagnosed with 
diabetes in 2010, and more than 300 million people were affected worldwide. One potential 
future treatment for diabetes is transplantation of bioengineered pancreas capable of restoring 
insulin function. However, bioengineering of the complex pancreas function is a significant 
engineering feat. It calls for appropriate combinations of cells, with biomaterials that provide 
structural support and a suitable extracellular environment to maintain cell survival and function 
in vitro and in vivo. 
The first objective of this work is to investigate a suitable 3D bioscaffold to support 
pancreatic cell types. Our result demonstrated that perfusion-decellularization of whole pancreas 
effectively removes cellular material but retains intricate three-dimensional microarchitecture 
and crucial extracellular matrix (ECM) components. To mimic pancreatic cell composition, we 
recellularized the whole pancreas scaffold with acinar and beta cell lines and cultured up to 5 
days. Our result showed successful cellular engraftment within the decellularized pancreas, and 
the resulting graft gave rise to higher insulin gene expression over individual ECM proteins. 
The second objective of this work is to evaluate the feasibility to repopulate the native 
organ-derived scaffolds with renewable cell types such as differentiating human pluripotent stem 
cells (hPSC). We developed an in-house bioreactor to support the regenerative reconstruction of 
pancreas. Our result demonstrated that hPSCs cultured and differentiated as aggregates are more 
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suitable than the parallel adherent cultures for organ repopulation. Upon continued culture with 
chemical induction in bioreactor, the seeded PP aggregates grow within the 3D organ scaffolds 
with homogeneity and mature in situ into monohormonal C-peptide positive cells. 
The last objective of this work is to evaluate the matrix-specificity of organ-derived 
ECM. We evaluated this by developing a miniaturized ECM array composed of organ-specific 
matrices derived from decellularized pancreas, liver and heart. Interestingly, our result showed 
higher PP cell adhesion and differentiation on liver-ECM over pancreas- and heart-ECM, 
suggesting that the requirement for ‘like-to-like” basis for tissue engineering approaches may not 
always be the case. Overall, the findings from this dissertation represent a notable step toward 
bioengineering of pancreas as an alternative therapeutic solution for diabetes. 
  vi 
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1.0  INTRODUCTION 
1.1 THE PANCREAS 
The pancreas is a critical glandular organ located beneath the liver and in between the stomach 
and spine. It has two functional components: the exocrine and endocrine portion, and is often 
referred to as two organs housed in one location. The exocrine portion of the pancreas is 
primarily responsible for secreting digestive juices in response to hormonal signaling from the 
digestive system. These hormones from the stomach and duodenum cause the basophilic cells of 
the pancreas to release inactive digestive enzymes including trysinogen and chymostrypsinogen 
which are used for the digestion of lipids and proteins [1]. Though the production of digestive 
enzymes is the primary function of the exocrine pancreas there are also centroacinar cells which 
release bicarbonates in response to heightened acid levels in the stomach. 
The endocrine pancreas, on the other hand, plays a vital role in maintaining blood glucose 
level by secreting hormones directly into the blood vessels. Endocrine functionality of the 
pancreas is isolated to cell clusters called Islets of Langerhans as illustrated in Figure 1.1. The 
predominant cell types within the Islets are glucagon-producing α cells, insulin-producing β 
cells, somatostatin-producing δ cells, pancreatic polypeptide-producing PP cells and ghrelin-
producing ε cells. These islet clusters are densely vascularized, allowing the cells of the Islets of 
Langerhans to distribute hormones directly into the blood stream. The endocrine hormones act in 
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harmony to regulate the glucose levels in the blood. When blood glucose levels begin to fall 
below the normal range (70-130 mg/dL, fasting), glucagon signals the liver to release glucose 
into the blood stream. In the opposite fashion, when blood glucose is high, insulin is produced to 
affect a number of cells, including muscle, red blood cells, and fat cells to absorb glucose out of 
the blood, thereby having the net effect of lowering the high blood glucose levels into the normal 
range [1]. 
 
Figure 1.1 General pancreas anatomy 
Exocrine cell interacts with the digestive system and endocrine cell (Islets of Langerhans) interacts with the 
blood stream. 
1.1.1 Pancreas development 
The pancreas is a branching epithelial organ derived from endodermal germ layer. Pancreatic 
development occurs in a dynamic environment with active signaling from surrounding tissues. 
The dorsal and ventral portions of the pancreas undergo distinctly different developmental 
routine, although they are functionally similar in the mature organ. The dorsal pancreas results 
from budding of the dorsal endoderm upon receiving permissive signals from adjacent 
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notochord, aorta and pancreatic mesenchyme [2-4].  The ventral pancreas, on the other hand, 
buds out of the ventral endoderm, which is adjacent to the cardiac mesoderm. Cells of the ventral 
endoderm which escape inhibitory signals from cardiac mesoderm (FGF, BMP) results in the 
ventral pancreatic bud [5]. These epithelial buds subsequently branch and invade into the 
surrounding mesenchyme around embryonic day (E) 9.5 in the mouse embryo. As the pancreatic 
epithelium develops, the various hormone expressing cells appear from the common pancreatic 
progenitor and become apparent around E13.5. Around this time the dorsal and ventral pancreas 
are brought into proximity by the rotation of the gut tube. As organogenesis proceeds the 
pancreatic progenitor cells differentiate further to give rise to three distinct cell types by E18: 
acinar cell clusters which produce digestive enzyme; ductal cells which form a network which 
drains the digestive enzymes into the duodenum; endocrine cells which organize into islet 
clusters [6]. 
1.1.2 Extracellular matrix components in developing pancreas 
The branching epithelial morphogenesis of pancreas has been well investigated, and known to be 
associated with alterations in extracellular matrix (ECM) organization [7]. The ECM is primarily 
composed of high molecular weight molecules that include laminin, fibronectin, collagens [8-10] 
and a diverse array of proteoglycans and glycoproteins [11]. Pancreas development occurs in a 
transient environment – the ECM undergoes constant remodeling through its intimate interaction 
with surrounding cells. As the pancreas forms as an epithelial evagination into the surrounding 
mesenchyme, a specialized ECM termed the basement membrane (BM) develops in the 
epithelial-mesenchymal interface. The pancreatic BM is largely composed of laminins (80%) and 
collagen IV [8]. Laminin α1 for instance, is detected in the BM of the developing mouse 
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pancreatic buds as early as E13.5 [12], but is down-regulated in adulthood [13, 14]. Importantly, 
Laminin α1 has been shown to play a role early in gestation where it is present in 
the mesenchyme, then becomes focused to the epithelial–mesenchymal interface and then, 
through interactions with epithelial α6-containing integrins, mediates pancreatic duct formation 
[15].  Gittes et al. [16] verified this by overlaying isolated E11 mouse pancreatic epithelial cell 
with Matrigel, whose major component is laminin, where it induced duct formation. In addition, 
Laminin α1 found in the mesenchyme was shown to mediate epithelial-mesenchymal 
interactions that lead to exocrine differentiation [17]. Laminin α1 has also been shown to have a 
pro-β-cell role slightly later in gestation. Specifically, laminin α1 as a substrate enhanced β-cell 
differentiation in dispersed E13 mouse pancreatic epithelial cells, through binding to α-
dystroglycan [12, 18].  De Breuck, et al. [19] reported that netrin-1, a diffusible laminin-like 
molecule is present adjacent to E15-E18 pancreatic exocrine and endocrine cells, along with the 
netrin receptor neognenin [20]. Later Cirulli’s group using embryonic pancreas as a model of 
developing epithelium, confirmed that netrin is localized to epithelial cells at their basal surface 
and binds α6β4 and α3β1 integrin during pancreatic epithelial adhesion and migration [21]. The 
integrin-ECM interactions in the developing human pancreas was demonstrated by Cirulli et al. 
by showing that αvβ3 and αvβ5 integrins mediates adhesion and migration on ECM [21]. 
Epithelial αvβ5 and αvβ3 integrins interacted with fibronectin, collagen-IV, and especially 
vitronectin to both maintain extracellular matrix anchorage (αvβ5) and allow epithelial migration 
(αvβ3). The expression pattern of these three matrix components was suggestive of their role in 
the migration of endocrine progenitor cells out of ducts to form islets. The same group further 
transplanted human fetal pancreas treated with RGD-blocking peptide 27O, which lead to a 
preferential loss of insulin-positive cells, or their precursors – this supports the vital role of 
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extracellular matrix components in guiding cell migration during early stages of islet 
morphogenesis [22]. The significance of vitronectin in early islet development was also 
demonstrated when upregulation of vitronectin receptor, αvβ1, in fetal compared to that of mature 
β-cells was observed [23]. 
1.1.3 Extracellular matrix components in adult pancreas 
The matrix composition of mature pancreas could vary significantly from developing pancreas. 
For example, while laminin plays a central role during pancreatic development, laminin α1 was 
not detected extracellularly in the adult mouse pancreatic islets but found in the BM of acinar 
cells and duct epithelium [8]. Othonkoshi et al. [24] reported similar findings in human pancreas 
as well. Using antibodies specific for human laminin they showed that laminin α1 is not 
expressed in the adult human pancreas but other isoforms of laminin were detected: α2 is 
expressed only in the exocrine pancreas; α4 is expressed in the blood vessel BMs; α5 and β1 are 
expressed both in the endocrine and endothelial BMs in the islets. The other ECM protein 
reported to be most associated with adult pancreas is Collagen-IV, however fibronectin and 
Collagen-I, Collagen-III and Collagen-V and Collagen-VI have also been detected [9, 25]. In the 
endocrine “islet capsules”, the predominant ECM component are collagen types I, III, IV, 
laminin and fibronectin [25]. The laminin detected here have different isoforms than the one 
found in developing pancreas (laminin α1). Studies in mouse islets have indicated the pancreatic 
islet cells interact with laminin associated with the pervading microvasculature, specifically 
laminin-2, laminin-8, and laminin-10 [23, 26-29]. Immunolocalization for laminin-V in rat and 
human islets demonstrated heterogeneous intracellular staining according to islet cell type, with 
stronger labeling on non-beta cells than beta cells, and negative labeling on the endothelial cells 
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or their associated basement membranes [30, 31]. Quantitative evaluation of the peripheral 
matrix composition of human islets demonstrated that the prevalence of collagen-VI was 
significantly greater than that of Collagen-I or Collagen-IV [32].  
1.2 PANCREATIC DISORDER 
Due to the functional disparity between the exocrine and endocrine portion of the pancreas, 
pancreatic disorder is also specific to either exocrine or endocrine pancreas. The exocrine 
pancreas is the primary target of pancreatitis and pancreatic cancer while diabetes types I and II 
is caused by malfunction of the endocrine pancreas. 
1.2.1 Exocrine pancreas disorder 
1.2.1.1 Pancreatitis 
Pancreatitis is an inflammatory complication of the exocrine pancreas arising from early 
activation of the digestive enzymes produced by the exocrine pancreas before they exit into the 
duodenum. This results in the enzymes attacking the tissue of the pancreas itself.  Pancreatitis is 
classified into two forms: acute and chronic. Symptoms of acute pancreatitis appear rapidly and 
can generally be relieved with a few days of therapy. Causes include gallstones blocking the 
pancreatic duct, abdominal trauma, or infection. Complications can range from severe pain to 
systemic problems such as low BP, kidney failure, or hypoxia. Treatment of pancreatitis 
generally involves resting the pancreas through fasting and antibiotics, or surgery to remove 
gallstones. Chronic pancreatitis, on the other hand, does not heal quickly and worsens over time 
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causing permanent damage to the pancreas. Common causes of chronic pancreatitis include 
prolonged alcohol abuse, cystic fibrosis, or hypercalcemia. Complications include sever pain, 
weight loss, and calcification of the pancreas requiring surgical intervention. Chronic pancreatitis 
can also lead to permanent damage of the insulin producing Beta cells of the pancreas, possibly 
leading to diabetes [33]. 
1.2.1.2 Pancreatic cancer 
Pancreatic cancer, having a very high mortality rate, is the fourth leading cause of cancer death 
in the developed world.  Risk groups include age, smoking, and chronic pancreatitis.  The most 
common form of it is adenocarcinoma, which occurs in the exocrine portion of the pancreas [34]. 
While removal of the pancreas is a possible treatment, only 10% of diagnoses are discovered 
before the cancer has spread.  If surgery is an option, either part or the entire pancreas is removed 
in addition to portions of the surrounding organs.  While pharmacological treatment with 
gemcitabine has been used to increase quality of life and survival length, removal of part or 
whole of the pancreas is the only current option for cure making early detection key in the 
treatment of pancreatic cancer [35].   
1.2.2 Endocrine pancreas disorder 
The endocrine pancreas is composed of cluster of cells (islets of Langerhans) that are distributed 
throughout the exocrine pancreas. Insulin and glucagon, the two key hormones that orchestrate 
fuel storage and utilization, are produced by the islet cells in the endocrine pancreas. Diabetes 
mellitus is the most common disease associated with disordered secretion of hormones of the 
endocrine pancreas. It is a global disease with immense economic and social burden that affects 
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at least 285 million people worldwide [36]. It can be categorized into type 1 diabetes and type 2 
diabetes according to their mechanism of action, even though type 2 diabetes itself is a whole 
family of disorders caused by an array of different factors [37]. 
1.2.2.1 Type 1 diabetes 
Type 1 diabetes is a disease characterized by lack of insulin producing beta cells due to cell 
destruction via a person’s own autoimmune response [38]. While there are various proposed 
models explaining the mechanism by which the immune cells infiltrate the Islets of Langerhans 
and destroy beta cells, the important aspect for treatment is that an alternate source of insulin 
must be adopted to maintain blood glucose level [39]. Hyperglycemia resulting from a loss of 
beta cell functionality can lead to blindness, cardiovascular complications, and kidney failure if 
left untreated [38]. While patients with type 1 diabetes lose pancreatic endocrine functionality, 
the pancreas maintains its ability to function as an exocrine organ as part of the digestive system 
[40].  
1.2.2.2 Type 2 diabetes 
Type 2 diabetes differs from type 1 diabetes in that the pancreas does produce insulin; however 
either in insufficient amounts or the body has developed a resistance to its effects.  As a result 
hyperglycemia occurs with similar complications to type 1 diabetes if left untreated, although 
onset is more gradual [39]. Obesity is a major cause of type 2 diabetes, as fat interferes with the 
ability for insulin to be used properly; however other factors such as age, high blood pressure, 
and genetic history are also factors.   
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1.2.3 Current treatment 
The major implication of diabetes is the loss of endocrine function of the pancreas.  This results 
in a complete loss or severely diminished capacity to regulate blood glucose levels, which results 
in a variety of complications. For this reason, therapeutic approaches focus on restoring the 
body’s ability to produce and regulate blood glucose level either through artificial introduction of 
insulin into the blood stream or regeneration/ transplantation of insulin producing cells. 
The most prevalent pharmaceutical treatment for type 1 diabetes is to artificially 
introduce insulin to the blood stream. This approach involves careful monitoring of the blood 
glucose levels along with daily insulin injections [38]. Even with constant vigilance there is still 
a chance for hypoglycemic reactions leading to both minor and major complications [38]. Type 2 
Diabetes can be effectively contained by either oral medications or injectable antidiabetic agents. 
Most of the pharmaceutical drugs for diabetes targets to maintain the blood glucose level by 
either (i) controlling glucose secretion by liver into the blood stream (ii) priming the body to 
respond better to insulin and (iii) inducing the pancreas to secrete more insulin. However in 
extreme cases Type 2 diabetes patients may also require to take insulin injection.   
Alternate strategies for diabetes treatment include gene therapy, where islet like behavior 
is induced in non-islet cell types. The primary function of the pancreatic islet is to sense the 
glucose level in blood and secrete insulin in response to that. Hepatocytes of the liver have been 
a target of such therapy due to their already existing ability to sense changes in the blood glucose 
levels.  Results so far have been limited in scope with precise control of insulin production in 
phase with blood glucose levels being problematic [41, 42]. 
Transplantation of donor islets has received considerable attention as an avenue for 
restoring insulin production in diabetic patients. The major breakthrough in Islet transplantation 
  10 
came with the success of the Edmonton Protocol in 2000 [43], which established an effective 
immunosuppressive regiment. Ever since, Edmonton protocol has been adopted by many of the 
Islet transplantation clinics worldwide, however this procedure still requires a large supply of 
islets from donor pancreas. Currently the major roadblocks in cellular therapy for diabetes are 
the lack of sufficient quantities of donor tissue and the need for lifelong immunosuppressive 
therapy [38, 44]. There has been concentrated effort in addressing the issue of immune rejection 
by encapsulating donor islets in specific substrates designed to protect the donor islet from 
cellular immune attack while still allowing diffusion of insulin and glucose. Lack of sufficient 
donor islets has triggered investigation of alternate cell sources with the potential to generate 
fully functional pancreatic islet cells which can be transplanted to re-establish euglycemia in 
diabetic patients. 
Pancreas transplantation remains the gold standard for patients who suffer from type 1 
diabetes who do not respond to conventional therapy [45]. It involves implanting a healthy 
pancreas from a cadaveric donor into the diabetic patient. Since the pancreas is a dual-
functioning organ also participating in the digestion process, the recipient's native pancreas is 
usually left in place, and the donated pancreas is placed in the right lower part of the patient's 
abdomen. The majority of pancreas transplantation (>90%) involve simultaneous transplantation 
of pancreas-kidney [46]. This treatment option is however limited by the low availability of 
donor pancreas [45] and other complications such as thrombosis, pancreatitis, infection, bleeding 
and rejection. The development of bio-engineered tissues/organs by regenerative medicine and 
tissue engineering strategies has the potential to provide alternative treatment avenues [47]. 
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1.3 PANCREAS TISSUE ENGINEERING 
In the past decade, pancreatic tissue engineering efforts have focused on recreating the natural 
the islet ‘niche’ to restore the critical signal loss between native islet cells and their ECM 
environment following islet isolation. The objective is to improve islet graft survival post 
transplantation, and making it immunologically compatible with the recipient. 
Microencapsulation and the addition of natural matrix substitutes such as collagen IV and 
laminin have provided an immuno-privileged islet niche while permitting waste and nutrient 
diffusion and improved islet function [48, 49]. More recently, combinations of cells, biomaterials 
and biologically active molecule have been integrated in an attempt to generate bioengineered 
pancreas to ameliorate type 1 diabetes and achieve complete insulin independence [50-52]. Many 
important milestones have been met toward the goal of generating bioengineered pancreas. 
Potential cell candidates have been derived from allogeneic or xenogeneic islets [53], trans-
differentiation of adult cells [54] or differentiation of pluripotent stem cells into insulin-
producing cells [55-58]. The construction of biomaterial scaffolds includes fabrication of 
synthetic and native biomaterials with the goal to rebuild the necessary microstructure and 
extracellular cues for cell attachment, differentiation, function and vascularization to enable 
formation of human size pancreatic constructs [59, 60]. Lastly, the development of bioreactor has 
facilitated the transport of biological signals to support the in vitro assembly, culture and 
maturation of bioengineered pancreas into functional tissue constructs [61]. 
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1.3.1 Cells 
Identifying a reliable source of mature cells is critical for regenerative medicine and tissue 
engineering studies. Early pancreas tissue engineering studies focused on the use of primary 
islets and immortalized endocrine β cell lines for demonstration of proof-of-concept [49-51, 62].  
The use of human islets is limited by the scarcity of donor organs. While immortalized endocrine 
β cell lines are abundant, nevertheless they lack significant clinical application due to tumor 
formation concern as a result of gene transfection to immortalize the cells [63]. The production 
of a bioengineered pancreas from renewable cell source such as human pluripotent stem cells 
(hPSC), on the other hand, would be ideal due to their unlimited potential for self-renewal, 
expansion and differentiation. These cell types can be differentiated into any cell type including 
islet cells that respond to glucose stimulation and could function as beta-cell substitutes. Here we 
summarize some key findings of hPSC differentiation into pancreatic islet cells. 
1.3.1.1 Pancreatic differentiation from human embryonic stem cells (hESC) 
Human embryonic stem cells (hESC) are pluripotent cells derived from the inner cell mass of the 
blastocyst, approximately 4-5 days after fertilization [64]. More than a decade ago, the first 
documented attempt to product insulin+ cells from hESC was introduced by Lumelsky et al. [65] 
by following a protocol for neuronal differentiation, as the developmental pathways for the 
central nervous system and pancreas are similar. Since then, multiple groups [61, 66-68] 
including ours [69-71] have attempted to create cells that more closely resemble pancreatic β-cell 
development rather than insulin-positive neural-like cells. By recapitulating the early pancreatic 
developmental stage, step-wise in vitro differentiation protocols have successfully generated 
pancreatic progenitors and insulin-producing cells from hESC [57, 58, 67, 68, 72]. However, 
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overcoming the immunogenicity issue after allogeneic transplantation remains a major challenge 
for hESC to be an optimal cell candidate for clinical applications. 
1.3.1.2 Pancreatic differentiation from human induced pluripotent stem cells (hiPS) 
hiPS cells can be engineered from somatic cells by the ectopic expression of four transcription 
factors (OCT4, SOX2, KLF4, and c-MYC) [73]. Virtually indistinguishable from ES cells, hiPS 
cells can be propagated indefinitely as undifferentiated cells and differentiated into practically 
any cell type. hiPS derived from patient's somatic cells opened the possibility of generating 
autologous cells, thus eliminating immune rejection concern. In 2009, Maehr et al. demonstrated 
the reprogramming of human skin fibroblast into hiPS from type 1 diabetic patients [74]. In 
addition to providing an immunologically matched autologous cell population, patient-specific 
hiPS derived cells make possible patient-specific disease modeling wherein the initiation and 
progression of type 1 diabetes can be studied. Several other groups have since derived their own 
hiPS lines and differentiated into pancreatic lineage and its successful in vivo maturation into 
functional insulin producing cells [66, 75-77]. Success with in vitro maturation was challenging 
until recently. In 2014, two groups have reported the in vitro differentiation and maturation of 
hPSC (both hESC and hiPS) into insulin-producing cells [78, 79]. The resulting hiPS derived 
islet cells secreted insulin in response to glucose stimulation in vitro and upon transplantation 
could restore glucose homeostasis in diabetic mouse model [78, 79]. 
1.3.1.3 Other cell types 
There is reported evidence to produce insulin+ cells from cells that are developmentally close to 
β-cells. For instance, pancreatic acinar and ductal cells have been demonstrated to be potential 
cell populations that can be differentiated into β-cells [80-83]. Other attempts include the 
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feasibility of transdifferentiating common progenitors such as hepatocytes into pancreatic β-cells 
[84, 85]. To date, however, these cell populations have limited success in producing functional β-
cell that reverse hypoglycemia in vivo [86]. It is still an active area of research, and if successful, 
would offer viable cell source of pancreatic tissue engineering. Islets from nonhuman source 
such as porcine islets have been investigated as alternative cell types. Several preclinical trials 
using macro and microencapsulation of porcine islets demonstrated efficacy for several years 
without the need for immunosuppressant [87]. Nonetheless, porcine islet transplantation remains 
an experimental procedure due to limited long-term viability and the current need for immuno-
protection [88]. 
1.3.2 Biomaterial scaffolds 
Here we summarize various synthetic and natural biomaterial scaffolds have been used in 
pancreatic tissue engineering. The main objective in the use of biomaterial scaffold is twofold. 
The first is to provide structural support and restore the critical signal loss between native islet 
cells and their ECM environment following islet isolation. Secondly, it provides immune-
protection upon transplantation into host animal or patients. 
1.3.2.1 Synthetic materials 
Poly glycolic acid (PGA) is a highly biocompatible polymer which has a very low toxicity of 
byproducts when degraded. Rat islet cells cultured on PGA scaffolds modified with poly-l-lysine 
(PLL) exhibited both longer survival time and increased insulin production [89]. Self-assembling 
peptide nanofibers have been shown to increase both cell viability and function for rat islets 
when cultured in a 2D microenvironment [90], but cell viability and insulin secretion increased 
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further when cultured within a scaffold formed from self-assembling peptide nanofibers which 
demonstrates the preference of the islets for 3D culture configurations [91]. PLL induced 
aggregation of PDX1 transfected fetal hepatocytes showed matured islet functionality and 
glucose responsive insulin release within 24 hours of culture. Similar maturation could not be 
induced on parallel cultures on collagen [92]. Cells maintained on PLL also showed increase in 
NeuroD, Gck and Glut2 expression compared to collagen and tissue culture plastic [92]. These 
results were attributed to previous observations that PLL is able to activate insulin receptor 
kinase [93]. In addition to primary islets cells, rat pancreatic precursor cells have also been 
cultured on synthetic scaffold such as poly-ethylene-glycol (PEG) hydrogels. The dissociated rat 
pancreatic precursor cells were viable after 7 days of culture and showed an increase in insulin 
and MafA expression. In contrast, cells grown on 2-D plastic tissue culture plates were found to 
de-differentiate into mesenchymal phenotypes.  Even though mature markers were sustained, 
these cells did not demonstrate mature functionality of glucose responsive insulin release, 
suggesting incomplete maturation [94]. While PEG alone failed to mature the pancreatic 
precursor cells, collagen entrapped in PEG was found to induce such maturation in subsequent 
studies [95]. Similarly, additional media supplementation by adding gamma secretase inhibitor to 
the pancreatic progenitors cultured in PEG hydrogels also resulted in adequate maturation with 
glucose responsiveness [96]. Taken together, 3D tissue culture configuration is deemed best 
suited for islet maintenance and function. 
1.3.2.2 Natural materials and decellularized ECM 
Given the importance of scaffold design in islet function, there also has been a focused effort to 
investigate natural and purified ECM due to their closer resemblance to biological tissue 
microenvironment. Alginate is a chemically inert non-degradable natural polymer, and most 
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importantly it has the capability to immuno-isolate encapsulated cells. Due to its relatively high 
biocompatibility and gelation in the presence of a divalent cation it has been widely used for cell 
encapsulation. Lim and Sun in 1980 [97] first used an alginate complex to microencapsulate rat 
islets using syringe pump extrusion.  Islets were first encapsulated in spherical alginate beads 
and then coated in poly-l-lysine.  These encapsulated islets were found to be viable under culture 
conditions for up to 4 months, and transplantation into streptozotocin induced diabetic rats 
demonstrated an increase in islet viability and blood glucose level maintenance from 6 to 8 days 
to close to three weeks when compared to directly transplanted islets [97]. Other natural material 
such as rat-tail collagen I has been used to embed isolated human islets and was noted to hold 
their three dimensional spherical shape and maintained higher insulin producing capacity when 
compared to islets plated on cell culture treated plastic plates. In addition islets cultured on a 
collagen I 2-d layer regained spherical shape and insulin function when overlaid with an 
additional layer of collagen. In both the embedded and multilayer collagen I islet groups 
survivability and insulin production lasted more than 8 weeks, significantly longer than the 14 
days maximum survival of islets cultured on uncoated cell culture treated plastic dishes [98]. 
Most of natural material scaffolds, however, use a purified single ECM protein and do not mimic 
the intricacy of the pancreatic ECM composition and ultrastructure. Recently there has been a 
shift towards multiple-matrix systems of purified proteins, which have been shown to improve 
stem cell proliferation and differentiation [99, 100] and promote isolated islet and β-cell survival 
and function [48, 49]. Alternatively, natural ECM derived from decellularized tissues and organs 
can provide physiologically relevant scaffold that recapitulates the complex in vivo 
microenvironment. Decellularization techniques allow us to extract this complex native ECM, 
and have been successfully demonstrated in various cells, tissues and organs [101]. Prior studies 
  17 
have shown the positive effect of endothelial cell derived ECM for the enhancement of islet and 
β-cell attachment and proliferation [102, 103]. This is consistent with the previous finding from 
Nikolova et al. that demonstrated the vascular basement membrane is a niche for insulin gene 
expression and beta cell proliferation [27]. Other works have also shown improved islet 
functionality when cultured on decellularized matrices derived from small intestinal submucosa 
(SIS) [104, 105] and pancreatic slices [106, 107]. Decellularized pancreas work described by De 
Carlo et al. [106] and Mirmalek-Sani et al. [107] revealed the benefits of 2D decellularized 
pancreas slices to support and maintain islet functions. More recently, decellularized scaffolds 
have extended to more complex three-dimensional (3D) ECM scaffolds such as decellularized 
whole heart [108-110], lung [52, 111-114], liver [115-117], kidney [118], and pancreas from our 
group [50] based on a platform technology called perfusion-decellularization [119]. The 
reconstruction of 3D engineered tissue based of this technology relies heavily on perfusion 
bioreactor for adequate nutrient transport which will be demonstrated in the next section. 
1.3.3 Bioreactor 
The basic requirement of a bioreactor is to facilitate media transport into and from 3D tissues by 
providing dynamic culture. The objective is to maintain the desired nutrient and gas 
concentration in the engineered 3D tissue constructs. The main components of a bioreactor 
apparatus usually include a temperature controlled sterile chamber to hold the cells and/or 
tissues, a perfusate pump and membrane oxygenator to provide a continuous supply of gases 
(e.g. oxygen, nitrogen, carbon dioxide) and nutrients for cell survival and growth. When 
possible, the nutrient supply of bioreactors is connected directly to existing vasculature of the 
engineered tissues. For instance, nutrient supply for recellularized heart is provided via 
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retrograde media perfusion through the aorta [108, 120]. For recellularized lung, it is flown 
antegrade via pulmonary artery [121] using a perfusion bioreactor. These bioreactor 
configurations limit dead zones and promotes mixing, as determined by mathematical modeling 
and experimentation [122]. Recently, a commercially available bioreactor was reported for 
decellularization, named Organ Regenerative Control Acquisition (ORCA) bioreactor (Harvard 
Apparatus Regenerative Technologies, HART) [123]. This bioreactor was demonstrated to 
efficiently decellularize multiple intact organs and also amenable to support the culture of 
recellularized lungs. In addition, these systems could also be modified to control critical 
environmental conditions and provide stimuli (e.g. electrical stimulation for cardiac 
regeneration), as well as incorporate data monitoring systems to record/adjust variables, such as 
temperature, perfusion flow rate, pressure and oxygen tension [47, 124]. Furthermore, specific 
sensors could also be incorporated to monitor organ growth and ensure a controlled culture 
environment. Recently, Uzarski et al. reported the monitoring recellularized kidney and liver by 
sampling of physical and biochemical markers  such as hydrodynamic pressure and soluble 
biomarkers (e.g. albumin and kidney injury molecule-1) respectively [125]. To further customize 
these systems based upon need, custom-designed perfusates and artificial oxygen carriers can 
also be added [126].  
1.4 SPECIFIC AIMS 
The goal of this dissertation is develop a regenerative bioengineered pancreas for the treatment 
of diabetes. The central hypothesis is that decellularized organ scaffolds with preserved micro-
environmental niche will act as a favorable 3D bioscaffold for the synthesis of a regenerative 
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bio-engineered pancreas using human embryonic stem cells (hESCs). The realization of this goal 
requires success in three challenging processes: i) adequate decellularization of the whole organ 
to obtain 3D ECM scaffold, followed by ii) its recellularization with relevant cell types and iii) 
subsequent phenotypic maturation to reconstruct organ specific function. To understand the 
contribution of decellularized organs, it is also critical to evaluate the matrix-specificity and how 
it affects stem cell fate commitment. 
In the current dissertation, we will test our central hypothesis and address these critical 
challenges by pursuing the following SPECIFIC AIMS: 
1.4.1 Specific Aim 1: To decellularize a whole-organ pancreas and analyze the potential of 
the natural 3D scaffold to support pancreatic tissue engineering 
The objective of this aim is to generate a 3D bioscaffold from native pancreas and examine its 
potential to support pancreatic cell types. We achieved this by perfusion-decellularization of the 
whole pancreas, followed by a thorough characterization of the resulting bioscaffold. Upon 
recellularization, we evaluated its feasibility as a bioscaffold to support pancreatic tissue 
engineering. 
In Chapter 2, we detailed the generation of 3D bioscaffold supportive of pancreatic cell 
types; and evaluated the potential benefit of using native organ derived multi-faceted ECM 
scaffold over single protein derived ECM scaffold. This result demonstrated the proof-of-concept 
of using decellularized pancreas as a biocompatible scaffold for pancreatic tissue engineering. 
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1.4.2 Specific Aim 2: To repopulate the decellularized pancreas with hPSCs and mature 
into insulin-expressing cell in whole organ bioreactor culture 
The objective of this aim is to evaluate the feasibility of repopulating the native organ-derived 
scaffold with differentiating hPSCs and subsequent phenotypic maturation to reconstruct organ 
specific function in a bioreactor. This aim is spread across 2 chapters: Chapter 3 and Chapter 4. 
The organ reconstruction step is critically dependent on the engineering of a perfusion 
bioreactor system. In Chapter 3, we report the development and assembly of a perfusion 
bioreactor to enable regenerative reconstruction of pancreas. The assembled bioreactor is 
versatile enough to efficiently decellularize multiple organs, as demonstrated by complete 
decellularization of pancreas, liver and heart in the same set-up.  Further, the same system is 
amenable to support organ repopulation with diverse cell types such as MIN-6 β cells and 
differentiating hPSCs. The second part of this aim, in Chapter 4, we demonstrated the 
reconstruction of bio-engineered pancreas with both hPSC-derived PP cells and PP aggregates by 
using our in-house bioreactor system. The engraftment of these PP aggregates required a more 
extensive vascular support; hence we investigated the possibility of using an alternate, highly 
vascularized platform: decellularized liver, to allow reconstruction with PP aggregates and 
further maturation into mono-hormonal insulin expressing cells in a whole-organ bioreactor 
setting. 
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1.4.3 Specific Aim 3: To evaluate the matrix-specificity of organ-derived ECM in human 
embryonic stem cell differentiation 
The objective of this aim is to evaluate the matrix specificity of organ derived ECM and its effect 
in inducing pancreatic differentiation of human embryonic stem cells. Toward this end, in 
Chapter 5, we developed 2D and 3D ECM array from solubilized whole-organ ECM extracts of 
pancreas, liver and heart. This array system permits rapid evaluation of the matrix protein 
profiles of different organ-derived ECM, along with the sensitive measurement of the cell-ECM 
interaction both in 2D adherent cultures of hESC-PP cells as well as 3D non-adherent culture of 
hESC-PP aggregates.  
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2.0  PERFUSION-DECELLULARIZED PANCREAS AS A NATURAL THREE-
DIMENSIONAL SCAFFOLD FOR PANCREATIC TISSUE AND WHOLE ORGAN 
ENGINEERING 
2.1 INTRODUCTION 
In the first aim of this work, we investigate the development of a 3D native bioscaffold to 
support pancreas bioengineering. Our objective was to develop a bioscaffold that supports and 
enhances cellular function and tissue development. Perfusion-decellularized organs are a likely 
candidate for use in such scaffolds since they mimic compositional, architectural and 
biomechanical nature of a native organ. To this end, we investigate perfusion-decellularization of 
whole pancreas and the feasibility to recellularize the whole pancreas scaffold with pancreatic 
cell types.  
Three-dimensional (3D) scaffold plays a critical role in regenerative medicine and tissue 
engineering. For example, cell-scaffold interactions are important for the regulation of cellular 
behavior, including pancreatic islet-cell survival and insulin production through integrin-
mediated activation and downstream signaling events [127, 128]. Native tissues and organs are 
comprised of unique extracellular matrix (ECM) compositions, microstructures and 
biomechanical properties, which maintain distinct signals for resident cells [129, 130]. Ideally, a 
tissue engineered scaffold would provide the same or similar microenvironmental niche to the 
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seeded cells as that of a native ECM. Therefore, at present, the development of scaffolds for 
pancreatic tissue engineering have focused on recreating milieu similar to the native islet and 
surrounding ECM (summarized in review by Cheng et al. [62], Candiello et al. [131] and Tuch et 
al [132]).  
The novel concept of whole organ perfusion decellularization has been described recently 
to generate native ECM scaffolds from complex organs such as heart [108, 133-135], liver [116, 
117, 136, 137], lung [111-114, 121, 138], kidney [118, 139, 140] and more recently pancreas 
[52, 107, 141, 142]. Acellular matrices from whole organs provide an attractive scaffold for 
engineered tissue/organ because of the physiological resemblance with the original tissue, 
including intact 3D anatomical architecture, preserved spatial array of ECM components, 
vascular network, and biomechanical properties. These initial studies clearly motivate the need 
and indicate the potential benefits that can be attained by a whole organ 3D reconstruction of 
pancreas. The importance of 3D scaffold is well recognized for a better representation of the 
complex in vivo microenvironment and is important for proper regulation of cell behavior [143], 
yet recellularization of whole pancreas 3D scaffold remains to be demonstrated. We hypothesize 
that the optimal scaffold to support pancreatic tissue engineering may be the natural 3D ECM 
scaffold of the whole pancreas. To this effect, we propose that perfusion-decellularization of 
whole pancreas will yield an acellular scaffold suitable for pancreatic tissue and organ 
engineering. 
This chapter presents the feasibility of generating an acellular whole pancreas scaffold by 
a perfusion decellularization technique and utilizing this scaffold to support whole organ 
pancreas regeneration. Toward this end, we characterized the resultant native pancreatic ECM-
scaffold for preservation of ECM composition, 3D structural integrity, and biomechanical 
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properties. We then repopulated the decellularized pancreas with endocrine and exocrine cell 
types to demonstrate the feasibility of recellularization. Furthermore, the effects of pancreas 
derived ECM scaffold on modulating cell function such as insulin gene expression was 
determined. 
2.2 METHODS 
2.2.1 Mouse Pancreas Harvest and cannulation 
All animal work performed was in accordance with animal welfare act, institutional guidelines 
and approved by Institutional Animal Care and Use Committee of the University of Pittsburgh). 
Female ICR mice (Taconic), between the ages of 6-12 weeks were euthanized by CO2 inhalation 
followed by cervical dislocation. Sterile conditions were observed when removing the pancreas. 
A laparotomy was performed and a 24 G catheter was inserted approximately 1 cm into the 
anterior hepatic portal vein and sutured in place. The distal end of the superior mesenteric vein 
and large branches of splenic arteries and veins were carefully ligated to prevent leakage. The 
pancreas was then carefully dissected free from all adjacent structures including the stomach, 
intestine, spleen and mesenteric tissue.  
2.2.2 Perfusion Decellularization of Mouse Pancreas 
The isolated pancreas was connected to a perfusion system to allow retrograde perfusion at 
8ml/min, in which solutions flowed through the hepatic portal vein, into the splenic vein, and 
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throughout the vasculature of the pancreas. Next, ionic detergent, 0.5% SDS (Invitrogen) in 
deionized water was used as perfusate to rinse cells and cell debris out of the pancreas. After the 
tissues became translucent (about 325 min), subsequent steps of perfusion were 15 min of 
deionized water perfusion and 15 min of 1% Triton X-100 (Sigma Aldrich) in deionized water. A 
solution of benzonase (90U/ml, Sigma) was perfused for 15 min and a final washing step of 10% 
fetal bovine serum (FBS, Life Technologies) in PBS with Pen/Strep (100U/ml) perfused the 
pancreas for additional 48 hours to clear remaining cellular debris. 
2.2.3 Cell culture 
The AR42J acinar cell line (CRL-1492, ATCC, VA, USA) was used at passage 18-25. AR42J 
was cultured in F-12K medium (ATCC, VA, USA) supplemented with 20% FBS (Life 
Technologies) and 100 U/ml penicillin/streptomycin (Life Technologies) on T75 tissue culture 
flasks. The MIN-6 β-cell was used at passage 19-26. MIN-6 was cultured in Dulbecco’s 
modified Eagle’s medium (Life Technologies) supplemented with 15% FBS (Life Technologies) 
and 100 U/ml penicillin/streptomycin (Life Technologies) on T75 tissue culture flasks. Both cell 
types were cultured at 37°C and in a 95% air / 5% CO2 atmosphere. 
2.2.4 In vivo implantation of decellularized pancreas 
All animal work was approved by the Institutional Animal Care and Use Committee of the 
University of Pittsburgh. For preliminary biocompatibility studies, a 1 cm2 perfusion-
decellularized pancreas construct was surgically placed within a dorsal subcutaneous pocket of 
an adult mouse. Female C57BL/6 mice, age 6–8 weeks, were purchased from Jackson 
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Laboratories (Bar Harbor, ME). The mouse was anesthetized and maintained at a surgical plane 
of anesthesia with 1.5–2.5% isoﬂurane in oxygen and positioned in dorsal recumbency. The 
surgical site was prepared in sterile fashion by swabbing with 10% povidone-iodine solution 
followed by the placement of sterile drapes. For the subcutaneous surgical implantation: A 
central longitudinal incision measuring approximately 1.5 cm in length was made in the 
epidermis, dermis, and fascia to expose the underlying muscle tissue on the dorsal side. Dermal 
layers and underlying connective tissue was undermined to create a pocket with similar size to 
the implant construct. The decellularized pancreas construct was sutured to the underlying 
muscle with four non-absorbable marking sutures (3-0 prolene) and the skin was closed over the 
implant site in uninterrupted fashion. A minimal amount of suture material was placed only at 
the construct corners to avoid eliciting a host response to the suture that would obscure the host 
response to the implanted material. The incision was covered in betadine ointment after closure 
and assessed for signs of infection for 2 days post-surgery. The mouse received Buprenex 
(buprenorphine hydrochloride, 0.25 mg/kg) for analgesia, and Baytril (enroﬂoxacin, 20 mg) an 
antibiotic, for 3 days postoperatively. The animal survived the surgical procedure and its 
predetermined study period without complications. After 14 days the mouse was euthanized with 
5% isoﬂurane in oxygen followed by an intracardiac injection of potassium chloride to induce 
cardiac arrest. Following euthanasia the implant along with the surrounding skin and muscle 
were harvested and fixed in 10% NBF for histologic evaluation.   
2.2.5 Recellularization and culture of seeded-pancreatic construct 
MIN-6 cells (30x106) were trypsinized and diluted in 3mL of medium. The cell suspension was 
introduced into the decellularized pancreas by means of retrograde gravity perfusion via the 
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hepatic portal vein in 3 steps, 1mL each, with 20 min interval between each step. MIN-6 seeded 
pancreas was immersed and cultured in the same MIN-6 cell culture medium described above for 
5 days. For co-recellularization strategy, AR42J was used as the second cell type for the 
recellularization. Similarly, AR42J (30x106 cells) were trypsinized and diluted in 3mL of 
medium. The AR42J cell suspension was inoculated into the pancreas by retrograde perfusion 
through the pancreatic duct but the MIN-6 cells were introduced through the vasculature. The 
two cell types were seeded in sequence, with the same multi-step repopulation mentioned for 
single-cell type seeding. Cells were allowed to attach for 2 hours before introducing a gentle 
rinse through both the hepatic portal vein and pancreatic duct in order to wash out any 
unattached cells. The cell-seeded pancreatic construct was left undisturbed and submerged in co-
recell culture medium (DMEM/F12 supplemented with 15% FBS and 100 U/ml Pen/Strep). Both 
cannulation to the portal vein and pancreatic duct were kept intact to allow perfusion feeding of 
media every day. The seeded pancreas was cultured under static conditions at 37°C with a 95% 
air / 5% CO2 atmosphere for 5 days. 
2.2.6 MIN-6 seeded on different ECM substrates and 2D thin slices of Decellularized 
Pancreas 
Growth factor-reduced Matrigel (BD) was used as a thin coating according to 
manufacturer’s instruction. Collagen IV (BD) and fibronectin (Milipore) were used at a 
concentration of 5 mg/ml. These ECM substrates were used for coating non-tissue culture-treated 
12-well plates (BD). Collagen type I (BD) was used as 5 mm thick gels. Coated and untreated 
(UT) plates were blocked with 1% BSA (Sigma). Control culture was conducted on UT plates 
blocked with 1% BSA (Sigma). To prepare thin decellularized pancreata slices, decellularized 
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pancreata were filled with 1.1% alginate solution, and submerged in 100mM Calcium Chloride 
solution to crosslink the alginate. The solidified pancreas was sliced with a tissue slicer (Thomas 
Scientific) to yield thin, uniform, transverse sections. The alginate within the thin slices of 
pancreas were dissolved in a sterile dissolution buffer consisting of 50 mM tri-sodium citrate 
dihydrate (Sigma), 77 mM sodium chloride (VWR International, Leicestershire, UK), and 10 
mM HEPES (Sigma) in PBS for 15–20 min while stirring gently at room temperature.  Finally, 
the thin slices of pancreas were rinsed and covered with sterile PBS with Pen/Strep (100U/ml), 
and placed at 4°C until use. Cloning cylinder (Fisher) was applied and sealed with sterile silicone 
grease (Dow Corning) to the pancreatic slice to consolidate the seeded cells only to the 
pancreatic slice. MIN-6 cells (25,000 cells/cm2) were cultured on these various different ECM 
substrates for 5 days before harvest for qPCR analysis. 
2.2.7 Two-photon Microscopy 
Two-photon microscopy was performed with an upright Olympus FV1000 MPE multi-photon 
microscope (Olympus, Central Valley, PA, USA) and a Mai Tai DeepSee femtosecond-pulsed 
laser (Spectra-Physics, Santa Clara, CA, USA) tuned at 800 nm. The pancreatic slice was line-
scanned and fluorescence emission was captured by three non-descanned external 
photomultiplier tube (PMT) detectors coupled to the following long-pass dichroic mirrors and 
band pass emission filters: 505 nm mirror and 460–500 nm filter (blue channel), 570 nm mirror 
and 520–560 nm filter (green channel) and 575–630 nm filter (red channel). The pancreatic slice 
was placed on an imaging dish having a #1.5 coverslip and immersed in PBS. Fixed xy planes 
spanning 505 × 375 μm at a resolution of 0.994 μm/pixel and depth of 1–50 μm from the surface 
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of scaffold were imaged using a high numerical aperture (NA = 1.05), water-immersion 25X 
objective. 
2.2.8 Immunohistochemistry (IHC) 
Native, decellularized and recellularized pancreas were fixed, sectioned and stained following 
protocol previously described[144]. Briefly, tissue samples were fixed with 4% formaldehyde 
(ThermoFisher), cryoprotected with 30% sucrose and cut into 7 µm thick sections. For 
immunostaining, the following primary antibodies were used: rabbit anti-laminin, rabbit anti-
collagen I, rabbit anti-collagen IV, rabbit anti-fibronectin (Abcam, 1:200), rabbit anti-Cpeptide 
(Cell signaling, 1:100) and rabbit anti-α-Amylase (Sigma Aldrich, 1:200). Secondary antibodies 
used were: donkey anti-rabbit Alexafluor 488 (1:500, Invitrogen) and donkey anti-rabbit 
Alexafluor 555 (1:500, Invitrogen). For co-labeling using antibodies from the same host species, 
sequential staining was conducted. After the first primary antibody staining, an additional 
blocking step was included prior to the addition of a second primary antibody. For actin staining, 
phalloidin rhodamine (Cytoskeleton, 1:200) was implemented and stained for 30 min in the dark. 
The slides were washed again three times with 1x PBS (5-10 min) each before being mounted 
with ProLong® Gold Anti-fade Reagent with DAPI (Invitrogen). Images were recorded with 
Metamorph 7.5.6.0 (Molecular Device) on an Olympus IX81 inverted microscope (Olympus, 
Central Valley, PA, USA). 
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2.2.9 ECM Digestion and Proteomics Analysis 
The ECM pellet was digested for 2h with each of the following enzymes: 0.15 mU/µl heparan 
sulfate lyase and chondroitin ABC lyase from Flavobacterium heparinum and Proteus vulgaris, 
respectively (Seikagaku Corporation, Japan) and washed in PBS. The ECM proteins were 
dissolved in 8M urea and 1x reducing SDS sample buffer. The proteins from the ECM 
preparation were separated on 3.5-15% gradient SDS PAGE under reducing conditions [145]. 
The gel lane was divided into 11 slices and taken through a typical in-gel digestion procedure. 
Briefly, gel bands were destained, reduced with 2.5mM tris (2-carboxyethyl) phosphine and 
alkylated with 3.75mM iodoacetamide, followed by in-gel digestion with 13ng/µl of trypsin 
(Promega) overnight at 370C. Peptide digests were analyzed by nano Liquid Chromatography-
tandem mass spectrometry (LC-MS/MS), on a Thermo Fisher LTQ OrbitrapVelos connected to a 
Waters Acquity UPLC system (Waters Corp., Milford, MA), using a 90 minute gradient. Protein 
identification was performed with Proteome Discoverer 1.3 using the Sequest search engine. 
Database searches used the Uniprot complete mouse database (downloaded in December 2012 
merged with a contaminant database from ABSciex, 50838 sequences, 24435643 residues). 
Settings were for a full trypsin digest, with two missed cleavages, one static modification 
(cysteine carbamidomethylation), two dynamic modifications (oxidized methionines and 
hydroxyproline), mass tolerance of 10 ppm for precursor mass and 0.5 Da for fragment masses.  
Percolator, a post-processing software using a target/decoy database approach, was used to 
evaluate the accuracy of peptide identifications. Peptide identifications were filtered with a q-
value cutoff of 0.01 (1% global False Discovery Rate, FDR). Proteins were grouped using the 
maximum parsimony principle and this list was imported to ProteinCenter (Thermo) and 
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compared with the IPI mouse database for statistical analysis to identify over-represented Gene 
Ontology terms and functional classification. 
2.2.10 DNA Quantification 
The decellularized pancreata (n=3) were digested with papain solution at 60°C for 6 h. The 
native pancreata (n=3) were digested in papain solution as controls. Papain (Sigma Aldrich) was 
dissolved at 400 mg/ml in 0.1 M phosphate buffer (pH 6.0), with 5 mM cysteine hydrochloride 
(Sigma Aldrich), and 5 mM EDTA (Sigma Aldrich). The lysates were used for detection of the 
DNA and sulfated glycosaminoglycan (sGAG) content. A DNA quantification kit - Quant-iT™ 
PicoGreen® dsDNA Assay kit (Invitrogen) was used to measure DNA content according to 
manufacturer’s instruction. The fluorescence reading (excitation: 485 nm and emission: 528 nm) 
was taken on a plate reader (Synergy 2, Biotek), and the absolute amount of DNA (ng/mL) was 
quantified against a lambda DNA standard curve (0 ng/mL- 1000 ng/mL). 
2.2.11 sGAG content characterization 
For qualitative determination of presence of GAG, Alcian Blue staining was done according to 
manufacturer’s instruction (Newcomer Supply). Briefly, slides were deparaffinized and hydrated 
through graded ethyl alcohols to distilled water. Next, slides were placed in 3% acetic acid for 3 
min and then directly into 1% Alcian Blue solution pH 2.5 and stained for 30 min in room 
temperature. The slides were washed in running tap water for 10 min followed by a distilled 
water rinse. The counterstaining was done in Nuclear Fast Red stain for 5 min before rinsing, 
dehydrated through graded ethyl alcohol and cleared in xylene. The slides were mounted with 
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xylene mounting medium. For qualitative measure of sGAG, the method to produce lysate for 
DNA quantification was used here as well. A sGAG quantification kit –Blyscan Sulfated 
Glycoaminoglycan Assay kit (Biocolor) was used to measure sGAG according to manufacturer’s 
instruction. Briefly, the specimen lysate was mixed with Blyscan dye to bind the GAG. The 
GAG-dye complex was then collected by centrifugation. After the supernatant was removed and 
the tube drained, the dissociation reagent was added. 100 µl solutions were transferred into a 96-
well plate. Absorbance against the background control was obtained at a wavelength of 656 nm 
on a microplate spectrophotometer and the GAG amount was calculated based on a standard 
curve obtained with the standard GAG supplied with the kit. 
2.2.12 Scanning Electron Microscopy (SEM) and Transmission Electron Microscopy 
(TEM) 
Native and decellularized pancreata were fixed in 2.5% glutaraldehyde in 0.1 M PBS (pH 7.4) 
for 60 minutes. The samples were washed thoroughly in 3 changes 0.1 M PBS for 15 minutes 
each. Next, the samples were fixed in 1% OsO4 in 0.1 M PBS for 60 minutes. This was followed 
by another 3 changes of PBS washing steps for 15 minutes each. The samples were then 
dehydrated in gradient series of alcohol for 15 min each. Additionally, samples were critical 
point dried and coated with Au/Pd using a Cressington Coater 108A sputter coater. Electron 
microscope images were taken using a Jeol JSM-6335F field emission SEM. For TEM, the tissue 
sample was fixed in 2.5% glutaraldehyde in PBS. The tissue sample was then post-fixed in 1% 
osmium tetroxide in PBS, dehydrated through a graded series of alcohols and embedded in Epon 
(Energy Beam Sciences, Agawam, MA). Thin (60-nm) sections were cut using a Reichert 
Ultracut S (Leica, Deerborn, MI), mounted on 200 mesh copper grids and counterstained with 
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2% aqueous uranyl acetate for 7 min and 1% aqueous lead citrate for 2 min. Observation was 
with a JEOL 1011 transmission electron microscope (Peabody, MA) 
 
2.2.13 Preparation of Pancreatic Tissue for Atomic Force Microscopy (AFM) 
Measurement 
Both native and decellularized unfixed samples from murine pancreas were cryoprotected by 
soaking in 30% sucrose solution in PBS for 24 hours.  The entire murine pancreas was then set in 
a mold and covered in OCT cold embedding media and frozen by exposure to dry ice overnight.  
The OCT block containing the pancreas was cryosectioned to a thickness of 20 microns and 
mounted on SuperFrostPlus glass slides.  All samples were thawed in PBS for 30 minutes prior 
to testing. 
2.2.14 AFM Measurement of Pancreatic Tissue Stiffness 
AFM force indentation measurements were performed using the MFP-3D Atomic Force 
Microscope (Asylum Research, CA, USA), mounted on top of an Olympus IX-71 fluorescence 
microscope (Olympus, Tokyo, Japan).  All force measurements and analysis was done using the 
MFP3D software (Asylum Research) built on IgorPro 6 (Wavemetrics) as previously described 
[146].  For all measurements a glass silica sphere (radius 3.5 micron) was attached to the tip of a 
100 micron silicon nitride cantilever (Veeco Systems) with a spring constant of ~0.6 N/m. The 
stiffness of each tissue sample was measured at n= 16 random locations on each sample. The 
Sneddon model was used to determine the tissue stiffness from the force indentation plots. 
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2.2.15 Quantitative RT-PCR 
RNA was extracted using NucleoSpin kit according to the manufacturer’s protocol. The sample 
absorbance at 280 nm and 260 nm was measured using a BioRad Smart Spec spectrophotometer 
to obtain RNA concentration and quality. Reverse transcription was performed using ImProm II 
Promega reverse transcription kit following the manufacturer’s recommendation. qRT-PCR 
analysis was performed for insulin markers, ins1 and ins2. 
The cycle number at the threshold level of log-based fluorescence is defined as Ct 
number, which is the observed value in most real-time PCR experiments, and therefore the 
primary statistical metric of interest. ΔCt is equal to the difference in threshold cycle for target 
and reference or control (ΔCt = Cttarget−Ctreference). ΔΔCt is equal to the difference between 
ΔCtsample and ΔCtcontrol (ΔΔCt = ΔCtsample−ΔCtcontrol). The fold change of a target gene is defined 
by, fold change = 2-∆∆Ct. qRT-PCR analysis was repeated in triplicate. 
2.2.16 Statistical Analysis 
Quantification data were expressed as mean ± SD. Significant differences among groups were 
determined by Wilcoxon rank-sum test for two-group comparisons or ANOVA followed by post-
hoc analysis for multiple group comparisons. Probability values at P < 0.05 (*) indicated 
statistical significance. 
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2.3 RESULTS 
2.3.1 Perfusion-decellularization of whole organ pancreas  
Isolated mouse pancreata were cannulated and retrograde perfused via hepatic portal vein with 
anionic based detergent, 0.5% SDS to remove cellular content. Alternately, retrograde perfusion 
via pancreatic duct was also attempted for pancreas decellularization, however the process took 
longer and was also less effective in cell removal (data not shown). Macroscopically, a gradual 
change of color was observed during the perfusion decellularization process (Figure 2.1 (A-D)). 
Perfusion was continued until whole pancreas turned completely translucent (about 325 min) as 
depicted in Figure 2.1(D). This generated an acellular pancreas scaffold while retaining the gross 
anatomical structure of the pancreas. Histological examination by H&E staining showed no 
remnant cells after the completion of decellularization (Figure 2.1(E)).Immunostaining of two 
major constituents in native pancreas – acinar cells (Amylase) and islet β-cells (C-peptide) 
confirmed no residual presence of major pancreatic markers in the decellularized pancreas (Fig. 
1F). To further assess the efficacy of decellularization, DNA quantification was performed using 
Picogreen assay. Picogreen analysis showed that DNA content decreased from 7442.3 ± 2450.2 
ng/mg dry weight in normal pancreas to 41.3 ± 11.9 ng/mg dry weight in decellularized pancreas 
(P < 0.01) (Figure 2.1(G)). These results suggest that perfusion mediated decellularization of 
pancreas efficiently removes pancreatic cellular components. Feasibility of this perfusion 
decellularization technique in human-sized organ was also demonstrated by decellularization of 
bovine pancreas (Figure A.1).  
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Figure 2.1 Perfusion-decellularization of murine pancreas 
(A-D) Panel images depict gradual change of color from perfusion-decellularization of mouse pancreas 
with 0.5% SDS. Resulting decellularized pancreas after 325 min (D) appeared translucent. (E) Histological 
comparison of native and decellularized pancreas by H&E staining showed removal of cells. (F) IHC evaluation of 
native and decellularized pancreas depict presence of major pancreatic constituents  (C-peptide – red, and Amylase – 
green) in native pancreas (left) but absence in decellularized pancreas (right). (G) DNA quantification via picogreen 
analysis demonstrated less than 50ng/mg dry weight of DNA material present in the decellularized pancreas. 
 
  37 
2.3.2 ECM characterization: Immunohistochemistry and Mass spectrometry-based 
proteomics analysis 
To first characterize the decellularized pancreas, immunohistochemical (IHC) staining was 
performed for the evaluation of major ECM components’ spatial presence relative to that of 
native pancreas. In native pancreas, the ECM is composed primarily of networks of collagens 
and other structural proteins filled with a hydrogel of proteoglycans [9, 25]. IHC staining showed 
that collagen I, IV, fibronectin and laminin were detected in the native pancreas (Figure 2.2(A)).  
After decellularization, all four major ECM components were preserved, without any detectable 
DAPI or actin staining (Figure 2.2(B)). This finding suggests complete removal of cellular and 
cytoskeletal elements while maintaining the ECM composition. In addition, the resulting ECM 
structure and fibril orientation looked identical to that of the native organ (Figure 2.2(B)). The 
preservation of sulfated glycosaminoglycan (sGAG) proteins was evaluated qualitatively by 
alcian blue staining (Figure 2.2(C)), which demonstrated that sGAG proteins were retained after 
decellularization process. In addition, sGAG content was also assessed quantitatively using a 
blyscan assay which demonstrated considerable retention of sGAG content in the decellularized 
pancreas, amounting to 52% of that in native pancreas (P<0.01) (Figure 2.2(D)). 
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Figure 2.2 ECM characterization of decellularized pancreas 
(A) IHC staining showed the presence of major ECM composition – Col I, Col IV, Fibronectin, laminin 
and phalloidin actin staining (green) in native pancreas. (B) Comparison with decellularized pancreas, IHC staining 
demonstrated the corresponding ECM markers found in native pancreas also preserved in decellularized markers but 
DAPI and actin cytoskeletal element were absent. This indicates complete removal of cellular materials but 
preservation of important ECM proteins. (C) Alcian blue staining qualitatively determined the retention of sGAG 
protein after decellularization. (D) Blyscan assays quantitatively determined the sGAG retention in decellularized 
pancreas was on average 52% of that in native pancreas (P<0.05). 
 
Insolubility of the ECM is a challenge to characterizing the pancreatic ECM proteome by 
mass spectrometry-based proteomics. In order to improve solubility, pancreatic ECM was 
deglycosylated to remove GAG side chains of proteoglycans followed by solubilization in high 
molar urea. A GeLC-MS/MS proteomics approach was used whereby the high molecular weight 
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ECM proteins were separated by low percentage 1D gels, in-gel trypsin digested followed by 
LC-MS/MS analysis. Database searching used stringent 1% false discovery rate to report protein 
identifications. After protein grouping, a total of 114 unique proteins were identified in the 
pancreatic ECM (Supplemental table 1), the majority of which belonged to the ECM family 
based on Gene Ontology (GO) Cellular localization. The entire list of identified proteins was 
compared with the reference IPI mouse database to identify overrepresented GO cellular 
localization terms. The topmost GO terms included ECM and basement membrane (data not 
shown), suggesting that the decellularization process successfully removes cellular proteins yet 
preserves the ECM components. Table 2.1 is a categorized list of collagens, laminins, 
proteoglycans and ECM associated proteins.  
 
Table 2.1 Mass Spectrometry Composition Analysis 
Protein Family Gene Description 
Collagens Col6a3 Collagen alpha-3(VI) chain 
 Col1a2 Collagen alpha-2(I) chain 
 Col4a2 Collagen alpha-2(IV) chain 
 Col4a1 Collagen alpha-1(IV) chain 
 Col1a1 Collagen alpha-1(I) chain 
 Col5a2 Collagen alpha-2(V) 
 Col6a2 Collagen alpha-2(VI) 
 Col6a1 Collagen alpha-1(VI)  
 Col5a1  Collagen alpha-1(V) chain 
 Col3a1 Collagen alpha-1(III) 
 Col14a1 Collagen alpha-1(XIV) chain 
 Col6a6 Collagen alpha-6(VI) chain 
 Col5a3 Procollagen, type V, alpha 3 
 Col7a1 Col7a1 Collagen alpha-1(VII) chain 
 Gm7455  Collagen alpha-5(VI) chain 
 Col4a3  Collagen alpha-3(IV) chain 
 Col18a1 Collagen alpha-1(XVIII) chain 
Laminin Lamb2 Laminin subunit beta-2  
 Lamc1 Laminin subunit gamma-1 
 Lama2 Laminin subunit alpha-2 
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Table 2.1 (continued) 
 Lama5 Laminin subunit alpha-5 
 Lamb1  Laminin subunit beta-1 
 Lama1 Laminin subunit alpha-1 
 Lama4  Laminin subunit alpha-4 
Proteoglycans Hspg2 Basement membrane-specific heparan sulfate proteoglycan 
core protein 
 Agrn Agrin 
Nidogens Nid1  Nidogen-1 
 Nid2  Nidogen-2 
Elastin associated Fbn1 Fibrillin-1 
Matricellular Tnxb Tenascin-X 
 
2.3.3 Biophysical Characterization: structural and mechanical properties of 
decellularized pancreas 
Integrity of the vasculature within the decellularized pancreas was analyzed by trypan blue dye 
retrograde injection through hepatic portal vein to visualize the continuity of the circulatory 
branching (Figure 2.3(A)). Rapid diffusion through the vascular tree was also observed (Figure 
2.3(A)). Transmission electron microscopy (TEM) and scanning electron microscopy (SEM) 
were performed to evaluate the effect of the decellularization procedure on the 3D architecture 
and ECM micro-structures of the decellularized pancreas. TEM analysis revealed intact 
basement membrane and organized fibers of collagen preserved upon decellularization (Figure 
2.3(B-C)). SEM analysis of the cross-sectional images of the decellularized pancreatic constructs 
revealed that large ductal structures were retained whereas the microvilli cells lining the ducts 
were removed (Figure 2.3(D-E)). Nanofibrous structures of the ECM were well retained within 
the parenchyma (Figure 2.3(F-G)). Hollow and void spaces observed within the decellularized 
pancreas are likely attributes of the “footprints” left from pancreatic cells removed during the 
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decellularization process (Figure 2.3(H)). The recognizable scalloping pattern of arteries also 
indicates the preservation of vascular structure likely branched from the greater pancreatic artery 
(Figure 2.3(I)). These results suggest that perfusion decellularization of the pancreas adequately 
retained the ultrastructure and architecture of the native pancreas. 
 
Figure 2.3 Ultrastructural characterization of decellularized pancreas 
(A) Trypan blue dye infusion visualized the progressive flow from large vessels to the fine blood vessel 
branches along the channels without leakage. Inset shows light microscopy image of vasculature branches remained 
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intact after decellularization. (B) TEM of decellularized pancreas depicted the intact basement membrane 
(arrowhead points to the underlying basement membrane). (C) TEM image of decellularized pancreas showed the 
interstitial space with organized fibers of collagen (arrowhead). (D-E) SEM comparison of native and decellularized 
pancreas demonstrated preservation of 3D micro-structure of pancreatic duct after decellularization. Inset shows the 
absence of lining ciliated microvilli cells from the luminal surface of the duct after decellularization process. (F) 
SEM image of decellularized pancreas showed ECM fibers within the parenchymal space. (G) Higher magnification 
of 3D meshwork showed a variety of fibers - large bundle of Type I collagen (black arrowhead) associated with a 
variety of smaller fibers (white arrowhead). (H) SEM image of decellularized pancreas demonstrated large/small 
fibers interlinked in a plane that forms a boundary such as to previously occupied pancreatic parenchymal cells. (I) 
SEM image of decellularized pancreas demonstrated scalloping appearance of the internal elastic lamina of an 
artery, indicating intact blood vessel (BV). 
 
Biomechanical characteristics of the decellularized pancreas were analyzed using AFM. 
Representative cantilever displacement/sample deflection curves (Figure 2.4(A)) shows that 
there was a discernible difference between the native and decellularized pancreas, with the stiffer 
decellularized sample having a much steeper slope. Young’s modulus as determined from the 
AFM curves was found to be 1210±77 Pa for native mouse pancreas, while the Young’s modulus 
of decellularized pancreas is on average 3 times greater (3736±1893 Pa) (Figure 2.4(B)). 
 
Figure 2.4 Biomechanical properties of decellularization pancreas 
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(A) Representative deflection plot from AFM evaluation of native and decellularized pancreas shows a 
steeper slope than force curve of decellularized pancreas from native pancreas, indicating higher Young’s modulus. 
(B) Bar graph representatives of AFM force curve shows on average 3 times higher stiffness in the decellularized 
pancreas than native pancreas. 
2.3.4 In vivo response to decellularized pancreas 
Pancreas ECM was implanted subcutaneously in order to preliminarily evaluate in vivo 
biocompatibility in a mouse model. At 14 days post-surgery, histological analysis of the 
subcutaneous implantation site showed the presence of mononuclear cells surrounding the 
partially degraded ECM (Figure 2.5(A)) The pancreas ECM was non-cytotoxic after 14 days and 
like other efficiently decellularized ECM scaffolds [147, 148], was not associated with presence 
of multinucleate foreign body giant cells or other pathological signs of the foreign body response 
(Figure 2.5(B)). Furthermore, active angiogenesis was a feature of the decellularized pancreas 
implantation site (Figure 2.5(B), arrows). These preliminary results suggest that the perfusion-
decellularized pancreas ECM described herein represents a cytocompatible scaffold capable of 
integrating within host tissue. 
 
Figure 2.5 Biocompatibility of perfusion-decellularized pancreas ECM 
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A perfusion-decellularized pancreas ECM construct was surgically implanted within a subcutaneous pocket 
in a C57Bl/6 mouse model. After 14 days Mason’s trichrome staining of the implant site (A) showed the ECM 
scaffold (#) infiltrated with host mononuclear cells. H&E staining (B) showed no signs of multinucleate giant cells 
and the presence of blood vessel (arrows). (Scale bars = 50um, inset = low power magnification, inset scale bar = 
200um) 
2.3.5 Recellularization of Decellularized Pancreatic Scaffold 
To evaluate the potential of decellularized pancreas as a scaffold for pancreatic tissue 
engineering, it was recellularized using relevant pancreatic cell lines. We first explored the effect 
of two dimensional (2D) slices of decellularized pancreatic matrix as a substrate for cell culture 
(Figure 2.6(A)). Decellularized pancreatic matrix was cut into slices of about 10-20 µm 
thickness, as evaluated by multi-photon microscopy (Figure 2.6(B)). MIN-6 cells (25,000 
cells/cm2) were seeded on the 2D slice and cultured for 5 days.  After 5 days, MIN-6 cells were 
found attached and spread on the surface of 2D slice (Figure 2.6(C)). 
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Figure 2.6 MIN-6 culture on 2D slice pancreatic matrix 
(A) Diagram illustrates the generation of 2D pancreatic slice. White dashed circle depict the cloning 
cylinder applied to pancreatic slice to consolidate seeded cells to pancreatic substrate. (B) Multi-photon imaging on 
second harmonic generation (SHG) signal to visualize the collagen fibers demonstrated that thickness of the 2D slice 
pancreatic matrix is about 10-20 µm. (C) H&E staining demonstrated the attachment of MIN-6 cells on 2D 
pancreatic slice after 5 days of culture, and insulin expression (C-peptide: green) was maintained. 
 
To evaluate whole organ recellularization potential, endocrine β cell line, MIN-6 cells 
(30x106) were first seeded into the decellularized pancreas via hepatic portal vein by multistep 
infusion technique following the seeding strategy described for liver recellularization [117, 136]. 
Approximately 10x106 cells were introduced at each step, for a total of 3 steps, with 20-min 
intervals between each step. Upon cell seeding, a uniform color change was observed throughout 
the whole decellularized pancreas, indicating a homogenous cell delivery (Figure 2.7(A-B)). The 
repopulated pancreas was then maintained in static culture for 5 days with culture media changed 
by perfusion through the pancreas every day. After 5 days, the reconstructed pancreas was 
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analyzed for engraftment, survival and functionality by IHC. From the histology, MIN-6 cells 
appeared to be engrafted both surrounding the parenchymal region and around the larger vessels 
(Figure 2.7(C)). TUNEL staining detected only minimal apoptosis (<18%), suggesting that the 
3D decellularized pancreas scaffold is cytocompatible and supportive of cell growth (Figure 
2.7(D)). Furthermore, these engrafted cells maintained their insulin expression over 5 days as 
evidenced by positive C-peptide staining (Figure 2.7(F)).  
 
Figure 2.7 Recellularization of decellularized pancreas 
(A) Decellularized whole pancreas before cell seeding. (B) Recellularization of the same pancreas via 
multi-step infusion of about 30 million cells via portal vein infusion. (C) H&E staining of the recellularized pancreas 
after 5 days showed the engraftment of the seeded cells at surrounding parenchymal region. (D) TUNEL staining of 
the recellularized construct showed less than 18% of apoptotic cells (arrowhead), demonstrating the 
cytocompatibility of the scaffold. (E) Positive control of TUNEL staining by adding DNAse to the consecutive 
sections of recellularized pancreas’s histological slide. (F) IHC of recellularized pancreas with MIN-6 only showed 
C-peptide+ cells engraftment around the larger vessel (arrowhead). 
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The native pancreas is a dual-functioning glandular organ comprised and capable of both 
endocrine and exocrine tissue and function, to this end, next the decellularized pancreas was 
reconstructed with both the endocrine β cell line (MIN-6) and exocrine acinar cell line (AR42J) 
by simultaneous seeding. The β cells were perfused through the hepatic portal vein as before, 
while the acinar cells were perfused through the pancreatic duct (Figure 2.8(A)). The two cell 
types were seeded in sequence, with the hepatic duct perfusion of the MIN6 cells preceding the 
pancreatic duct perfusion of acinar AR42J cells. This seeding strategy attempts to retain the 
cellular composition of native pancreas and the anatomical proximity of the cells to different 
secretory locations: (i.e.; endocrine β cells – vasculature; exocrine acinar cells – ductal system). 
As before, the dual cell-seeded pancreas constructs was maintained for up to 5 days in static 
culture. At day 5, IHC analysis showed that both cell types attached and localized to their 
specific topographical locations as a result of their different cell seeding route (Figure 2.8(B)). 
Immunofluorescence staining confirmed the expression of C-peptide, as an analogue of insulin 
marker identifying endocrine β-cells and amylase as a digestive enzyme identifying exocrine 
acinar-cells (Figure 2.8(B-C)). Most C-peptide+ cells were localized to the luminal spaces of 
large vessels and parenchymal regions similar to that observed in single cell reconstructed 
pancreas. Distinct from the localization of C-peptide+ cells, tubular ductal spaces lined with 
acinar cells expressing amylase were observed (Figure 2.8(C)). No inter-dispersed population of 
the two cell types were observed within the engraftment region, suggesting the preservation of 
the distinct architecture of vasculature and ductal structure (Figure 2.8(C)). These results indicate 
that the decellularized pancreas is capable of supporting multiple pancreatic cell types and this 
co-seeding strategy allows the reconstitution of major cellular constituents as in the native 
pancreas. 
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Figure 2.8 Dual recellularization strategy with β- and acinar cell types 
(A) Two different cell types (MIN-6 and AR42J) were inoculated into the decellularized pancreas 3D 
scaffold utilizing two different seeding routes. (B) IHC of recellularization with both MIN-6 and AR42J cell lines 
showed engraftment of both cell types. Both cell types maintained their respective functional markers – MIN-6 
(Cpeptide – green) and AR42J (Amylase – red). (C) Vasculature and pancreatic duct situated next to each other with 
their respective seeded different population of cells (vasculature-MIN6 and duct-AR42J). Inset shows single channel 
images. This indicates that preservation of architecture of vasculature and ductal structure, hence different cell 
population were not inter-dispersed after seeding. 
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2.3.6 Modulation of β-cell Insulin Gene Expression by Native Pancreatic ECM 
Both primary pancreatic islets and individual isolated pancreatic β-cells have been demonstrated 
to have better in vitro function when cultured on ECM-derived substrates [102, 104-106, 149] 
and purified ECM proteins [27, 49, 150, 151]. Having confirmed engraftment and survival of the 
relevant pancreatic cell types in the native pancreatic scaffold, the contribution of this pancreas-
derived ECM scaffold on cell function was next evaluated by the insulin gene expression level. 
For comparative evaluation, control cultures of MIN-6 cells (25,000 cells/cm2) were plated on 
surfaces with the following ECM proteins: collagen I, collagen type IV, fibronectin, and growth 
factor-reduced (GFR) Matrigel. In addition, the MIN-6 cells were also cultured on 2D slice 
configurations of pancreatic ECM for comparison between the effects of 2D versus 3D culture 
configurations. Upon plating, the MIN-6 cells readily attached to all tested substrates and 
remained viable over the culture period (data not shown). The cells were cultured for 5 days, 
after which the cell lysate was analyzed for insulin gene expression (ins1 and ins2 expression) by 
qRT-PCR (Figure 2.9).  Quantitative RT-PCR of MIN-6 demonstrated significantly higher ins1 
and ins2 gene expression when cultured on these ECM proteins and pancreatic ECM scaffold 
(P<0.05) compared to control (untreated plate) with the exception of collagen I gel. Among the 
ECM proteins tested, collagen IV and fibronectin substrates induced similar insulin gene 
expression levels. Matrigel promoted the highest insulin gene expression (6.9-fold ins1 and 4.1-
fold ins2). MIN-6 seeded on 3D pancreatic ECM exhibited higher insulin gene expression than 
2D pancreatic ECM. Furthermore, 3D pancreatic ECM also demonstrated higher insulin gene 
expression when compared to single ECM proteins such as collagen IV and fibronectin but 
displayed similar level of insulin gene expression with the Matrigel coated surface (no 
significant difference). These results clearly demonstrate that β-cells interact closely with the 
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ECM substrates, and that interaction with specific substrates can significantly affect insulin gene 
expression. The native organ derived of decellularized pancreas was found to have a strong 
positive attribute to ins1 and ins2 gene expression, comparable to Matrigel coating and 
significantly higher than other tested single purified molecules.  
 
Figure 2.9 Comparison of ECM mediated insulin gene expression of MIN-6 cells 
qPCR data demonstrated modulation of MIN-6 cell insulin gene expression by different types of ECM 
protein. 3D Pancreatic ECM demonstrated higher ins1 and ins2 genes expression than Collagen I, Collagen IV, 
Fibronectin and 2D pancreatic slice ECM but only comparable to Matrigel. Normalization was performed to MIN-6 
cells seeded on control non-tissue culture treated plastic. * indicates P<0.05 
2.4 DISCUSSION 
The objectives for successful decellularization are 1) complete or near complete removal of 
cellular material, and 2) preservation of ECM composition [152]. Commonly reported 
decellularization protocols require mechanical agitation or freezing and thawing which may take 
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up to days or weeks to remove all cellular materials [153-155]. Such protocols do not guarantee 
preservation of the ECM microstructure, which has been shown to be instrumental for the 
generation of functional tissue engineered constructs [156]. In contrast, our approach of whole 
organ perfusion decellularization reduces the diffusion distance required for decellularization 
agents to reach the cells and facilitates removal of the cellular material from the tissue by 
convective transport [60, 152, 157]. This technique allowed the efficient generation of acellular 
scaffold with preserved ECM, 3D architecture and perfusable network resembling a native organ 
(approximately 325 min as shown in our data Figure 2.1(D). The resulting decellularized 
pancreas met the stringent requirement to define a successful decellularization [147] - absence of 
nuclear material with DAPI and H&E staining, and retained only less than 50ng dsDNA per mg 
ECM dry weight as shown by quantitative DNA measurement (Figure 2.1(E-G)). This 
requirement is crucial because residual DNA fragments in decellularized ECM have shown to 
lead to cytocompatibility issues in vitro and adverse immunological response upon implantation 
[148, 158, 159]. We and other groups have tried decellularization using similar strategies on 
other circulatory networks to reduce diffusion distance (e.g., bile duct in liver, pancreatic duct in 
pancreas) but it was much less effective likely due to incomplete distribution of a conduit 
network to reach all the cells throughout the target organ. 
Another important consideration for organ decellularization is minimizing the 
undesirable alteration and loss of biologically active ECM components. Decellularized pancreas 
scaffolds demonstrated maintenance of key ECM proteins in adult pancreas [9, 25], including 
collagen I, collagen IV, laminin, and fibronectin, as well as sulfated GAG. Most of the ECM 
proteins retained their physiological organization after decellularization as noted by IHC (Figure 
2.2(A)). This finding was further substantiated by mass spectrometry analysis to 
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comprehensively characterize the proteome of the decellularized pancreatic ECM. Retention of 
ECM protein/glycan compositions is typically characterized by IHC; this approach is however 
limited by its robustness and only confined to a small number of ECM candidates studied. 
Proteomic analysis by mass spectrometry is unbiased and does not require specific probes. 
Though our analysis was qualitative, notably all the top scoring proteins belonged to the ECM 
family (supplemental table 1). These identifications have a high number of peptide spectral 
counts providing rough measures of protein abundance. 
Biomechanical evaluation of engineered scaffolds and decellularized constructs is an 
important assessment for the rate of preservation of functional integrity. Numerous studies have 
shown that biomechanical properties change after decellularization of tissues [138, 160, 161]. By 
using AFM, we measured the stiffness of the decellularized pancreas ECM. Our results 
demonstrated that Young’s modulus of decellularized pancreas is on average 3 times greater than 
the native pancreas (P<0.01, Figure 2.4(A-B)). This is partially attributed to the loss of GAG 
content from the decellularization protocol (Figure 2.2(D)). GAG proteins have a myriad of 
biological functions and some of them are associated with structural and biomechanical 
properties. GAGs possess a fixed negative charge that renders them hydrophilic and attracts 
water into the tissue causing an osmotic swelling, which in turn could contribute to tissue 
physical properties. Removal of GAG side chains by heparitinase/chondroitinase treatment has 
been shown to increase stiffness of basement membrane of tissue [131]. Although our result 
showed a higher Young’s modulus in decellularized pancreas than native pancreas, it is still well 
within the mechanical property range of “soft tissue.” [162, 163]. While the magnitude of 
increase depends on the specific organ under study, some studies have shown that a slight 
alteration of tissue biomechanical properties was not associated with any detrimental effect on 
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cellular functionality. For instance, successful repopulation of a cardiac matrix was demonstrated 
despite a higher tangential modulus was detected within the decellularized heart when compared 
to native rat ventricles [108], which is consistent with our findings. 
Recent studies have suggested that the ECM composition and expression pattern are 
specific to a given anatomical location to direct or support site-appropriate cell attachment and 
function [111, 164]. In the native pancreas, the primary functional units of the pancreas divide 
easily into endocrine cells and exocrine cells. The endocrine cells are arranged mainly in groups 
as islets of Langerhans and secrete different polypeptides delivered to other parts of the body via 
the vasculature. In contrast, the secretions of acinar exocrine cells are carried away through the 
ductal system. To reconstitute the major functional processes in pancreas, we utilized these 
unique differential secretory channels to deliver two major pancreatic cell types – endocrine (β-
cells) and exocrine (acinar cells) – in close proximity to their respective native niches. Our result 
showed that both cells types retained their functionality and distinct location upon 
recellularization (Figure 2.8(B-C)). 
Reestablishment of a critical ECM-β-cells interaction has been shown to improve β-cells 
survival and functions [27, 49, 105, 149-151]. In this study, we evaluated the effect of substrate 
on β-cell function. Insulin gene expression of MIN-6 cultured on Matrigel was found to be 
significantly higher than coated single purified proteins. This finding indicates that β-cells are 
responsive to ECM substrate differences. Hence it was expected that native pancreatic ECM 
scaffold with preserved native ECM milieu will also likely enhance insulin gene expression. 
Consistent to our hypothesis, ins1 and ins2 expression of MIN-6 cultured on decellularized 
pancreas 3D scaffold was higher than single purified molecules (P<0.05, Figure 2.9) and 
comparable to Matrigel (no statistical difference). However, 2D substrates of pancreatic ECM 
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only showed similar level of insulin gene expression with single purified molecules. This is 
likely due to the reason that pancreatic cell niche in vivo is a 3D environment and previous 
studies have shown that cell-matrix interaction in 3D matrices are more favorable from those on 
2D substrates [165, 166]. Our result was supportive of this previous finding with the 3D 
pancreatic scaffold demonstrating better support of β-cell function. The high insulin gene 
expression observed when β-cells are cultured on Matrigel suggests the benefits of synergistic 
effects from multi-faceted ECM proteins. Similarly, decellularized pancreas scaffold also 
possesses multiplex ECM composition and the effects are proving to be similar when compared 
to Matrigel. Even though Matrigel is widely used in various tissue engineering studies, it is 
limited in its translational potential due to its tumor cell origin. In contrast, decellularized 
xenogenic sources of ECM scaffolds are typically regulated by the FDA as medical device and 
currently in wide clinical use [167]. Hence, the development of a bioscaffold using 
decellularized pancreatic ECM will provide a better clinical translation opportunity for 
pancreatic tissue engineering and regenerative medicine applications. 
2.5 CONCLUSION 
This chapter presents the first step toward successful decellularization and 3D reconstruction of 
whole pancreas. Thorough characterization revealed that the decellularized pancreas retained its 
native 3D architecture, vasculature and ductal channels along with important ECM compositions. 
The preserved pancreatic ECM scaffold was non-cytotoxic, supportive of representative 
pancreatic cell types, and enhanced insulin function when seeded with β-cells. Such native organ 
derived scaffold is likely to have a great impact in pancreatic tissue engineering, by providing a 
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niche microenvironment for pancreatic cell types and even stem/progenitor cells. In conclusion, 
perfusion-decellularized pancreas offers a promising platform for pancreatic tissue engineering 
and regenerative medicine based strategy for whole-organ replacement. 
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3.0  DEVELOPMENT OF A PERFUSION BIOREACTOR FOR WHOLE ORGAN 
PANCREAS BIOENGINEERING  
3.1 INTRODUCTION 
The preceding chapter focused on the development and assembly of a perfusion bioreactor to 
enable regenerative reconstruction of pancreas. Advancement of this perfusion-decellularization 
technology relies heavily on the efficiency of the perfusion system to adequately deliver the 
decellularization agents throughout the harvested organ. More importantly, the reconstruction of 
decellularized organs and maintenance within a tissue culture environment will necessitate an 
adequate perfusion system for mass nutrient transport. Hence there has been a strong focus on 
developing perfusion system to support whole-organ decellularization and recellularization [125, 
168-173]. 
Early studies of perfusion-decellularization technology have employed gravity-based 
perfusion for whole-organ decellularization and recellularization. For instance, mouse kidneys 
were successfully decellularized by Ross et al. group with gravity-based perfusion at a constant 
physiologic fluid pressure of approximately 100 mmHg [140, 174]. Using similar gravity-driven 
approach, Scarritt et al. demonstrated complete decellularization of rat lungs using a column of 
liquid that was suspended 22 cm above the lung to drive the perfusion [175]. For 
recellularization, some groups including ours have adopted the same gravity perfusion method to 
  57 
periodically supply nutrients to the repopulated organs [50, 110, 176]. These repopulated organs 
are usually cultured statically by submersion in media without continuous media perfusion and 
have shown to support functional organ reconstruction in heart [110, 176] and pancreas [50]. 
However, gravity-based perfusion is a concern because it may not force perfusion especially 
during cellular debris clogging, which will lead to incomplete perfusion and reduced 
decellularization and nutrient transport efficiency. Furthermore, gravity-based perfusion usually 
involve manual changing of solution or culture media, which will lead to higher likelihood of 
contamination. Some other groups employed pump-based perfusion to exert the necessary 
pressure and drive the solutions (e.g. detergent or culture media) through the organ [119, 125, 
168-173]. While this approach has been successfully demonstrated in both small animal organs 
as well as large and human-scale organs, there is a dearth of information on the construction of 
the perfusion bioreactor which will allow convenient assembly of such a system in a research 
lab. Recently, a commercially available bioreactor named Organ Regenerative Control 
Acquisition (ORCA) bioreactor (Harvard Apparatus Regenerative Technologies, HART) was 
reported. This commercial bioreactor system is amenable to gas (e.g. O2 and CO2) sensors 
integration and automation, which has been used for whole lung decellularization and 
recellularization [123, 169]. However, the expensive commercial equipment has often limited the 
dissemination of this perfusion decellularization technology [177] to the organ engineering 
community. Hence, there is an unmet need of developing a simple, cost-effective and easily 
assembled perfusion bioreactor in research lab settings to catalyze the development of organ 
bioengineering. 
The objective of this chapter is to introduce a simple yet versatile bioreactor design which 
can be easily assembled with accessible resources in research laboratories. We described the 
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design, construction, and testing of a novel laboratory-scale bioreactor that is capable of 
decellularization of multiple intact whole organs (e.g. pancreas, liver and heart). With simple 
modification, the decellularization set-up was amenable to serve as a bioreactor to allow dynamic 
perfusion culture of reconstructed organs. We first demonstrated the bioreactor efficiency by 
maintaining the viable reconstruction of pancreas from a robust pancreatic β cell line for 7 days. 
Comparison with parallel static culture clearly indicated the superior performance of the 
perfusion bioreactor culture in promoting cellular engraftment, survival and function of the 
reconstructed pancreas. We further demonstrated the ability of this bioreactor to culture 
decellularized pancreas repopulated with hESC-derived definitive endoderm (DE) cells, as a first 
proof of concept towards regenerative reconstruction of pancreas. 
3.2 METHODS 
3.2.1 Organ isolation and preparation 
All animal work performed was in accordance with animal welfare act, institutional guidelines 
and approved by Institutional Animal Care and Use Committee of the University of Pittsburgh. 
Female ICR mice (Taconic), between the ages of 6-12 weeks were induced anesthesia by 
ketamine/xylazine injection, and placed in the supine position. A laparotomy was performed and 
a single dose of heparin (2.0 units of heparin per gram of body weight) was injected into the 
inferior vena cava (IVC). After 5 min wait time for systemic circulation of the heparin, organs of 
interest (e.g. pancreas, liver and heart) were isolated using aseptic techniques. Heparin pre-filled 
24G catheters were inserted into the arterial (heart) or venous vasculature (pancreas and liver) 
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and tightly secured with suture. The minor arterial and venous bifurcations were carefully ligated 
or cauterized to prevent leakage before placement into the decellularization chamber. 
3.2.2 Decellularization chamber design and components 
The decellularization chamber, shown in Figure 3.1 and Figure A.2, has three main components: 
the organ chamber, detergent reservoir and peristaltic pump. All the parts were autoclaved or 
sterilized with ethylene oxide (EtO) gas before use. All assembly and manipulations of 
decellularized organs, canulla attachments, and subsequent recellularization were done using 
aseptic techniques in laminar flow hoods to prevent contamination. 
3.2.2.1 Organ chamber 
The organ chamber houses the biologic sample. It is made of customized glass media bottle 
secured onto a ring stand in the working space. The glassware is sealed by a silicone rubber 
stopper (Cole Parmer, size 12) at the top. The bottom has a drainage outlet that leads to the 
detergent reservoir with a stopcock and connecting tube in between. Two holes are bored into the 
silicone rubber stopper to fit two stainless steel 304 cannulae (Small parts, hypodermic round 
tubing, gauge 8) with female luer fitting (Small part, stainless steel 303) soldered on one end. 
The first cannula holds the decellularized organ at the end of the cannula; the other end with 
soldered luer fitting connects to a three-way stopcock that leads to the inlet tubing and a syringe. 
The second cannula leads to a syringe filter that prevents pressure build up and facilitates 
drainage into the detergent reservoir. 
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3.2.2.2 Detergent reservoir 
The detergent reservoir contains the detergent solution (0.5% SDS and 1% Triton-X 100 as 
described in previous study [50]) for the peristaltic pump to draw from and perfuse the target 
organs. It also collects the outlet perfusate from the organ chamber. When cloudiness is 
observed, fresh detergent will be replenished into the detergent reservoir. It is sealed by a 
silicone rubber stopper (Cole Parmer, size 12) at the top. Three holes are bored into the stopper 
to fit three stainless steel 304 tubes (Small parts, hypodermic round tubing, gauge 8) with female 
luer fitting (Small part, stainless steel 303) soldered on one end. The first cannula connects to the 
upper organ chamber via a tubing line to collect effluent detergent and drain into the detergent 
reservoir. The second cannula connects to the peristaltic pump via an outlet tubing to draw and 
recirculate the detergent from the detergent reservoir back to the organ chamber. The third 
cannula leads to a syringe filter snuggly fit into the soldered female luer fitting to permit air 
exchange and equilibrate pressure in the reservoir. The first two cannulae are connected with 
their corresponding parts with 1/8-inch hose barb to luer connectors (Cole parmer). 
3.2.2.3 Peristaltic pump 
With the tubing size used in this system (Masterflex BioPharm tubing, L/S16) the peristaltic 
pump (Masterflex L/S Digital Drive, 600 RPM) is capable of accurately and consistently 
pumping flow rates from 0.8 to 480mL/min through the flow chamber. We used a flow rate 
setting of 2mL/min (pancreas and liver) and 4mL/min (heart) for decellularization. Each pump is 
capable of driving 2 pump heads. For a high throughput set-up, a 12-channel peristaltic pump 
(Cole Parmer) can be utilized with perfusate flow divided equally between all cultured 
reconstructed organs in one organ chamber as demonstrated by Sullivan et al. [139] 
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3.2.3 Corrosion casting of vascular and ductal conduits 
To determine the integrity of vascular and ductal network in the decellularized pancreas 
scaffolds, we performed the corrosion casting. Catheterization of the anterior hepatic portal vein 
and pancreatic duct was performed followed by injection of 0.5-2mL polymer mixture depending 
on the pancreas size using Batson’s 17 anatomic corrosion kit (Polysciences, Inc) as 
recommended by the manufacturer. Red pigment was added to perfuse the vasculature via the 
hepatic portal vein whereas blue pigment was added to perfuse the ductal network via the 
pancreatic duct. Polymerization took 4 h at 4ºC and was followed by maceration in 1N KOH 
solution 8–24 h. The morphology and distribution of vascular and ductal network was observed 
under dissecting scope (Nikon SMZ800) and images were recorded with Olympus DP25 camera. 
3.2.4 Cell culture 
3.2.4.1 MIN-6 β cell culture 
MIN-6 β cell culture was performed as previously described [50] in chapter 2.2.3. 
3.2.4.2 Human Embryonic Stem Cells (hESC) culture 
The H1 embryonic stem cell lines used in these experiments were obtained from the University 
of Pittsburgh Stem Cell Core, and are part of the NIH hESC registry eligible for NIH funding. 
Undifferentiated H1 hESCs were maintained in feeder-free culture in mTeSR medium (StemCell 
Technologies) on hESC-qualified Matrigel (BD Biosciences)–coated tissue culture plates. 
Cultures were fed every day with mTeSR medium and passaged with Accutase (StemCell 
Technologies) at 70% confluency. Experiments were performed with p55–p70 hESCs in 37ºC 
incubator, 5% CO2, and 100% humidity.  
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3.2.4.3 Human ESC-Derived Definitive Endoderm (hESC-DE) 
A basal media of DMEM/F12 plus 0.2% BSA and B27 serum supplement was used for the 
induction of DE. Once hESCs reached an average colony size of 1 mm in diameter, DE was 
induced using 100 ng/mL ActivinA (R&D Systems) with 25 ng/mL Wnt3A (R&D Systems) for 
4 days as previously described [69-71, 178, 179] . 
3.2.5 Recellularization of decellularized pancreas with MIN-6 and hESC-DE cells 
Recellularization of pancreas was performed according to the method previously described [50] 
in chapter 2.2.5.  For recellularization with DE cells, the cells were treated with 10 μM Y-27632 
(Millipore) for 2 h prior to passaging. Cells were incubated with Accutase (Life Technologies) 
for 5 min at 37°C to detach cells, and pipetted to obtain single cell. With the same step-wise 
inoculation method described with MIN6 recell, DE cells (9 x106) were introduced into the 
decellularized pancreas. For both recellularizations, cells were allowed to attach overnight. A 
gentle rinse through the hepatic portal vein was followed in order to wash out any unattached 
cells after which either static or perfusion culture was resumed. 
3.2.6 Cell labelling and LI-COR Whole Organ Imaging 
The cells were labeled with Vybrant DiD near infra-red (NIR) dye (Life Technologies) according 
to manufacturer’s instruction to visualize cell distribution upon recellularization. The 
recellularized pancreas with labelled cells was detected with LI-COR Odyssey (21 µm 
resolution, 1 mm offset with highest quality). The low auto-fluorescence from tissues and cells in 
the NIR results in excellent depth of tissue penetration (>2 cm) and provides a semi-quantitative 
estimate of signal, and shows cellular distribution. 
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3.2.7 Perfusion bioreactor design and components 
The perfusion bioreactor design, shown in Figure 3.4, utilized and recycled similar parts from 
decellularization chamber. It is composed of four main components: the organ culture chamber, 
air bubble trapper, coiled silicone oxygenator and peristaltic pump. All the parts were autoclaved 
or sterilized with EtO gas before use. After mounting the reconstructed organ into bioreactor, the 
whole set-up was placed in the incubator (37°C and 5% CO2) for whole organ culture.  
3.2.7.1 Organ culture chamber 
The reconstructed organ is contained within an autoclavable, glass media bottle (Fisherbrand) 
(Fig 3.4(B)). The organ culture chamber is sealed by a silicone rubber stopper (Cole Parmer, size 
6.5). Three holes are bored into the stopper to fit three stainless steel 304 tubes (Small parts, 
hypodermic round tubing, gauge 8) with female luer fitting (Small part, stainless steel 303) 
soldered on one end. The first cannula holds the reconstructed organ at the end of the cannula; 
the other end with soldered luer fitting connects to a three-way stopcock that leads to the inlet 
tubing and an air bubble trapper. Second cannula draws medium out and connects to outlet 
tubing to the peristaltic pump. The third cannula leads to a syringe filter snugged fit into the 
soldered female luer fitting to permit gas exchange. The first two cannulae are connected with 
their corresponding tubing with 1/8-inch hose barb to luer connectors (Cole Parmer). 
3.2.7.2 Air bubble trapper 
The bubble trapper (Figure 3.4(C)) consists of a silicone rubber stopper attached to a 50 mL 
Falcon tube cut at the 20mL marking. Two holes are bored into the silicone rubber stopper to fit 
two stainless steel 304 cannulae (Small parts, hypodermic round tubing, gauge 8) – one inlet and 
one outlet – with female luer fitting (Small part, stainless steel 303) soldered on one end. Bubble 
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trap was prefilled with 5 mL of culture medium. To validate that the flow through the bubble trap 
was not significantly affected, the flow from the pump and flow out of the bubble trap was 
measured over the course of 10 minutes. Total volume pumped out of the bubble trap and pump 
was measured to be 10.7 mL and 10.9 mL respectively, signifying that 98.2% of the flow rate is 
conserved through the bubble trap. 
3.2.7.3 Coiled silicone oxygenator 
Silicone tube oxygenator (Figure 3.4(D)) is composed of coiled silicone tubing to permit rapid 
equilibration of culture medium with most gas mixtures before reaching organ culture chamber. 
The inlet, outlet and oxygenator tubing are made of platinum-cured silicone (Masterflex 
BioPharm tubing, L/S16). The platinum-cured silicone tubing is gas permeable to oxygen and 
carbon dioxide. Furthermore, platinum-cured tubing is used to reduce the amount of leachable 
chemicals and is relatively low-protein binding. 
3.2.7.4 Peristaltic Pump 
The peristaltic pump (Figure 3.4(E)) for perfusion bioreactor consists of the same set-up as the 
perfusion decellularization chamber described above. The only difference is that the flow rate 
used is 1mL/min for continuous perfusion culture of whole pancreas. 
 
3.2.8 Static and perfusion culture conditions for recellularized pancreas 
A static culture condition was set up according to previously described method [50] in chapter 
2.2.5. For the perfusion culture condition, a perfusion bioreactor was set up to circulate the 
medium from the main organ chamber into the vasculature of recellularized pancreatic construct 
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at a constant flow of 1mL/min. Culture medium for the MIN-6 recellularized pancreas was the 
same as the MIN-6 cell culture medium as described above (DMEM, 15% FBS and 1% 
Pen/Strep). For the DE-recellularized pancreas, it was cultured in basal medium consisting of 
DMEM/F12 plus 0.2% BSA and B27 serum without additional growth factor supplement. Both 
conditions were cultured in an incubator at 37°C with a 95% air / 5% CO2 atmosphere for 7 days 
with a complete media change in day 4. 
3.2.9 Immunofluorescence and histology 
Native, decellularized and recellularized organs were fixed, sectioned and stained following 
protocol previously described [50] in chapter 2.2.8. The following primary antibodies and 
dilutions were used: goat anti-Cxcr4 (1:100, abcam), goat anti-Sox17, goat anti-PDX1 (1:200, 
R&D Systems Inc.), rabbit anti-KI67 (1:200, Santa Cruz) rabbit anti-FOXA2 and rabbit anti-
Cpeptide (1:100, Cell signaling). Secondary antibodies used were: donkey anti-rabbit Alexafluor 
488/555 (1:500, Invitrogen) and donkey anti-goat Alexafluor 488/555 (1:500, Invitrogen). 
Quantification of positive staining per mm2 was accomplished by converting all images to 
grayscale followed by analysis with Metamorph Image software.  
3.2.9.1 TUNEL staining 
For apoptotic cell detection, deoxynucleotidyl TUNEL assay (APO-BrdU TUNEL Assay Kit, 
Molecular Probes) was used, following the manufacturer’s instructions. Similarly with 
immunofluorescence staining, TUNEL quantification was performed by counting positive cell 
staining per mm2 and analyzed with Metamorph Image software. 
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3.2.10 Quantitative RT-PCR 
qRT-PCR was performed as previously described [50] in chapter 2.2.15. 
3.2.11 Statistical Analysis 
Statistical analysis was performed as previously described [50] in chapter 2.2.16. 
3.3 RESULTS 
3.3.1 Design of a perfusion bioreactor system for whole organ decellularization  
We have developed a perfusion bioreactor system which can be directly used to decellularize 
multiple intact organs without any design modification. The design of the bioreactor system for 
decellularization has an inlet connected to the organ mounted inside the organ chamber for 
detergent distribution throughout the organ via vasculature network perfusion. The effluent 
detergent fluid exits the organ’s venous system and drains into the detergent reservoir via the 
organ chamber’s outlet line (Figure 3.1(A), A.2, flow direction shown by arrow). The perfusion 
flow rate is maintained at 2mL/min for pancreas. This whole process is a closed-loop system 
where the detergent was recirculated back by a peristaltic pump from the detergent reservoir to 
organ chamber until complete decellularization was achieved (2-4 hours).  
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Figure 3.1 Perfusion bioreactor design for whole organ decellularization 
(A) Detergent (black arrow) flows from the detergent reservoir via a three-way stopcock to the organ 
chamber and into the organ by means of a peristaltic pump. The first cannula, #1 is connected to the three-way 
stopcock on one end and luer connection to the target organ on the other end. The second cannula, #2 is connected to 
a syringe filter to allow venting and prevent pressure build up. Perfused detergent is drained from the bottom of the 
organ chamber by gravity into the detergent reservoir via the third cannula, #3. The fourth cannula, #4 allows the 
drawing of detergent from detergent reservoir via peristaltic pump to the organ chamber. The fifth cannula #5 is 
attached to a syringe filter to permit air exchange in sterile fashion and equilibrate pressure in the detergent 
reservoir. (B) Bioreactor components: a) Stainless steel cannulae, b) three-way stopcock, c) silicone stopper and d) 
luer lock connectors (1/8-inch hose barb) that were used for assembling the perfusion-decellularization system. 
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Throughout the decellularization process, murine pancreas displayed progressive 
whitening culminating in a translucent appearance at the end of the process (about 325 min) 
(Figure 3.2(A)). At macroscopic level, decellularized pancreas maintained their overall shape 
and gross structure. At the microscopic level, no intact cellular material was observed 
histologically in the exocrine and endocrine components or pancreatic ducts of the pancreas 
(Figure 3.2(B)). In our previous study [50], we demonstrated that major ECM components (e.g. 
Col I, Col IV, Laminin, Fibronectin) and ultrastructure of the pancreas were preserved using this 
method of decellularization. In the current study we further performed corrosion casting of a 
decellularized pancreas to show preservation of vascular (red) and ductal (blue) system similar to 
a normal pancreas (Figure 3.2(G)). These results suggest that decellularized pancreas is devoid 
of any cellular material but still preserves architecture and microstructure resembling a native 
pancreas. 
The developed perfusion system was designed and built as a versatile and scalable 
apparatus targeting decellularization of other intact organs and multiple organs. First, the 
versatility of the perfusion bioreactor system in decellularizing other intact organs was verified 
by decellularization of liver and heart. Liver was perfused at the same flow rate as pancreas 
(2mL/min) while heart was perfused at a higher rate of 4mL/min given the high density of heart 
tissues [108]. Similar to pancreas, the decellularization of liver and heart generated translucent 
acellular liver and heart ECM scaffolds (within 320 min, Figure 3.2(C, E)). H&E staining 
showed no cell remnants with preservation of major ECM structure (Figure 3.2(D, F)). Secondly, 
the scalability of the developed system was demonstrated by adding a second pump head onto 
the peristaltic pump to connect an extra independent line and cannulae for mounting of additional 
organs to allow processing multiple organs in parallel (Figure A.3). These results demonstrate 
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that our simple perfusion bioreactor assembly is versatile enough to successfully decellularize 
various organs and easily scalable with only minor changes in operating parameter and design 
modification. 
 
Figure 3.2 Perfusion-decellularization of murine pancreas, liver and heart 
(A, C, E) Macroscopic images of cadaveric mouse pancreas, liver and heart (left) and the same pancreas, 
liver, heart after decellularization (right). (B, D, F) Representative H&E staining of sections from the cadaveric 
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mouse pancreas, liver, heart (left) and decellularized pancreas, liver, heart (right) showed removal of cells. (G) 
Representative photographs of intact microvascular (red) and ductal network (blue) from corrosion cast model of 
native pancreas (left) and the decellularized pancreas (right). (H) Representative macroscopic (scale bar 1mm) and 
microscopic (inset) photographs of intact microvascular (red) network from corrosion cast model of decellularized 
liver. 
3.3.2 Recellularization and perfusion bioreactor development for organ culture  
In order to demonstrate feasibility of viable and functional organ reconstruction, the 
decellularized pancreas was first reconstructed with MIN6, a well-established pancreatic β cell 
line. A concentrated suspension of MIN6 cells (30 million cells in 1mL) were instilled through 
the hepatic portal vein using multi-step cellular infusion steps as described previously by Soto-
Gutierrez et al. [117] and our group [50] (Figure 3.3A, B). The cells were labeled with Vybrant 
DiD near infra-red dye which allowed whole-organ imaging using Odyssey® CLx Infrared 
Imaging System. As illustrated in Figure 3.3C, pseudocolor fluorescence images showed the 
cells’ distribution throughout the head and the tail of the pancreas. This confirms the cell 
delivery and retention in the decellularized pancreas after multi-step cellular infusion steps 
(Figure 3.3(B, C)). After seeding and cells were allowed to attach for another 2 hours before the 
pancreatic construct was connected to the designed bioreactor set-up to provide a perfusion 
culture condition. In parallel, a static culture condition was also set up to compare the difference 
between these two culture conditions (as shown in schematic Figure 3.3(A)).  
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Figure 3.3 Recellularization of decellularized pancreas 
(A) Schematic summarizing the decellularization-recellularization of pancreas and in-vitro culture 
experiment comparing static and dynamic bioreactor culture for 7 days. (B) Decellularized whole pancreas before 
cell seeding (left) and recellularization of the same pancreas via multi-step infusion of about 30 million cells via 
portal vein infusion (right). (C) Pseudocolored fluorescence image illustrates the rapid dispersion of cells. The 
average signal intensity in the head region of the pancreas was higher than the average signal intensity of the distal 
pancreas indicating more cells concentrated in the head of the pancreas. 
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The culture of whole organs needs to be maintained under sterile in vitro conditions. 
Hence we designed our perfusion bioreactor to be small and self-contained to be able to fit inside 
a standard tissue culture incubator as shown in Figure 3.4(A). It contains an organ culture 
reservoir (Figure 3.4(B)) filled with culture media where the recellularized pancreas is mounted 
for perfusion. The bioreactor is a closed-loop system and the total volume of culture medium 
used is about 60mL. The perfusion to vascular network of recellularized pancreas is provided via 
a peristaltic pump (Figure 3.4(E)) that circulates the culture media from the organ culture 
reservoir (Figure 3.4B)) to the silicone oxygenator (Figure 3.4(D)) at 1mL/min to equilibrate 
with 5% CO2 and 95% room air followed by a bubble trapper (Figure 3.4(C)) before re-entering 
the organ culture reservoir and reaching the cannulated pancreas. The bioreactor design being 
completely enclosed may not facilitate adequate oxygen and CO2 exchange. Hence we adjusted 
the length of gas-permeable silicone tubing to allow equilibration with the incubator conditions. 
The tube length required to reach equilibration was mathematically modeled and determined to 
be 1 meter (Appendix A.1.1).  With the designed set-up we verified the maintenance of phenol 
red color in the culture medium all through the 7 days of whole-organ perfusion culture, to 
ensure proper gas exchange and pH regulation inside the bioreactor. However, the high 
permeability of silicone tubing may result in formation of air bubbles, which is detrimental to 
organ cultures [119, 180]. Hence we included a bubble trap in between the silicone tubing and 
the inlet to the reconstructed organ to eliminate air bubbles before entering the recellularized 
pancreas (Bubble trapper in action, supplementary video 1). Inclusion of the bubble trap only 
slightly damped the flow rate from the pump (~ 1.8%), as determined by measuring the flow into 
and out of the bubble trap. Finally, the sterility of the designed bioreactor was verified by 
periodically checking the perfused culture medium for contamination by conventional streak 
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samples throughout the 7 day culture period. The microbiological evaluation showed no 
microbiological contamination (Figure A.4) even after continued culture of 14 days. These 
results demonstrate the successful assembly of a compact, closed-loop system to maintain sterile 
in vitro culture of reconstructed pancreas. 
 
Figure 3.4 Perfusion bioreactor setup for reconstructed pancreas culture 
(A) Photograph of the perfusion bioreactor inside a standard tissue culture incubator. (B) Photograph of 
organ reservoir that houses the cultured reconstructed pancreas. It is composed a 250ml media glass bottle, three 
stainless steel cannulae and a silicone stopper (size 6.5). Cannula #3 brings the debubbled culture media from the 
bubble trapper to the cultured organ. Cannula #4 draws the media from organ reservoir and recirculates to silicone 
oxygenator by means of peristaltic pump. Cannula #5 connects to a syringe filter to allow venting and prevent 
pressure build up. (C) Photograph of the bubble trapper showing the first cannula, #1 is connected to the inlet 
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coming from silicone oxygenator and the second cannula #2 is connected to a three-way stopcock that leads to the 
organ reservoir. (D) Photograph of silicone oxygenator composed of extended length of silicone tubing coiled 
together. (E) Photograph of the peristaltic pump to drive the culture medium (black arrow) flows from the (B) organ 
reservoir through the (D) silicone oxygenator and (C) bubble trapper and circulates back into the organ. 
3.3.3 Perfusion bioreactor culture enhances β-cell engraftment, viability and insulin 
expression over static culture 
One of the main goals in pancreas bio-engineering is the maintenance of β-cell phenotype and 
insulin function. To test the feasibility of this objective in a whole-organ set-up, decellularized 
pancreas reconstructed with MIN-6 cells were cultured under static or perfusion culture 
conditions for 7 days, and subsequently characterized for engraftment, survival and insulin 
expression. After cell seeding through multi-step infusion, it was observed that the MIN6 β-cells 
lined the vascular channels and surrounding parenchymal region throughout the entire scaffold.  
Significant differences were subsequently observed between the static and perfusion cultures of 
the reconstructed pancreas after 7 days. As observed by H&E staining, reconstructed pancreas 
cultured in the bioreactor had significantly more cells per high-power field (HPF) than static 
cultured pancreas (202±38 vs. 89±21, P<0.05, Figure 3.5(A)). For cell survival assessment, 
TUNEL assay detected higher number of apoptotic cells under static condition (21.8±4.7%, with 
P<0.05, Figure 5(B, C)). Interestingly, most apoptotic cells in the static culture condition were 
located in the core region of the engraftment whereas cells located in the peripheral region with 
basement membrane contact were mostly negative for TUNEL staining (Figure 3.5(B)). This 
may be due to insufficiency of nutrient transport to the core region or lack of ECM contact to 
prevent β-cell apoptosis, often referred to as anoikis [49, 181]. In contrast, the perfusion culture 
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resulted in significant reduction in cell death with no preferential localization of TUNEL positive 
staining. 
Insulin/C-peptide synthesis is the primary function of pancreatic β cells. To first evaluate 
this function, immunostaining of C-peptide (cleaved molecule of insulin) was performed after 
exposure to static and perfusion culture. Consistent with engraftment and survival, perfusion 
culture also resulted in increased number of C-peptide+ cells (Figure 3.5(D)). The static and 
perfusion cultures were further compared by quantitative RT-PCR of the recellularized pancreas. 
We used a combination of proteinase K and mechanical homogenization to remove fibrous ECM 
for isolation of RNA from recellularized pancreas. Analysis of insulin (ins1 and ins2) gene 
expression by qRT-PCR demonstrated significantly higher ins1 and ins2 gene expression in 
perfusion bioreactor culture over corresponding static culture (1.82±0.35 and 1.43±0.18, P<0.05) 
(Figure 3.5(E)). Worth noting that RNA concentration was also significantly higher under 
perfusion culture suggesting that there is higher number of cells retaining insulin expression with 
this culture condition. Collectively, these results demonstrate that perfusion bioreactor culture 
enhances β cell engraftment, survival and insulin expression in the whole-organ setup. While 
suitable for proof-of-concept studies, β cell lines lack significant application for clinical or in-
vitro drug testing studies. The production of a regenerative reconstructed pancreas from 
renewable cell source such as human pluripotent stem cells, on the other hand, would be ideal 
due to its unlimited potential for self-renewal, expansion and differentiation. Hence, next we 
tested the feasibility of repopulating the decellularized pancreas with hESC-derived DE cells, as 
a first step towards regenerative reconstructed pancreas. 
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Figure 3.5 Comparison between static and bioreactor culture for repopulated pancreas with 
pancreatic β-cell, MIN-6 
(A) H&E images of repopulated pancreas after 7 days of static (left) and bioreactor (right) culture showing higher 
cellular engraftment in bioreactor culture. (B) Representative TUNEL staining of the repopulated pancreas showed 
higher number of apoptotic cells detected in the static culture (left) compared to the bioreactor culture (right). 
Localization of TUNEL+ cells in static culture were found predominantly in the core region, away from basement 
membrane. (C) Image analysis of TUNEL staining showing higher percentage of TUNEL+ cells in the static culture. 
(D) IHC analysis showed higher number of C-peptide+ cells detected in the bioreactor culture (right) compared to 
static culture (left). (E) Quantitative RT-PCR analysis showed higher ins1 and ins2 gene expression in bioreactor 
culture than static culture.  * indicates P<0.05 
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3.3.4 Perfusion bioreactor culture enhances proliferation and differentiation of hESC-DE 
repopulated pancreas over static culture 
Towards regenerative reconstruction of whole pancreas, hESCs were first pre-differentiated in 
vitro towards a DE phenotype via a stage-wise directed differentiation protocol. We have 
previously reported a highly efficient protocol to direct hESCs towards endoderm lineage using 
Activin A and Wnt3A [69-71, 178, 179] (Figure 3.6(A)). At day 4, the specific DE marker genes, 
SOX17 and FOXA2 were highly upregulated as evidenced by qRT-PCR analysis (Fig. 6B). Next, 
we checked the co-expression of CXCR4 and SOX17 to confirm the DE commitment by 
immunostaining (Figure 3.6(C)). In addition, flow cytometry analysis demonstrated that the 
culture at day 4 comprised an average of 85% SOX17 and 90% CXCR4 positive cells (Figure 
3.6(D)). These data confirm the successful derivation of DE cells from H1 hESCs using 
exogenous factors. 
  78 
 
Figure 3.6 Differentiation of human embryonic stem cells (H1) to definitive endoderm 
(A) Schematic showing the in vitro differentiation protocol. Lower panel is the corresponding bright field 
images of undifferentiated H1 and definitive endoderm cells after chemical induction. (B) Quantitative RT-PCR 
analysis on day 4 showing upregulation of definitive endoderm genes (sox17 and foxa2) relative to undifferentiated 
day 0 cells. (C) Immunostaining analysis detected positive definitive endoderm markers - nuclear staining of SOX17 
(red) and cytoplasmic staining of CXCR4 (green). (D) Flow cytometry analysis of differentiated human ES cells 
revealed that after 4 days’ induction with ActivinA and Wnt3A, more than 85% of cells were positive for definite 
endoderm markers, SOX17 and CXCR4. 
Next, DE committed hESC (hESC-DE, 3x106 cells) were seeded into the decellularized 
pancreas following a similar seeding procedure as described above for MIN-6 β-cell and  
cultured in the reconstructed pancreas in either static or perfusion bioreactor condition for 7 
days. We seeded 10-fold less cells compared to MIN-6 cells and examined the feasibility of 
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subsequent in situ expansion of DE cells as a potential alternative to large-scale expansion of 
pluripotent stem cells in vitro for the repopulation of decellularized organs. After 7 days culture, 
the reconstructed pancreata were characterized for engraftment, proliferation and maintenance of 
DE phenotype. Consistent with our previous observation, perfusion bioreactor culture of the 
recellularized pancreas resulted almost two times higher engraftment of the hESC-DE cells as 
compared to static culture (Figure 3.7(A, C)). The static culture configuration resulted in a more 
sporadic and heterogeneous cell distribution, with some areas remaining relatively acellular and 
other displaying notable lower cell attachment and retention (Figure 3.7(A)). Cell proliferation 
within the whole pancreas cultured under 2 different culture conditions were assessed by the 
quantification of KI67+ cells from all DAPI+ cells (Figure 3.7(B)). Quantitative image analysis 
demonstrated markedly reduced proliferation of cells in the pancreatic constructs maintained 
under static culture for 7 days (45%±5%, Figure 3.7(C)), whereas 72%±7% of the cells cultured 
in perfusion bioreactor were positive for Ki67 antibody. This suggests that under perfusion 
culture condition, the hESC-DE-cells can be maintained in a proliferative state, hence suggesting 
the feasibility of in situ expansion for whole organ reconstruction. 
Having confirmed the viability and proliferation of the engrafted DE cells, the next step 
was to analyze its phenotype. DE phenotype of the engrafted cell population was confirmed by 
nuclear FOXA2 expression. While FOXA2+ cells were detectable for both static and perfusion 
bioreactor cultured pancreas, there were significant higher number of FOXA2+ cells detected 
under perfusion culture than static culture (29%±4% vs. 13%±5%, P<0.05) (Figure 3.7(D,E)). 
Also under static culture some engrafted cells acquired a flattened morphology and lost 
expression of FOXA2 transcription factor. We further quantified the gene expression of DE 
markers under 2 different culture configurations with qRT-PCR. Consistent with 
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immunostaining assessment, gene expression analysis showed a 2.2-fold (P<0.05) increase in 
FOXA2 expression in perfusion culture over static culture (Figure 3.7(F)).   
Since DE phenotype was adequately preserved in the perfusion cultured whole pancreas, 
we further analyzed if any of the early pancreatic markers were expressed in this endoderm 
population. While no pancreas specific chemical induction is being presented to the DE cells, 
they are interacting with pancreas-specific ECM. Although we are exposing human cells to ECM 
from mouse origin, studies have shown that components of ECM (e.g. collagens, glycoproteins, 
proteoglycans, mucins, elastic fibers, and growth factors) are generally highly conserved across 
species [182, 183]. We analyzed the cells for transcription factor pancreatic and duodenal 
homeobox1 (PDX1) expression, which is the master regulator giving rise to all pancreatic 
lineage cells [184]. As illustrated in Figure 3.7(G-H), a small fraction of the DE cells were 
indeed observed to express PDX1 transcription factor in the perfusion bioreactor cultured 
pancreas. However no such detectable population was observed in the static culture condition 
(Figure 3.7(G, H)). qRT-PCR analysis corroborated with this finding with minimum to no PDX-
1 gene expression detected in the static culture condition (7-fold increase over static culture, 
Figure 3.7(I)). These results clearly indicate the superior performance of perfusion bioreactor 
culture over static culture while reconstructing whole organ pancreas. Taken together, our results 
demonstrate for the first time the capacity of regenerative reconstruction of pancreas using hESC 
derived cell types. When cultured under perfusion, the hESC derived DE cells demonstrated 
excellent engraftment, proliferation and maintenance of phenotype. Furthermore, the engrafted 
cells retained the potential for further differentiation into the pancreatic lineage, as judged by the 
spontaneous PDX1 expression.  
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Figure 3.7 Comparison between static and bioreactor culture for repopulated pancreas with hESC-
derived DE 
(A) H&E images of repopulated pancreas after 7 days of static (left) and bioreactor (right) culture showing 
higher cellular engraftment in bioreactor culture consistent with observation in the MIN-6 repopulated pancreas 
culture. (B) Representative KI-67 staining of the repopulated pancreas showed higher number of proliferative cells 
detected in bioreactor culture (right) than the static culture (left). (C) The corresponding image analysis of KI-67 
staining showing higher percentage of KI67+ cells detected in bioreactor culture and corroborated the qualitative 
immunostaining observation. (D) Representative images of definitive endoderm marker, FOXA2 (red) showed 
higher number of definitive endoderm committed cells in the bioreactor culture (right) than static culture (left), 
indicating better maintenance of definitive endoderm phenotype with bioreactor culture. (E) The corresponding 
image analysis of FOXA2 staining showing higher percentage of FOXA2+ cells detected in bioreactor culture and 
corroborated the qualitative immunostaining observation. (F) Quantitative RT-PCR analysis on day 7 of bioreactor 
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culture showing higher upregulation of FOXA2 genes relative to static culture. (G) Representative immuno-staining 
image showing minimal PDX-1+ cells detected only in bioreactor culture condition (right). (H) The corresponding 
image analysis of PDX-1 staining showing a low percentage of PDX1+ (~4%) cells detected in bioreactor culture 
and corroborated the qualitative immunostaining observation. (I) Quantitative RT-PCR analysis detected higher 
PDX-1 gene expression in bioreactor culture relative to static culture.  
* indicates P<0.05 
3.4 DISCUSSION 
The design of perfusion systems and bioreactors to facilitate the development of organ 
engineering strategies is a nascent but rapidly growing field [108, 112, 171, 172, 177, 185]. 
Herein, we present the design and assembly of a simple and cost-efficient perfusion system 
comprised of parts that are routinely found in research laboratories for the decellularization and 
in vitro bioreactor culture of reconstructed pancreas seeded with MIN-6 beta cells and hESC 
differentiating cells. We show that bioreactor culture of reconstructed pancreas display improved 
cell engraftment, viability and phenotypic maintenance over static culture. 
In spite of its simplicity, our bioreactor is versatile and scalable. We tested this perfusion 
decellularization set-up on multiple intact organs: pancreas, liver and heart. Our assembled 
perfusion system achieved complete decellularization of the three tested organs with minor 
adjustments of the flow rate based on the inherent characteristics of the tissues. For example, we 
used only 2mL/min of flow rate for pancreas and liver given the high vascular density and 
delicate capillary network. Conversely for the heart with higher density of tissue, we increased 
the flow rate to 4mL/min to achieve complete decellularization – consistent with reports by other 
groups [108, 186, 187]. Notably, it may be possible to use low or graduated flow rates to allow a 
more gradual adaptation to changes in vascular resistance and flow, while minimizing the 
  83 
chances of ECM damage [168, 188]. Recently, several groups reported a decellularization 
technique to vary volume, flow or pressure with automation [168, 169, 189]. This enables better 
control of perfusion parameters in a reproducible matter and reduces the variability between 
investigators and experiments. While it is possible to implement such varying flow in our 
existing set-up, currently even with a fixed low flow rate  we could consistently preserve the 
ECM structure and micro-architecture such as intact vasculature and ductal conduit of the 
decellularized pancreas and liver as demonstrated by corrosion casting assay (Figure 3.2G-H). 
We demonstrated the feasibility for scale-up in Figure A.3, a higher throughput can be achieved 
by using a larger reservoir and silicone stopper to house additional organs and incorporate more 
cannulae for additional lines respectively. Similar approach was successfully demonstrated by 
Sullivan et al. using a 12-channel peristaltic pump to accommodate additional pump heads to 
drive the perfusion of additional lines for decellularization of porcine kidneys [139].  
Upon recellularization with relevant cell types, the whole organ construct needs to be 
cultured under media perfusion in order to allow adequate nutrient supply to ensure cell viability 
throughout the thickness of organ. This is particularly important for whole organs, where the 
thickness is too high for simple diffusive transport to meet the oxygen demand of engrafted cells 
cultured under high seeding density. Our bioreactor design allowed nutrient circulation via the 
preserved organ vasculature in a closed and compact system amenable to aseptic culture in a 
standard tissue culture incubator. However since the bioreactor is completely closed loop we 
took special measures to ensure gas exchange within the incubator, by including extra lengths of 
silicone tubing. Silicone tubing is highly permeable to oxygen and carbon dioxide, as well as 
most other common gasses [190]. We incorporated a mathematical model to determine the 
residence time within the silicone tubing required to allow perfusate gas concentration to 
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equilibrate with the surrounding of 5% CO2 and 95% room air before reaching the recellularized 
pancreas (Appendix A.1.1). Extending the length of the silicone tubing to meet the calculated 
residence time based on the slowest flow rate ensured adequate gas exchange. With this slow 
flow rate (1mL/min), Petersen et al. has reported to be suitable in delivering nutrients for in vitro 
culture of engineered tissues/organs [185]. Conversely, high perfusion flow rate (>5mL/min) 
may lead to undesired shear stress to seeded cells [191, 192]. In case of an enhanced oxygen 
demand from a higher cell density of the reconstructed organ, or more mature cells with higher 
oxygen demand, it is possible to further supplement with oxygen carriers such as 
perfluorocarbons [126, 193]. While extended silicone tubing is a simple contraption to allow gas 
exchange, it can result in a build-up of air bubbles. Hence we designed a bubble trap to capture 
the air bubbles before they enter the vasculature of the recellularized pancreas. This is a critical 
step in the bioreactor setup since introduction of air bubbles within the organ vasculature can 
have the severely detrimental effect of completely halting fluid flow [180], and cause extensive 
tissue damage [119]. 
The lack of an abundant source of human pancreatic islets is a major limitation in cell 
therapy approaches to diabetes treatment, hence prompting investigation into alternative cell 
sources. Human pluripotent stem cells have emerged as a promising avenue, and recent 
breakthroughs in pluripotent stem cells differentiation established the feasibility of generating β 
cells in vitro [55, 56]; this offers the unique opportunity to reconstruct pancreatic tissues from an 
expandable and renewable cell source. When compared with mature cells, stem/progenitor cells 
may have higher proliferation capacity, innate hypoxic resistance, superior functional plasticity, 
and the ability to migrate and localize within a given site-appropriate 3D anatomical location 
[111, 153, 194, 195]. Toward this end, we examined the feasibility of reconstructing 
  85 
decellularized pancreas with hESC-derived DE cells for in situ expansion and subsequent 
differentiation into pancreatic cell types within their native 3D environment. Our result showed 
that perfusion bioreactor culture significantly improved the cellular engraftment of hESC-DE 
seeded pancreatic construct. Static culture of the recellularized pancreas was found to be 
inadequate to maintain cellular proliferation and DE phenotype. With the perfusion bioreactor 
culture, on the other hand, we not only observed enhanced proliferation and phenotype 
maintenance, a small number of cells were also observed to demonstrate pancreatic commitment 
(as evidenced by PDX-1+ cells). Importantly, the DE-seeded pancreatic construct was cultured in 
basal culture medium without any growth factor induction. This reflects the potential role of 
decellularized ECM in directing stem cell fate as suggested by others [140, 153, 176, 186, 195, 
196]. 
The system we have described in this report is expected to help the tissue and organ 
engineering community build their own bioreactors in-house. While the proposed design is 
sufficient to decellularize as well as maintain reconstructed organ culture, it can further benefit 
from continued design improvements to allow for successive advancements in perfusion 
bioreactor design. For instance, the importance of monitoring organ growth and development 
using noninvasive imaging detection is not to be overlooked. Current data metrics from whole 
organ culture typically involves end-point analysis to assess cell survival, proliferation and 
function on the growing organ. New, noninvasive methods to evaluate organ and cell growth 
such as near-infrared (IR) imaging allows for deep tissue imaging with limited tissue scattering 
and auto-fluorescence [197]. We have demonstrated the feasibility of this noninvasive method of 
monitoring in our recellularized pancreas (Figure 3.3C). Ren et al. recently reported a non-
invasive resazurin reduction perfusion assay to assess cell viability and proliferation on bio-
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engineered whole organ constructs [198]. Another group, Uzarski et al. reported the monitoring 
of recellularized kidney and liver by sampling of physical and biochemical markers  such as 
hydrodynamic pressure and soluble biomarkers (e.g. albumin and kidney injury molecule-1) 
respectively [125]. Another area of improvement is the potential to fit the bioreactor with 
specific sensors to ensure a controlled environment. Biomimetic physical, electrical, or chemical 
stimuli could also be built-in to improve and promote its function. For example, mechanical 
stretching of heart tissue has been found to promote cell alignment [199] while electrical 
stimulation causes the coordinated beating of heart cells [200]. In addition, further studies are on-
going in our laboratory to define the optimal perfusion parameters and chemical growth factor 
complementation to promote differentiation and functional maturation of the reconstructed 
pancreas.  
3.5 CONCLUSION 
This chapter presents the development of a simple, cost-effective and scalable organ perfusion 
system that could be implemented to both decellularization and recellularization of vascularized 
intact organs. The reported design was successfully applied to pancreas, liver and heart to obtain 
whole organ bioscaffolds. Repopulation and culture of an engineered whole-organ pancreas 
could be performed in the adapted perfusion bioreactor with a β-cell line and hESC-derived DE 
cells toward the goal of producing an intact bio-engineered pancreas. After establishing the 
design and assembly of the bioreactor system, we next examine the feasibility to repopulate 
decellularized scaffolds with renewable hPSC in the chapter 4. 
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4.0  REPOPULATION OF DECELLULARIZED ORGAN SCAFFOLD WITH 
HUMAN EMBRYONIC STEM CELLS-DERIVED PANCREATIC PROGENITOR 
CELLS  
4.1 INTRODUCTION 
After developing a perfusion bioreactor that could be implemented to both decellularization and 
recellularization in Chapter 3, here in chapter 4 we focus on establishing the feasibility to 
repopulate whole organ scaffolds with renewable cell types such as human embryonic stem cells 
(hESC). Recent progress in repopulation of decellularized organ scaffolds with human 
pluripotent stem cells present a promising new avenue for the development of regenerative 
organs for the treatment of injured or diseased organs. Significant progress has been achieved 
using this approach in the whole organ engineering of heart [120, 135], lung [195, 196, 201, 
202], and kidney [140, 203]. With the same approach, pancreas organ engineering will likely 
have tremendous impact in regenerating bio-engineered pancreas for diabetes therapy. The 
objective of this chapter to study the potential of hPSC derived pancreatic lineage cells to 
repopulate and differentiate in decellularized organ scaffolds. 
Identifying a regenerative cell source is critical for tissue engineering and regenerative 
medicine therapy. Pancreatic tissue engineering studies to date have focused on the use of 
primary islets and immortalized endocrine β cell lines for restoring insulin function in diabetic 
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animal models [49-51, 62]. Primary human islets from donors, however, are scarce and also 
difficult to maintain in long term culture and cannot be expanded in vitro. Hence there is great 
interest in the use of human pluripotent stem cells (hPSC) (i.e. human embryonic (hESC) or 
induced pluripotent stem cells (hiPS)) to derive functional islets. The unlimited self-renewal 
potential of hPSCs make them particularly attractive for regenerative therapy. Hence hPSC 
derived pancreatic cell types will likely be attractive cell source for reconstruction of 
decellularized organ. By recapitulating the early pancreatic developmental stage, step-wise in 
vitro differentiation protocols have successfully generated pancreatic progenitors [61, 66-68] and 
insulin-producing cells from hPSC [78, 79]. Similarly, cardiac and lung lineage cells have been 
generated from hPSC and shown to successfully repopulate decellularized hearts [120, 135] and 
lungs [195, 196, 201, 202]. In addition, the complex ECM from these decellularized organs 
promoted further maturation into functional cell types (e.g. contractile cardiomyocytes for heart, 
and multi-ciliated airway cells for lungs). These prior studies clearly motivate the need and 
indicate the potential benefits that can be attained by repopulating whole organ scaffolds with 
hPSC differentiated cells. We hypothesize that similar enhancement may be expected in pancreas 
bioengineering. To this effect, we propose the repopulation of decellularized organ scaffolds 
with hPSC derived pancreatic cells. 
In the present chapter, we will evaluate the possibility of repopulating decellularized 
organ scaffolds (e.g. pancreas and liver) with pancreatic progenitor cells derived from hPSC. We 
have previously reported efficient differentiation of pancreatic progenitor cells from hPSCs on 
adherent cultures [70, 71], which we used to repopulate our decellularized pancreas. More 
recently, we reported an efficient derivation of PP aggregates by alginate encapsulation of hPSCs 
and subsequent differentiation under encapsulation [69]. The differentiated hPSC-PP aggregates 
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not only express enhancement of pancreatic differentiation than the parallel adherent cultures, 
but also retain cell-cell contact which makes them more amenable to organ repopulation. 
However, engraftment of these hPSC-PP aggregates required a more extensive vascular support, 
which was found to be superior in decellularized liver over the decellularized pancreas scaffold. 
Decellularized liver repopulated with hPSC-PP aggregates resulted in extensive and uniform 
cellular engraftment and viability throughout the thickness of the scaffold. More importantly, the 
seeded hPSC-PP aggregates matured into mono-hormonal C-peptide positive cells after 9 days of 
bioreactor culture. This chapter demonstrated the feasibility of using decellularized organ 
scaffolds for regenerative bioengineering of pancreas with potential applications in diabetes 
therapy, drug discovery and regenerative medicine. 
4.2 METHODS 
4.2.1 Human pluripotent stem cells (hPSC) culture and two-dimensional (2D) pancreatic 
differentiation 
The H1 embryonic stem cell lines were maintained in feeder free conditions as previously 
described in chapter 3.2.4.2. The first step of pancreatic differentiation is definitive endoderm 
(DE) induction. Once hESCs reached an average colony size of 1 mm in diameter, DE was 
induced as previously described [71] in chapter 3.2.4.3. Pancreatic progenitor was induced with 
0.2 μM KAAD-cyclopamine for 2 days and 0.2 μM KAAD-cyclopamine with 2 μM retinoic acid 
(Sigma-Aldrich) for 2 days. Finally, maturation was induced by 10 μM nicotinamide (Sigma-
Aldrich) for 2 days and 10 μM nicotinamide with 30 μM DAPT (Santa Cruz Biotechnology) for 
7 days. A basal media of DMEM/F12 plus 0.2% BSA and B27 serum supplement was used for 
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the differentiation. Cultures were performed with p55–p70 hESCs in 37ºC incubator, 5% CO2, 
and 100% humidity. All cytokines and small molecules were from R&D Systems unless 
otherwise specified. 
4.2.2 Decellularization of pancreas and liver 
All animal work performed was in accordance with animal welfare act, institutional guidelines 
and approved by Institutional Animal Care and Use Committee of the University of Pittsburgh. 
Mouse pancreas and liver were perfusion-decellularized using SDS and TritonX-100 protocol as 
previously described [50] in chapter 2.2.2 and chapter 3.2.2.  
4.2.3 Characterization of decellularized pancreas and liver 
Removal of cellular material from decellularized pancreata and livers was confirmed using 
hematoxylin & eosin (H&E) staining and scanning electron microscopy (SEM). Preservation of 
matrix protein was confirmed with immunostaining of matrix proteins (e.g. collagen IV). To 
characterize the preserved vascular network in the decellularized pancreas and liver scaffolds, we 
performed the corrosion casting using Batson’s 17 anatomic corrosion kit (Polysciences, Inc) and 
quantify vasculature network and organization using ImageJ angiogenesis analyzer [204, 205]. 
4.2.4 Differentiation of hPSC in alginate capsules 
Single-cell suspension of undifferentiated hESCs was encapsulated according to previous study 
[69]. Briefly, hESCs were pretreated with 10 μM Y-27632 (Millipore) before harvested into 
single cells with Accutase (Life Technologies). Single-cell solution of hESC (1×106 cells/mL) 
were suspended in filtered 1.1% (w/v) low-viscosity alginate (Sigma-Aldrich) with 0.2% (v/v) 
gelatin (Sigma-Aldrich) and added drop-wise to a solution of 100 mM CaCl2 (Sigma-Aldrich) 
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with 10 mM HEPES (Sigma-Aldrich) using a 22-gauge needle. Alginate capsules were incubated 
for 6–8 min in the CaCl2 solution. Capsules were washed three times with phosphate-buffered 
saline (PBS) and suspended in appropriate medium with 10 μM Y-27632 for 4 days prior to 
differentiation. To initiate differentiation, similar step-wise induction cocktails were utilized as 
described in the 2D protocol above. First, DE was induced using 100 ng/mL ActivinA and 
25 ng/mL Wnt3A for 4 days. Afterward, PP was induced with 0.2 μM KAAD-cyclopamine for 2 
days and 0.2 μM KAAD-cyclopamine with 2 μM retinoic acid (Sigma-Aldrich) for 2 days. All 
cytokines and small molecules were from R&D Systems unless otherwise specified. All 
differentiation media were made using DMEM/F12 (Life Technologies), supplemented with 
0.2% bovine serum albumin (BSA; Sigma-Aldrich) and 1xB27 (Life Technologies). 
4.2.5 Seeding of hPSC derived PP cells and 3D PP aggregates in decellularized scaffolds 
Cell seeding was performed according to the method previously described [50] in chapter 2.2.5 
and 3.2.5. For seeding with 3D PP aggregates, cells were first decapsulated with 100 mM EDTA 
(Sigma) and washed twice with PBS followed by same seeding steps as hESC-PP. For both cell 
types, cells were allowed to attach overnight. A gentle rinse through the hepatic portal vein was 
followed in order to wash out any unattached cells after which bioreactor culture was resumed. 
4.2.6 Bioreactor culture of repopulated pancreas and liver 
For in vitro culture of repopulated pancreata (n=2) and livers (n=3) with hESC-derived PP cells, 
a perfusion bioreactor was set up as previously described in chapter 3.2.8. The repopulated 
organs were cultured in maturation media consists of DMEM/F12 plus 0.2% BSA and B27 
serum with nicotinamide (10 μM, Sigma Aldrich) and notch inhibition (30 uM DAPT, Santa 
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Cruz) for 9 days. The bioreactor was placed in an incubator at 37°C with a 95% air / 5% CO2 
atmosphere with one complete media change in day 4. 
4.2.7 Cell labelling and LI-COR Whole Organ Imaging 
Cell labeling and LI-COR whole organ imaging was performed as previously described in 
Chapter 3.2.6.  
4.2.8 Flow cytometry analysis 
hPSC-PP and 3D PP aggregates were characterized by flow cytometry using primary antibodies 
including goat anti-PDX1 and goat anti-NKX6.1 (1:200, R&D Systems). First the cells were 
treated with Accutase and passed through cell strainer (40µm, Fisherbrand) to obtain uniform 
single-cell suspension. Next, the cells were fixed with 4% formaldehyde (Thermo Scientific) in 
PBS for 30 min followed by permeabilization with 0.1% Saponin (Sigma-Aldrich) with 0.5% 
BSA in PBS for 30 min. Blocking for nonspecific binding was performed by incubating cells 
with 3% BSA with 0.25% dimethyl sulfoxide and 0.1% Saponin in PBS for 30 min. After 
primary antibodies incubation for 30 min at room temperature, samples were washed 3 times (5 
min each) before incubating with secondary antibodies Alexafluor 555 (Life Technologies) for 
30 min at room temperature. Secondary antibodies stained only samples were used as the 
negative control. In the final step, samples were washed and suspended in PBS before 
transferring to flow cytometry tubes. Accuri C6 © Flow Cytometer was used to quantify the 
protein expression. The gate was set beyond cells positive for secondary antibody only to 
eliminate false positives. 
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4.2.9 Histology and immunofluorescence staining 
Decellularized and recellularized organs were fixed, sectioned and stained following protocol 
previously described [23] in chapter 2.2.8. The following primary antibodies and dilutions were 
used: (1:100, abcam), goat anti-Sox17, goat anti-PDX1, goat anti-ISL1, goat anti-NKX6.1 
(1:200, R&D Systems Inc.), rabbit anti-KI67 (1:200, Santa Cruz) rabbit anti-FOXA2 and rabbit 
anti-Cpeptide (1:100, Cell signaling). Secondary antibodies used were: donkey anti-rabbit 
Alexafluor 488 and 555 (1:500, Invitrogen) and donkey anti-goat Alexafluor 488 and 555 (1:500, 
Invitrogen). For apoptotic cell detection, deoxynucleotidyl TUNEL assay (APO-BrdU TUNEL 
Assay Kit, Molecular Probes) was used, following the manufacturer’s instructions.  
4.2.10 Quantitative RT-PCR 
qRT-PCR was performed as previously described [50] in chapter 2.2.15. 
4.2.11 Statistical analysis 
Statistical analysis was performed as previously described [50] in chapter 2.2.16. 
4.3 RESULTS 
4.3.1 hPSC-derived pancreatic progenitors (hPSC-PP) engraft in decellularized whole-
organ scaffolds and maintain pancreatic phenotype 
Figure 4.1A-D illustrates the overall workflow used to repopulate decellularized mouse pancreas 
with hPSC. To examine the potential of hPSC to repopulate decellularized whole-organ scaffolds 
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and generate pancreatic tissue in vitro, the first step was to obtain decellularized pancreatic 
scaffolds from adult mice. Using a perfusion-decellularization protocol with SDS, TritonX-100 
detergent solution as previously described [50] (Figure 4.1D), we achieved rapid and complete 
decellularization of the mouse pancreas. Histologic staining and electron microscopy (EM) 
analyses of decellularized scaffolds confirmed removal of all host cells (Supplementary Figure 
A.7). 
Next, we differentiated hPSCs to the pancreatic progenitor stage (hPSC-PP) and used it to 
repopulate the decellularized pancreas. This stage seems most suitable because of their 
commitment to express the transcription factor pancreatic and duodenal homeobox1 (Pdx1), 
which is the master regulator giving rise to all pancreatic lineage cells [184]. We used our 
previously published directed differentiation protocol [70, 71] to induce the differentiation of 
pancreatic progenitors (PP) from human H1 ES cells (Figure 4.1A-C). During embryonic 
development, pancreatic-specific progenitors originate from definitive anterior endoderm found 
in the developing foregut [58, 206, 207]. Therefore, we first generate definitive endoderm from 
hPSC using Activin A (100 ng/ml) and Wnt3a (25 ng/ml) for 4 days (day 0-4). At day 4, uniform 
expression of endoderm transcription factor Sox17 was observed by immunostaining, quantified 
to be 82 ± 8% by image analysis (Figure 4.1B), indicating DE fate commitment of hPSC. This is 
consistent with previously reported flow cytometry analysis of DE differentiation [71]. We then 
induce pancreatic progenitor cell fate by sonic hedgehog inhibition (KAAD Cyclopamine, 
0.2µM) for 4 days (day 4-8) and retinoic acid from days 6-8. We detected an average of 29% ± 
5% of cells expressing the transcription factor pancreatic and duodenal homeobox1 (Pdx1) 
(Figure 4.1C, 2E). These results indicate the success in inducing pancreatic lineage by exogenous 
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growth factors as has also been previously described by other groups with hPSCs [57, 58, 69, 70, 
78, 79, 206]. 
After the derivation of PP cells from hPSC, we then seeded the hPSC-PP cells (10 million 
cells in 3 steps) into the decellularized pancreas scaffold via the portal vein and cultured the 
repopulated pancreas in an in-house designed bioreactor (manuscript in preparation). The 
bioreactor allows media perfusion through the preserved vasculature and maintain viability of the 
repopulated organ. The repopulated pancreas was maintained under perfusion culture in the 
bioreactor with circulating maturation media for 9 days. The media was supplemented with 
Notch inhibitor (10 μM nicotinamide with 30 μM DAPT), a known inducer of beta cell 
maturation [57, 76, 208, 209]. In parallel, we also seeded hPSC-PP cells on matrigel – a 
commonly used substrate, as control. After culturing for 9 days, the recellularized pancreata were 
characterized for engraftment, proliferation and pancreatic fate of the seeded cell population. 
Histologic assessment revealed notable cell engraftment within the scaffold (Figure 4.1E). 
Human nuclei staining confirmed the engrafted cells were from human origin (i.e. hPSC-derived 
PP; Figure 4.1F). Cell proliferation within whole-pancreas cultures was confirmed by Ki-67 
staining (Figure 4.1G). Immunostaining for endoderm transcription factor, Foxa2, revealed a 
small population of cells still expressing Foxa2 (Figure 4.1H). However prior studies have 
shown that Foxa2 expression persists to adulthood, where it is expressed throughout the islet and 
in acinar cells [210, 211]. Pdx1 expression could be detected in the nucleus of the engrafted 
cells, confirming the retention of pancreatic progenitor phenotype (Figure 4.1I). In contrast, the 
matrigel control showed strong Pdx1 expression only in the small portion of cells which formed 
mini-clusters with strong cell-cell contact (Figure 4.1L), and not in majority of the cells spread 
on the matrix.  
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The Notch signaling pathway promotes the maintenance of pancreatic progenitor 
properties and their expansion [212, 213]. Small molecule DAPT, a gamma-secretase inhibitor 
that blocks Notch signaling has been reported to be effective for differentiating human ES cells 
and iPS cells into insulin-producing cells [57, 76, 209]. However in our experiment with 
recellularized pancreas with hPSC-PP cells, treatment with DAPT did not result in further 
specification toward insulin positive phenotypes. A small number of Nkx6.1+ cells were detected 
(Figure 4.1J) but no insulin (C-peptide) expression was found by immunostaining (Figure 4.1K).  
Taken together, these data indicate that the decellularized pancreas is suitable for 
reconstruction with hPSC derived cell types. However pancreatic differentiation also seems to be 
favored by the strong cell-cell contact, which is lost in the current setting where the hPSC 
derived cells are harvested from adherent cultures into single cell suspension by enzyme 
digestion. Instead, maintaining the hPSCs in aggregates, with retained cell-cell contact, can be 
expected to be advantageous. Several groups have developed techniques for deriving hPSC-PP in 
aggregate cultures [72, 75, 78, 214]. We [69] have recently demonstrated the advantage of 
aggregate cultures over adherent culture in enhancing pancreatic phenotype. Hence, in the next 
step we tested the feasibility of repopulating the decellularized scaffolds with hPSC-PP 
aggregates. 
 
  97 
 
 
Figure 4.1 Schematic summarizing the hPSC differentiation and decellularization-recellularization of 
pancreas. 
 (A-C) Two-dimensional (2D) directed differentiation protocol of hPSC to pancreatic progenitor (PP) cells 
in vitro. (B) Immunostaining staining of definitive endoderm (DE - green) intermediates, Sox17+ cells. (C) 
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Immunostaining of PP, Pdx1+ cells (red). Cytokines were added at different steps indicated on top of panel. (D) 
Perfusion-decellularization of cadaveric pancreas and the seeding with hPSC-PP for 9 days bioreactor culture. (E) 
H&E staining of decellularized pancreas (left) and repopulated pancreas after 9 days bioreactor culture (right). (F) 
Positive human nuclei staining (hnuclei - green) demonstrates the engrafted cells are from human origin (hPSC-PP) 
but not from residual mouse pancreatic cells (G) Immunostaining of proliferation marker, Ki67 - green (H) 
endoderm transcription factor, Foxa2 endoderm marker (green), and (I) pancreatic progenitor marker, Pdx1 - red. (J) 
Immunostaining detection of endocrine progenitor transcription factor, Nkx6.1 (red) but (K) no detection of insulin 
expression, C-peptide (green). (L) Immunostaining of Pdx1 (red) was only found positive in clustering cells of 
matrigel control sample. 
4.3.2 hPSC-PP aggregates as an alternate candidate to repopulate decellularized scaffolds 
We have previously developed a platform to enable efficient differentiation of hPSCs to PP, 
enclosed within alginate capsules [69]. Figure 4.2A outlines the procedure, where self-renewing 
hPSCs are encapsulated in alginate capsules and propagated for 6 days, at which time the cells 
form small colonies. The encapsulated colonies are further differentiated following the procedure 
detailed earlier (Figure 4.1A), inducing DE differentiation at Day 10 and pancreatic progenitor 
phenotype at Day 14. At the end of the PP stage differentiation (day 14), the size of the spherical 
clusters were within the range of 100–300 µm in diameter (Figure 4.2B). The hPSC-PP 
aggregates could be conveniently decapsulated by 100 mM EDTA treatment. Immunostaining of 
the decapsulated hPSC-PP aggregates showed highly co-localized Pdx1+ and Nkx6.1+ staining 
(~75%, Figure 4.2C), hence indicating strong pancreatic commitment. qRT-PCR analysis 
revealed strong upregulation of pancreatic progenitor transcription factors Pdx1 and Nkx6.1 and 
downregulation of pluripotency marker Oct4; these were significantly higher than parallel 
differentiation under adherent cultures (P<0.01, Figure 4.2D). Flow cytometry analysis also 
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confirmed higher population of differentiated cells in 3D aggregates as compared to adherent 
cultures, as judged by fraction of cells expressing Pdx1 (55.9% ± 7.1% versus 24.2% ± 4.5%, 
P<0.01; Figure 4.2E) and Nkx6.1 (37.8% ± 5.6% versus 15.0 ± 2.4%, P<0.01; Figure 4.2E). 
Recent evidence suggests that Nkx6.1 strongly correlate with endocrine specific differentiation 
and β cell function [66, 68]. Accordingly, the reduced number of Nkx6.1+ cells obtained from 
our adherent cultures (Figure 4.1I-J) could be the reason behind lack of maturation of the 
engrafted cells in the decellularized scaffold. 
 
Figure 4.2 Schematic summarizing the large scale differentiation of hESC in alginate capsules and 
repopulation into decellularized pancreas and liver.  
(A) Step-wise differentiation protocol in alginate capsules to derive 3-dimensional (3D) PP aggregates. (B) 
Bright-field image of decapsulated 3D PP aggregates after differentiation for 14 days. (C) Immunostaining of 3D PP 
aggregates demonstrates high co-localized staining of Pdx1 – red and Nkx6.1 – green, in the nucleus. (D) qRT-PCR 
analysis of 2D differentiated PP and 3D PP aggregates (data normalized to GAPDH and average fold change of gene 
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expression over hESC). (E) Flow cytometry analysis for the percentage of pancreatic progenitor cells, Pdx1 and 
Nkx6.1 between 2D differentiated PP and 3D PP aggregates. (F) Growth curve of hESC-3D PP aggregates using 
alginate capsules technology. Error bars indicate ± SEM and n=3 independent experiments for qRT-PCR and flow 
cytometry. ** P<0.01. 
4.3.3 An alternate, highly vascularized platform to allow reconstruction with cell 
aggregates: Decellularized liver scaffold 
Our previous analysis clearly demonstrates the enhanced efficiency of pancreatic differentiation 
when hPSCs are cultured and maintained as aggregates. Even from islet functionality standpoint 
there is evidence that both primary β-cells [215, 216] and pluripotent stem cells (PSC) derived β-
cells [69, 75] secrete more insulin when maintained in 3D aggregates than in adherent 
monolayers. However, while 3D aggregates improve cell function it also restricts nutrient 
availability into aggregate core. Diffusive transport can at best support the nutrient demand for 
cell clusters up to 200 μm [217], beyond which active convective transport or intra-cluster 
vasculature will be required for nutrient delivery. Furthermore, the inclusion of aggregates in 
whole organ scaffolds will introduce an additional mass transfer resistance, where the transport 
efficiency will be largely dependent on the vascular network of the decellularized organ. To 
determine a suitable scaffold for hPSC-PP aggregates, but from the vascular standpoint, we 
attempted to decellularize liver because of its unique liver sinusoids blood vessels, giving them a 
larger cross-sectional area (about 30 μm in diameter) than capillaries [218], hence permitting 
efficient media perfusion and enhancing nutrient delivery. In addition, liver originates from 
endodermal germ layer with close anatomical proximity and association with pancreas. To this 
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end, we hypothesized that decellularized liver could yield an alternate compatible organ scaffold 
to support the repopulation of hPSC PP-aggregates. 
Similar to pancreas, the decellularization of liver generated translucent acellular liver 
ECM scaffolds (Figure 4.3A-B). Histology and immunostaining showed no cell remnants with 
preservation of major ECM structure (Figure 4.3C-D). In order to quantitatively compare the 
preserved vascular network in pancreas and liver, we first performed corrosion casting on both 
the decellularized organs. The preserved vascular network and organization was quantified using 
ImageJ angiogenesis analyzer [204, 205] (Figure 4.3E-F). Comparing between liver and pancreas 
vasculature, we found that decellularized liver has a significant higher number of branching 
points per field (285 ± 39 versus 101 ± 19, P<0.01; Figure 4.3H) and higher vessel density 
(36.5% ± 9.8% versus 15.4% ± 5.2%, P<0.01; Figure 4.3H) than decellularized pancreas. Hence 
decellularized liver has a more extensive preserved vasculature which is expected to enhance 
nutrient perfusion and hence more suitable for repopulation with hPSC-PP aggregates. 
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Figure 4.3 Decellularization and characterization of mouse liver.  
(A) Panel images depict gradual change of color from perfusion-decellularization of mouse liver. (B) 
Resulting decellularized liver after 134 min appeared clear and translucent. (C) Histological comparison of native 
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and decellularized liver by H&E staining showed removal of cells. (D) Immunohistochemistry demonstrated the 
presence of major ECM protein (Collagen IV – green) in native liver also preserved in decellularized liver but 
cellular stain (DAPI) were absent. (E-F) Top panel shows threshold images from decellularized pancreas and liver 
used for ImageJ angiogenesis analysis, bottom panel shows the marked skeleton detected by the angiogenesis 
analyzer. The resulting calculation output of (G) branch points and (H) vessel density between decellularized 
pancreas and liver. Error bars indicate ± SEM and n=3 independent experiments for vessel image analysis. ** 
P<0.01. 
To test this hypothesis, we delivered the decapsulated hPSC-PP aggregates (using the 
same multi-step seeding approach) into both the portal vein of a decellularized liver and into 
decellularized pancreas. Both the reconstructed organs were cultured in perfusion bioreactor for 
9 days with maturation medium described above. In order to track the cells within the organ 
scaffold, the hPSC-PP aggregates were pre-labelled with Vybrant DiD near infra-red (NIR) dye 
before seeding into decellularized scaffolds. The pseudocolor fluorescence images from LI-COR 
presented in Figure 4.4A (pancreas) and Figure 4.4B (liver) illustrates the cells’ distribution 
throughout the repopulated liver and pancreas scaffolds. This confirms the cell delivery and 
retention in the decellularized liver and pancreas after the multi-step cellular infusion steps. The 
repopulated pancreas scaffold displayed a few saturated fluorescence spots, suggesting cellular 
occlusion. This will likely lead to pressure drop and subsequent under perfusion of media to the 
repopulated pancreas. In contrast, the cellular distribution in the repopulated liver scaffold were 
homogenously distributed as evidenced by uniform pseudocolor fluorescence detected 
throughout the liver scaffold. Quantitative comparison of the mean fluorescence intensity (MFI) 
of the reconstructed scaffold between the two organs revealed a significantly higher MFI in liver 
than in pancreas at all three seeding steps (P<0.05; Figure 4.4C), confirming higher cellular 
engraftment in liver. In parallel, we also directly quantified the post-seeding cellular retention 
within the organ by collecting the perfusate and counting the total cell loss after each seeding. As 
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illustrated in Figure 4.4D, the repopulated liver retained significantly more cells than the 
repopulated pancreas (78% ± 5% versus 59% ± 6%, P<0.05), which is consistent with the results 
from LI-COR imaging. In particular, after the 3rd seeding, a very high number of cells (2 - 4 
million) were observed in the perfusate, perhaps due to the near saturation of the scaffold with 
the seeded cells. Both the reconstructed scaffolds were connected to bioreactor and cultured for 9 
days. As illustrated in Figure 4.5, reconstructed liver retained a near complete cellular coverage 
(Figure 4.5D), and was significantly higher than repopulated pancreas (Figure 4.5A). 
 
Figure 4.4 Cell seeding and distribution comparison between repopulated pancreas and liver.  
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(A-B) LICOR images of repopulated pancreas and liver with labeled DiD dye demonstrate the cell 
engraftment and distribution within the scaffolds. (C) Relative mean fluorescence intensity (MFI) of the both 
repopulated organs at three seeding steps (signal was normalized to pre-seeded decellularized scaffolds). (D) Cell 
count of percentage cell loss after each seeding step. Error bars indicate ± SEM and n=3 independent experiments 
for cell seeding analysis. * P<0.05; ** P<0.01. 
Histological analysis of the reconstructed pancreas revealed majority of the hPSC-PP 
aggregates were concentrated along the vascular channel (Figure 4.5B) and less so in the 
parenchyme. Also significant cell debris and apoptotic cells were apparent in the reconstructed 
pancreas, as confirmed by TUNEL staining (Figure 4.5C). In contrast, we obtained large cellular 
engraftment of approximate 1000 µm in the repopulated liver (Figure 4.5D, E, 6B). Further, 
TUNEL staining was minimal in the repopulated liver (<5%, Figure 4.5F). Taken together, these 
data suggests that the vascular structure of the liver allows large engraftment of the hPSC-PP cell 
aggregates, but in repopulated pancreas hPSC-PP primarily gets localized in the vessels. 
Furthermore, the liver vasculature allows adequate nutrient perfusion to retain viability of the 
engrafted cells. Hence overall, decellularized liver was deemed to be more suitable for 
reconstruction with 3D hPSC-PP aggregates. 
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Figure 4.5 Engraftment and viability of repopulated pancreas and liver after 9 days bioreactor 
culture.  
(A) LICOR image of repopulated pancreas shows cellular distribution localized only at certain regions of 
the scaffold. (B) H&E staining of repopulated pancreas shows cellular engraftment concentrated on the larger vessel 
of pancreas with high number of cellular debris (C) Corresponding section stained with TUNEL (green) detected 
high number of apoptotic cells. (D) LICOR image of repopulated liver shows homogenous cellular distributed 
throughout the scaffold. (E) H&E staining of repopulated liver shows high cellular engraftment within the scaffold, 
asterisk denotes presence of vessel lumen. (F) Corresponding section of TUNEL staining (green) shows engraftment 
cells were viable with minimal TUNEL+ cells (<5%) detected. 
4.3.4 Pancreas regeneration in liver scaffold 
While liver is not the native environment for endocrine pancreas, the significant engineering 
advantages of the liver scaffold prompted us to investigate feasibility of maintaining pancreatic 
phenotype and maturation of the hPSCs in a liver scaffold. This will allow us to harness these 
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scaffolds’ extensive vasculature to repopulate and grow engineered organs. With the promising 
success in engraftment and viability, we next evaluated the consistency of engraftment across the 
tissue depth. We analyzed this through H&E staining at different depths of repopulated liver 
after 9 days of bioreactor culture. As illustrated in Figure 4.6A, we observed significant cell 
engraftment in all the tested tissue depths, demonstrating that decellularized livers were 
thoroughly and homogenously repopulated after seeding. 
Having confirmed thorough engraftment of the hPSC-PP cells, we cultured the 
repopulated liver in the bioreactor, with maturation media, and analyzed for pancreatic specific 
markers. Quite encouragingly, a high number of Pdx1+ cells were detected throughout the 
repopulated liver, lined by basement membrane proteins collagen IV, as illustrated in Figure 
4.6B. We further confirmed that the engrafted cells were from hPSC origin by staining for 
human specific nuclei marker (Figure 4.6C). The repopulated liver also stained positive for 
proliferation marker, Ki67 (Figure 4.6D), although at a much reduced level as compared to the 
repopulated pancreas with hPSC-PP cells from adherent cultures (Figure 4.1G). Immunostaining 
for islet-cell specific markers such as Isl-1 and Nkx6.1 confirmed a larger pool of endocrine 
progenitor population (Fig. 4.6G-J) in the repopulated liver. In contrast, Isl-1+ cells were 
undetectable and Nkx6.1+ cells were only found in minimal numbers in repopulated pancreas 
with hPSC-PP cells from adherent cultures (Figure 4.1J-K). These results suggest that the 
decellularized liver scaffold repopulated with hPSC-PP aggregates gives rise to a more mature 
phenotype, with an increase in the number of endocrine lineage differentiated cells and a 
concurrent reduction in cell proliferation.  
Several studies over the past decade have demonstrated that it is possible to generate 
pancreatic cells from hPSC; including both monohormonal insulin-expressing cells as well as 
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polyhormonal cells expressing insulin and glucagon [78, 79, 219]. Normally, polyhormonal cells 
do not express Nkx6.1 and are non-glucose responsive [6, 220]. In contrast, monohormonal 
insulin+ cells typically express Nkx6.1, and are glucose responsive. In our reconstructed organ 
scaffold, we detected a small number of C-peptide+ cells with almost all of them co-expressing 
Nkx6.1+ (arrowhead, Figure 4.6M). Furthermore, among the C-peptide+ cells, none were co-
expressed with glucagon, indicating that they represent monohormonal endocrine cells (Figure 
4.6L). In contrast, cultures on matrigel control revealed significant double positive staining of C-
peptide and glucagon (Figure 4.6K) and only low numbers of Nkx6.1+ cells were detected 
(Supplementary Figure A.8), suggesting a predominantly polyhormonal population. qRT-PCR 
analysis also corroborated this finding and revealed significantly higher Nkx6.1 gene expression 
in the repopulated liver than matrigel (937-fold versus 1.3-fold, P<0.01; Figure 4.6N). Although 
the insulin gene expression was about the same between repopulated liver and the matrigel 
control, the glucagon expression was significantly higher in matrigel than the repopulated liver 
(7.48-fold versus 2.23-fold, P<0.05; Figure 4.6N). This is consistent with the immunostaining 
result and could be attributed to the polyhormonality observed in matrigel. Altogether, these 
results indicate that decellularized liver reconstructed with hPSC-PP aggregates exhibit excellent 
engraftment throughout the organ. The engrafted cells show high pancreatic islet specific 
markers (Pdx1, Isl1 and Nkx6.1) and could be further matured into monohormonal C-peptide-
positive cells. 
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Figure 4.6 Characterization of 3D PP aggregates repopulated liver after 9 days bioreactor culture. 
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(A) H&E staining of day 9 tissue sections generated from various depths shows repopulation of entire 
decellularized liver. (B) Immunostaining of repopulated liver section shows lined cells (DAPI-blue) throughout the 
thickness (500 – 1000 μm) of the liver matrix protein (Collagen IV – green). Inset shows high magnification of 
pancreatic committed, Pdx1+ (red) cells detected within the repopulated liver. (C) Positive human nuclei (hnuclei – 
green) confirmed engrafted cells were from human origin (i.e. 3D PP aggregates) but not from residual mouse liver 
cells. (D) Lower number of proliferative cells, Ki67+ (green) was detected compared to when repopulated with 2D 
differentiated PP cells. (E) Immunostaining of repopulated liver detected positive cells with Pdx1 transcription 
factor. (F) Higher magnification inset shows the nuclear localization of Pdx1. (G-H) Immunostaining of the few 
engrafted cells acquired more pancreatic endocrine progenitor fate showing Isl-1+ cells (red). (I-J) Immunostaining 
at day 9 also detected Nkx6.1+ cells. (K) Immunostaining of matrigel control shows positive for polyhormonal cells 
(Glucagon – red, Cpeptide – green). (L) Repopulated liver shows maturation into mono-hormonal insulin+ 
(Cpeptide – green) cells (without glucagon – purple) and co-expressed Nkx6.1 (red), endocrine marker. (M) Co-
expression staining of C-peptide and Nkx6.1 (white arrowhead). (N) qRT-PCR analysis of 3D PP aggregates seeded 
into mouse liver scaffold in bioreactor and compared to matrigel culture. (data normalized to GAPDH and average 
fold change of gene expression over pre-seeded 3D PP aggregates). Error bars indicate ± SEM and n=3 for matrigel 
experiment, n=1 for repopulated liver qRT-PCR analysis. 
4.4 DISCUSSION 
Recent progress in repopulation of decellularized organ scaffolds with human pluripotent stem 
cells present a promising new avenue for the development of regenerative organs for the 
treatment of injured or diseased organs. Significant progress has been achieved using this 
approach in the organ engineering of heart [120, 135], lung [195, 196, 201, 202], liver [116, 117, 
136] and kidney [140, 203]. With a similar approach, organ engineering of pancreas is likely to 
have tremendous impact in regenerating bio-engineered pancreas for diabetes therapy. However, 
this has not been achieved to date. In this chapter, we report, for the first time, the repopulation 
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of decellularized organs with hPSC-derived pancreatic progenitor cells. We demonstrated the 
feasibility of repopulating decellularized pancreas with hPSC-PP cells from adherent culture. 
However, given the enhanced differentiation potential and the retention of cell-cell contact of 
hPSC-PP in aggregates, we explored repopulation with the hPSC-PP aggregates instead. But, the 
additional mass transfer resistance of aggregates requires an extensive vasculature network for 
efficient nutrient transport, which was found to be superior in liver over pancreas scaffold. 
Hence, we demonstrated the feasibility of repopulating decellularized liver with hPSC-PP 
aggregates, which showed significantly higher cellular engraftment and viability than 
repopulated decellularized pancreas with hPSC-PP aggregates. Finally, with chemical 
complementation and bioreactor culture, these seeded PP aggregates grown within the whole 
liver scaffold with homogeneity and matured in situ into monohormonal insulin-expressing cells. 
Early organ engineering studies primarily focused on repopulating decellularized organ 
scaffolds with primary cells or immortalized cell lines [108, 111, 136]. While these studies 
present a promising new avenue for organ regeneration, the lack of abundant functionally mature 
cells is a major limitation to the clinical application of engineered organs. Human pluripotent 
stem cells (i.e. ES and iPS cells) represent an attractive cell source owing to its virtually 
unlimited replicative capacity and the potential to differentiate into a variety of cell types. By 
recapitulating embryonic and fetal developmental stages using external growth factors or small 
molecule inhibitors, recent PSC differentiation protocol has enabled the generation of pancreatic 
β cells in vitro with high efficiency [78, 79]. In our previous study and current work, we 
demonstrated that alginate encapsulated hPSCs exhibited significantly matured pancreatic 
phenotypes (higher Pdx1 and Nkx6.1 expressions) than parallel adherent cultures on matrigel 
coated TCP. Furthermore, these differentiated hPSC-PP aggregates allow convenient harvesting 
  115 
for reseeding into the scaffold, without greatly disrupting the cell environment within the 
aggregates. In contrast, harvesting of differentiated cells from adherent cultures results in single-
cell suspension from the enzymatic digestion. This will lead to loss of critical cell-to-cell contact, 
which is known to activate apoptotic pathway in hPSCs. While Rho-associated protein kinase 
(ROCK) inhibitor (i.e. Y-27632) has been illustrated to boost cell survival in this process, it only 
improves the viability by ~20% [221, 222]. Because of the preserved cell-cell and cell-ECM 
contact within the aggregates it was hypothesized to be a superior candidate for organ 
reconstruction. While the large aggregate dimension (diameter varies between 100 to 350 μm) 
may present other challenges such as vessel occlusion which will lead to under perfusion and 
necrotic core from nutrient deprivation, our histological analysis in repopulated liver revealed 
that lumen of liver capillary segments remained patent surrounded by large viable engraftment of 
PP aggregates (Figure 4.5E).  
Previous reports of successful reconstruction of decellularized organ scaffolds with PSC-
derived cell types [120, 135, 195, 196, 201] have reinforced the importance of a 3D ECM setting 
for supporting cell adherence, organization, and maturation. Organ-specific differences in ECM 
composition, morphology, and structural properties may also potentiate lineage specification 
after recellularization and maturation within native organ’s environment [164, 196, 223]. 
Accordingly, decellularized pancreas will be deemed best suited for pancreatic maturation of 
hPSCs. However pancreas is a complex organ supporting two different functions by two distinct 
cell population: 1) the endocrine cells, arranged mainly in groups as islets of Langerhans 
composed of different cells (α, β, δ and PP), and 2) the exocrine (acinar) cells. It is noteworthy 
that only 2% of the pancreas is made up of endocrine cells, with the rest of it predominantly 
exocrine cells. Hence, in pancreas scaffold it is likely that the repopulated cells will be majorly 
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exposed to the exocrine microenvironment of the pancreas. While there is reported evidence of 
feasibility to reprogram exocrine cells into endocrine lineage [81, 82], it is not obvious if the 
exocrine ECM will be specifically supportive of endocrine differentiation. Although extracting 
endocrine ECM from isolated islets will be the most relevant, however there are still technical 
challenges in retaining islet-specific ECM due to its low availability in pancreas. In addition, the 
complex inter-dispersed ECM components of islets makes it difficult for detergent extraction 
without compromising the native islet ECM structure [127]. 
In this chapter, we propose to use the decellularized liver as an alternate organ scaffold to 
reconstruct pancreas. Despite the organ-specific differences between liver and pancreas, both of 
these organs have the same development origin of endoderm germ layer. There is also some 
reported evidence of feasibility of trans-differentiation of mature hepatocytes into functional 
endocrine pancreas [84, 85]. However, the most significant advantage using liver over pancreas 
as a supporting scaffold stems from a bioengineering perspective. The liver possesses 
significantly higher vascular density which allows for thorough media perfusion, enhancing 
nutrient delivery to and waste removal from the 3D reconstructed organ. As a result, we 
observed more homogenous repopulation of the hPSC-PP aggregates with higher viability within 
the liver scaffold as compared to pancreas. Furthermore, the complex native liver ECM has been 
reported to maintain a higher open fenestrations upon cellular seeding than individual ECM 
components and matrigel [224]. Thus, this unique feature is likely to facilitate free movement of 
plasma into the parenchymal space and further enhance the nutrient transport for the seeded cell 
population. From a clinical perspective, liver has been used as a supportive transplantation site 
for pancreatic islets via portal vein infusion [225] (same delivery route as our seeding method). 
The relatively simpler architecture of liver with distinct inlet and outlet vasculature facilitate the 
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process of vessel anastomosis when connecting the reconstructed organ to host vessels during 
transplantation. Some other groups have also shown that alternate organ scaffolds can be 
supportive of cellular function from a different tissue origin. For example, Willenberg et al. 
seeded immortalized beta cell lines into kidney scaffold and demonstrated the feasibility of 
repurposing of kidney scaffolds for growth of insulin producing beta cells [226]. More recently, 
Sionov et al. reported long term maintenance of human islets insulin secretion (three months) 
when seeded on lung acellular microscaffolds [227]. 
Our decellularized liver reconstructed with hPSC-PP cells under perfusion bioreactor 
culture with appropriate chemical complementation, demonstrated further maturation into mono-
hormonal insulin-expressing cells. In contrast, the parallel cultures on matrigel control under 
identical chemical induction differentiated into immature polyhormonal cells (co-expression of 
C-peptide+ and Glucagon+). This is consistent with other studies that have reported β-cell 
colonies or organoids grown in Matrigel expressed β-cell markers at low or undetectable levels 
and were not responsive to glucose [186, 228]. Matrigel is a solubilized ECM preparation 
extracted from the Engelbreth-Holm-Swarm (EHS) mouse sarcoma, despite the abundance of 
ECM protein, however it lacks the proper ECM configuration of a native organ, which likely 
limits the maturation of hPSC-PP cells. Another possible explanation could be attributed to the 
synergistic effect of appropriate combination of complex ECM proteins in decellularized organs 
and chemical complementation. Decellularized organs preserve a plethora of ECM proteins and 
matrix associated proteoglycans that are important modulators of growth factor binding and 
signaling [101, 229]. When supplemented with appropriate growth factors, ECM and its 
associated proteins function to stabilize the ligand receptor complexes, increase the local 
gradients and promote ligand internalization and processing [230-232]. 
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Despite the importance of native ECM, the decellularized organ ECM alone is likely to 
be limited in its ability to provide all of the necessary signals required for differentiation of ESCs 
without the additional chemical complementation or use of appropriate growth factors [135, 
223]. In our previous study of pancreas reconstruction with hPSC derived DE cells (manuscript 
in preparation), we only saw minimal differentiation of DE cells toward PP cells when cultured 
in basal medium without any growth factor/small molecule induction. This limitation was also 
reported by Nakayama et al. where they did not observe an organ-specific effect of kidney versus 
lung scaffolds on ESC differentiation without chemical complementation [223]. 
For whole organ reconstruction, there is a need for integrating other stromal cell 
population to reconstitute the overall supporting microenvironment for organ regeneration. 
Seeding of supporting cell types such as fibroblast, endothelial and mesenchymal stem cells has 
shown to enhance the attachment, viability and matrix remodeling of the repopulated organs 
[233-235]. In the context of pancreas, our previous work has shown the importance of co-culture 
and the critical role of endothelial cell populations in supporting islet differentiation [70, 236, 
237]. In this study, we primarily studied pancreas reconstruction with hPSC-PP aggregates, but 
we also attempted to co-seed PP cells with endothelial cells to examine the feasibility of multiple 
cell type repopulation (supplemental Figure A.9). 
As discussed earlier, our choice of liver as a viable scaffold is purely from a 
bioengineering standpoint. With decellularized pancreas we did not observe significant viable 
engraftment when seeded with hPSC-PP aggregates; hence the organ specific effect of pancreas 
scaffold on islet maturation remains to be investigated. The multitude of complex biochemical 
and biophysical properties (e.g. stiffness, topology, ECM, growth factors, etc.) within a whole 
organ scaffold makes it challenging to identify the specific contributing factor that leads to a 
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certain desirable cell fate. One way to make a more level comparison between organ-specific 
scaffolds is to dissolve the decellularized ECM into hydrogel bioink solutions as recently 
reported by Skardal et al. [238]. These bioink solutions can then be integrated with a 3D 
bioprinting platform to provide the important biochemical cues of different tissue types and 
evaluate the cellular response. Similarly, organ ECM extract can be spotted onto protein 
microarray to examine matrix specificity effect on stem cell behavior which will be investigated 
in the next chapter.  
4.5 CONCLUSION 
Although our results represent only an initial step toward the ultimate goal of generating fully 
functional bio-engineered pancreas in vitro, these studies are the first demonstration of feasibility 
to regenerate endocrine pancreas with renewable source of human pancreatic progenitors in 
decellularized organ scaffolds, paving way for diabetes therapy, organ engineering and drug 
discovery applications. 
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5.0  FABRICATION OF 2D AND 3D ORGAN-SPECIFIC ECM ARRAY FOR 
INVESTIGATING CELL-ECM INTERACTION DURING STEM CELL 
DIFFERENTIATION 
5.1 INTRODUCTION 
Organ specific ECMs have been used for regenerative medicine and tissue engineering in 
humans [239-241], typically to match ‘like with like’ [154, 196] – for instance, stem cells 
cultured on liver ECM to create new liver tissue [136]. However, in the previous chapter, we 
observed the compatibility of liver ECM scaffold in supporting pancreatic differentiation of 
hPSC. A broader screening of organ ECM properties may elucidate variability in ECM 
composition and mechanism of how organ specific ECM influences cell behavior in vitro. Here 
in Chapter 5, we describe the development of miniaturized 2D and 3D ECM arrays composed of 
organ-specific ECM. With this tool, it permits rapid evaluation of the matrix-specificity of 
organ-derived ECM and its cell-ECM interaction during stem cell differentiation. 
The ECM is a complex tissue-specific structure composed of collagens, proteoglycans, 
and glycoproteins. Multiple studies using variety of techniques (summarized in review by 
Rozario et al. [231]) have confirmed the effect of ECM on stem cell fate commitment. In vitro 
studies with isolated ECM proteins have shown the effects of laminin and fibronectin on 
definitive endoderm differentiation of mouse embryonic stem cells [242]. Furthermore, varying 
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combinatorial ECM proteins such as fibronectin, laminin, and collagen type IV interspersed 
within collagen I hydrogel have demonstrated to influence the osteogenic and endothelial 
differentiation of human embryonic stem cells [243]. Recognizing the need for a multi-matrix 
system in reconstructing the ECM microenvironment, there has been a focused effort in 
developing high throughput multicomponent ECM array platforms. Most of these platforms are 
ECM protein microarrays to facilitate the screening of stem cell fate after exposure to various 
ECM molecules in an adherent two-dimensional (2D) configuration [100, 244-247]. Further 
recognizing the benefits of reproducing the three-dimensional (3D) culture microenvironment 
has initiated the development of 3D hydrogels on a chip by depositing cell-laden alginate 
solution using microarray spotting techniques [248, 249]. More recently, multiplexed 3D cellular 
microarray was developed for combinatorial screening of stem cell differentiation in response to 
multiple ECM and growth factors [100, 248-252]. Majority of these approaches use purified 
ECM proteins and its combinations in an attempt to reconstruct the cell environment. While 
promising, there is still inadequate information on engineering the complexity of the native, 
tissue-specific ECM in an in-vitro setting. To date, attempts to generate tissue-mimetic ECM that 
recapitulate the function of the ECM in vivo have had limited success using combinatorial single 
purified ECM [253, 254]. On the other hand, tissue/organ-specific ECM has been shown to 
expose the cells to a more physiologically relevant milieu with higher fidelity to in vivo 
condition and promote tissue-specific cellular development and maturation [196, 238, 255].  
Advancement in organ decellularization techniques have made it possible to extract 
organ/tissue specific ECM while closely preserving their native composition and microstructure 
[101, 254-256]. The resulting decellularized tissue/organ ECM have been shown to be promising 
in regulating stem cell differentiation in-vitro and to study the comprehensive roles of ECM in 
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mesenchymal stem cell phenotype commitment [254, 256, 257]. More recently in the context of 
pluripotent stem cell (PSC), it was observed that exposure to organ-specific decellularized ECM 
scaffolds can enhance organ-specific maturation of PSC in lung [196, 201, 258] , heart [120, 135, 
259], and kidney [140, 203]. These studies exposed the cells to a multitude of biochemical and 
biophysical properties contained within the decellularized tissue/organ scaffolds. In addition to 
the effect from ECM compositional differences, for instance when comparing hPSC seeded in 
decellularized lung versus kidney scaffolds [223], the cells also experience different tissue 
stiffness and topological structure, which both influence stem cell fate [162, 260, 261]. There is 
currently lack of systematic quantitative studies to unravel the contribution of each factors 
related to organ-specific properties. Hence, it remains a challenge to study the effects of organ-
specific ECM composition that leads to a desirable cell fate. 
In this chapter, we report the fabrication of an array platform to expose the organ-derived 
ECM to cells cultured in either adherent 2D configuration or non-adherent 3D aggregates. We 
demonstrated that these miniaturized arrays could function as a tool to investigate cell-ECM 
interaction during hPSC differentiation, while being compatible with rapid quantitative imaging 
using LI-COR scanner. We first derived organ-specific matrix by extracting ECM from 
decellularized pancreas, liver and heart using chaotropic agents. Characterization of resulting 
ECM extracts revealed the retention of complex and diverse ECM compositional profiles in all 
three organs. To elucidate the role of organ-specific ECM in influencing stem cell function, 
organ-specific ECM extracts were immobilized onto the array surface in 2D and 3D 
configurations. We demonstrated the utility of the ECM array in 2D configuration by examining 
the cell-ECM adherence of human PSC derived pancreatic progenitor (PP) cells. Our result 
showed differential adherence profiles when hPSC-PP cells were plated onto the 2D ECM array, 
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suggesting hPSC-PP cells were sensitive to organ-specific differences in the decellularized 
matrices. In the 3D ECM array with non-adherent PP aggregate culture, our platform showed 
excellent compatibility with enhanced maturation into insulin expressing cells in organ-derived 
ECMs compared to matrigel. Collectively, this platform demonstrated the use of complex native-
derived ECM in an array platform to rapidly interrogate stem cell fate and function. The 
developed platform will pave way for rational design of engineered tissue-specific stem cell 
niches and support the developing field of stem cell biology, tissue engineering and regenerative 
medicine. 
5.2 METHODS 
5.2.1 Organ decellularization and ECM extraction 
We used a perfusion decellularization protocol reported previously [50], to obtain organ-specific 
decellularized pancreas, liver and heart scaffolds. The decellularized organs were lyophilized in 
Virtis Benchtop K freeze dryer, operating at 60 mTorr for 3 days. 30-50 mg of the lyophilized 
tissues was pulverized (Figure 5.1Aii). This was followed by treatment with 50 µg/ml DNase 
(Roche) for 10 min and washing 3 times with PBS. Each decellularized tissues were incubated in 
4M guanidine HCl, 8M Urea in PBS overnight with gentle shaking at 4ºC. Samples were 
centrifuged at 13,000 g for 10 min at 4ºC to remove insoluble material and the supernatants were 
dialyzed on floating V-series membranes (Millipore) against PBS for one hour. The final ECM 
extracts were filter-sterilized through PVDF syringe filter units (0.22 mm, Millipore), and then 
stored at 4ºC until further use.  
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5.2.2 ECM characterization and SDS-PAGE 
Organ’s ECMs were assessed for protein and ECM content as follows: bicinchoninic acid (BCA) 
assay (Thermofisher) was used for protein quantification (n=3 for each organ) according to 
manufacturer's instruction. For ECM quantificaion, the ECM extracts (n=3 for each organ) were 
analyzed with the Sircol Collagen and Blyscan GAG assay kits (Biocolor Life Sciences Assays, 
Carrickfergus, UK) according to the manufacturer’s instructions. The ECM content was 
normalized to the starting dry weight of each lyophilized decellularized organ. 
For SDS-PAGE, ECM samples were loaded at 4ug per well. 20ul of sample was mixed 
with 20ul of 2X NuPAGE LDS sample buffer + 5% β-mercaptoethanol and heated at 98ºC for 5 
minutes. This resulting mixture was loaded onto a NuPAGE 3-8% Tris-Acetate Gel in 1X Tris-
Acetate Running Buffer for 5 hours at 60V constant. Gel was stained using Bio-Rad Bio-Safe 
Coomasie stain for 4 hours, and destained overnight in distilled water. The resulting gel was 
imaged using The Bio-Rad ChemiDoc XRS+ system. 
5.2.3 Nitrocellulose coating of slides and dishes 
Patterning substrates were prepared by first coating Superfrost™ Plus Microscope glass slides 
(Fisher) or 6-well tissue culture plates (Fisher) with nitrocellulose [262]. Static water contact 
angle measurements were performed to assess the hydrophobicity of the coated surface. Matrigel 
was used as a control ECM to pattern the surface and test protein immobilization efficiency. 
Matrigel was applied to nitrocellulose-coated surface in droplets of 1µl-3µl containing 100 µg/ml 
concentration. After about 1 min, droplets were removed by aspiration, and the substrate surface 
was blocked by washing twice with 1% bovine serum albumin (BSA)/PBS (Sigma Aldrich). 
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Lectin peanut agglutinin (PNA) –Alexa 647 (Invitrogen, Molecular Probes) was used to detect 
the immobilized ECM protein and to verify the efficiency of the spotted ECM. PNA lectin stain 
was used at a concentration of 200 µg/ml in PBS and followed by three PBS washes. Microspot 
diameters were measured using slide scanning images recorded with Metamorph 7.5.6.0 
(Molecular Device) software on an Olympus IX81 inverted microscope. The fluorescence 
intensities (RFU) of the PNA lectin stain was quantified with LI-COR odyssey scanner using the 
700nm wavelength channel. 
5.2.4 2D organ-specific ECM array fabrication 
Each of the organ-derived ECM extracts was diluted to 100 µg/ml, and 1 µl of ECM solution 
were spotted with a repeater pipette (Eppendorf) onto the nitrocellulose-coated glass slides or 
tissue culture plates. After about 1 min, droplets of ECM solutions were aspirated and blocked 
by washing twice with 1% BSA/PBS. Five by five microspots were generated in square arrays 
per well in a 6 well plate, and six by four microspots were generated in rectangular arrays on 
glass slides. The arrays can be stored in blocking buffer at 4ºC until further use. All arrays were 
used within 3 months after fabrication. 
5.2.5 Atomic Force Microscopy (AFM) surface roughness and stiffness measurement 
Roughness measurements and AFM (MFP3D, Asylum Research) imaging of the 2-D 
immobilized ECM was performed in PBS at room temperature at a scan speed of 1 Hz with a 
resolution of 256 × 256 pixels. The scan size was 10 x 10 microns. Surfaces were scanned with a 
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silicon nitride conical tip of k = 0.8 N m−1 (Veeco, Ltd), and root mean square (RMS) surface 
roughness analysis was performed on 4 regions per sample [263].  
For stiffness measurement of 3D ECM arrays containing organ-derived alginate 
microspots, silicon nitride cantilevers (k = 0.2 N m−1) attached to silica microspheres (r = 3400 
nm) were used. Force measurements were taken at 16 locations over a 4 x 4 grid and two 
microspot samples were measured per condition. The resulting force curves were analyzed 
within the AFM-MFP3D software using Hertzian-fit for indentation depth of <10 microns [146]. 
5.2.6 Human embryonic stem cell culture and differentiation into pancreatic progenitor 
cells 
The H1 hESC lines culture and differentiation into pancreatic progenitor cells were performed as 
previously described [71]  in chapter 4.2.1. 
For 3-D PP aggregates, alginate-encapsulated cells [69] were grown into small aggregates 
as previously described in Chapter 4.2.4 and treated using the same induction protocol to as 
described above. DMEM/F12 plus 0.2% BSA and B27 supplement was used for the 
differentiation. Cultures were performed with p55–p70 hESCs in 37ºC incubator, 5% CO2, and 
100% humidity. 
5.2.7 Cell adhesion on 2D ECM arrays 
Cell adhesion assays were carried out on 2D ECM array in chamber glass slides (Nunc™ Lab-
Tek™). hPSC-derived PP cells were treated with 10μm of the rock inhibitor (RI) Y-27632 for 4 
hours before dissociation into single cells using TrypLE Express (Fisher). Single-cell 
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suspensions of hPSC derived-PP cells in serum free media (DMEM/F12 with B27) were plated 
into the patterned ECM microspots. For short-term attachment assays, cell suspensions were 
incubated for 2 hours in serum free medium and shaking the plates every 15 minutes. The arrays 
were then gently aspirated to remove unattached cells and fixed for cell staining and counting. 
For long term attachment, after first 2 hours of cell attachment and removal of unattached cells, 
fresh culture medium with serum was added and the cells were allowed to attach overnight.  
5.2.8 Differentiation of PP aggregates in 3D ECM array 
For PP aggregate differentiation in 3D ECM arrays, PP aggregates were generated using the 
alginate differentiation platform described above. Alginate differentiated PP aggregates were 
treated with 10μm of the rock inhibitor (RI) Y-27632 for 4 hours before decapsulation with 
100mM EDTA. This was followed by passing the PP aggregates through 100 µm mesh-sized cell 
strainer to avoid inclusion of larger aggregates in the microspots. Approximately 8,000-12,000 
PP aggregates were mixed in 1ml of alginate and ECM extract solutions to micro-spot on top of 
the BaCl2/PLL bottom layer using the repeater pipette. Subsequently, the cell-laden 3D ECM 
array was cultured in maturation medium consisting of DMEM/F12 plus 0.2% BSA and B27 
supplement with nicotinamide (10 μM, Sigma Aldrich) and 10μm of the rock inhibitor (RI) Y-
27632 for 2 days. Fresh maturation media with notch inhibition (30 uM DAPT, Santa Cruz) was 
added and cultured for another 7 days. The medium was changed daily for a total for 9-day 
culture period. 
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5.2.9 Cell viability assay: live/dead staining and quantification 
Cell viability on the 2D and 3D ECM array was assessed via a Live/Dead assay (Invitrogen). 
Briefly, calcein AM (1 µM) and EthD-1 (2 µM) were added together with culture medium to the 
cell seeded arrays and incubated for 15 minutes under light protection at room temperature. 
Samples were washed twice with PBS. Live cells (green) and dead cells (red) were identified by 
epifluorescence microscopy. Quantification of live/dead cells was accomplished by converting 
all individual (red and green) channels to grayscale and followed by analysis with Metamorph 
Image software. 
5.2.10 On-chip immunofluorescence assay and LI-COR Odyssey scanner analysis 
2D cells or encapsulated cells in 3D ECM arrays were fixed for 15 min with 4% formaldehyde 
(Thermo Scientific). ImmEdge Hydrophobic Barrier Pen (Vector Laboratories) was used to 
confine the antibody solutions to microspot of interest. For 3D ECM array staining, we used 
dH2O supplemented with 10mM BaCl2 to replace PBS for all the washing steps. The blocking 
buffer was also supplemented with 10mM BaCl2 when staining on 3D ECM arrays. Following 
fixation, samples were permeabilized with 0.1% TritonX100 for 15 min and blocked with 
Odyssey Blocking buffer (LI-COR Biosciences) for 1 hour. We used the following primary 
antibodies: goat anti-PDX1 (1:400, R&D Systems), goat anti-NKX6.1, rabbit anti-Cpeptide 
(1:200, Cell signaling). Incubation time for primary antibodies was overnight in 4°C. Slides were 
washed three times (5–10 min) with PBS. Infrared anti-goat and anti-rabbit IRDye800CW 
secondary antibody (1: 800, LI-COR Biosciences) and DRAQ5 (1: 10,000, Invitrogen) in 
blocking were then added to the arrays and incubated for 1 hour at room temperature. This was 
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followed by washing with PBS for three times. The plates were imaged on an Odyssey infrared 
scanner using slide or plate settings with sensitivity of 5 in both the 700 and 800 nm wavelength 
channels. Data were acquired by using Odyssey image studio software, exported and analyzed in 
Excel (Microsoft). The background was assessed by staining with only secondary antibody only, 
and the control values were then subtracted from the specific staining. The imaging data were 
normalized to cell numbers by dividing by the DNA (DraQ5) fluorescence signal. 
5.2.11 3D ECM array fabrication 
Following the protocol by Fernandes et al. [248], poly-L-lysine (PLL) (0.01% w/v) (Sigma 
Aldrich) and BaCl2 (0.1M) were mixed in 1:2 volume ratio and spotted on the nitrocellulose 
coated surface using a repeater pipette (Eppendorf). A mixture of 1.1% (w/v) low-viscosity 
alginate (Sigma-Aldrich), ECM extracts and hPSC-PP cell suspension (2.5x106 cells/ml) in 
DMEM/F12 media was prepared and micro-spotted on top of the BaCl2/PLL bottom layer using 
a repeater pipette. 
5.2.12 Immunofluorescence staining and confocal imaging of 3D cultures 
The immunofluorescence staining protocol is identical to the on-chip immunofluorescence 
protocol described above except for the following. For blocking buffer, 10% donkey serum 
(Jackson Immuno) was used. Anti-rabbit 488 and 555 Alexafluor secondary antibodies (1:500, 
Invitrogen) were used. The only primary antibody used here is Cpeptide (1:100, Cell signaling). 
Z–stacks images were acquired using a Nikon A1 laser confocal system (5 µm steps). 
 
  130 
5.2.13 Array microscopy imaging and quantification 
Microscope images of each array were acquired at 4x using an Olympus IX81 microscope. 
Images were recorded using Metamorph 7.5.6.0 (Molecular Device) software. The arrays were 
imaged using phase-contrast, DAPI, GFP, Cy3 and Cy5 optics. Scan slide module from 
Metamorph software were utilized, and array images were montaged. For quantification 
purposes except for live/dead staining, the slides were acquired using Odyssey image studio 
software, exported and analyzed in Excel (Microsoft). Each array (on glass or tissue culture 
wells) was imaged using a focus height that gave the maximum signal for each wavelength 
channel (700nm and 800nm) at the center of the array. 
5.2.14 Statistical analysis 
Statistical analysis was performed as previously described [50] in chapter 2.2.16. 
5.3 RESULTS 
5.3.1 Preparation and characterization of decellularized organ ECM extracts 
Figure 5.1A illustrates the overall workflow used to create an ECM array using decellularized 
organ ECM extracts. The first step consists of perfusion-decellularization of whole organs to 
obtain organ-derived ECM scaffolds. We have previously demonstrated perfusion-
decellularization of whole-organs [50] using an in-house bioreactor. With the same 
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decellularization protocol, we successfully decellularized whole organ pancreas, liver and heart. 
Figure 5.1A(i) depicts the translucent acellular organ scaffolds generated after the complete 
removal of the cellular materials from the native organ. This is followed by lyophilization and 
pulverization steps to obtain organ-specific ECM powder (Figure 1A(ii)). We then extracted the 
ECM using high molar of chaotropic agents (8M Urea and GuHCl), a commonly used protocol 
for ECM preparation [264-266]. The resulting extracts were dialyzed against PBS to yield 
pancreas-, liver- and heart-organ-specific ECM extracts (denoted as P-ECM, L-ECM and H-
ECM respectively). We first characterized the organ-derived ECM extracts through sodium 
dodecyl sulphate (SDS)–PAGE for the presence of ECM proteins or other peptides (Figure 
5.1B). We loaded the same concentration of organ-derived ECM extracts (4µg/well) and controls 
(collagen I and matrigel) on each well of the gel. SDS page analysis revealed that all three organ-
derived ECM extracts contained a number of high molecular weight ECM proteins (~250 KD) 
and low molecular weight (<100 KD) protein components that were absent in commercial bovine 
collagen type I and matrigel (Figure 5.1B). There were also considerable differences in terms of 
the bands detected among the three organ-derived ECM extracts. Next, the organ-specific ECM 
extracts were analyzed for protein (BCA assay) and ECM content such as collagen and 
glycosaminoglycans (GAGs). BCA assay revealed highest protein content in H-ECM (8.07 ± 4.7 
µg/mg dry weight), followed by L-ECM (6.90 ± 3.1 µg/mg dry weight) and P-ECM (3.98 ± 1.5 
µg/mg dry weight) but without statistical significance among the three extracts (n=3, P>0.05; 
Figure 5.1C). For the ECM content, sircol collagen assay demonstrated significant higher 
collagen content in H-ECM (0.78 ± 0.2 µg/mg dry weight, n=3) than L-ECM (0.48 ± 0.05 µg/mg 
dry weight, P<0.05; Figure 5.1D) but not significantly higher than P-ECM (0.53 ± 0.07 µg/mg 
dry weight, P>0.05). There was also no significant difference between L-ECM and P-ECM in 
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terms of the collagen content (P>0.05). While L-ECM was low on collagen content, it was high 
for sGAG content, as quantified by Blyscan assay to be 0.14 ± 0.02 µg/mg dry weight,) 
significantly higher than H-ECM and P-ECM (0.08 ± 0.01 and 0.03 ± 0.001 µg/mg dry weight 
respectively, P<0.01; Figure 5.1E). This observation indicated that P-, L-, and H-ECM preserved 
complex multi-faceted ECM proteins, suggesting better mimicry of the native organs’ intricate 
ECM composition. 
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Figure 5.1 Fabrication and characterization of ECM extracts from decellularized pancreas, liver and 
heart. 
(A) Schematic illustrating the experimental workflow to generate organ-specific 2D ECM array. Step 1: 
Whole organ-decellularization of pancreas, liver and heart and schematic illustration of the ECM extraction process 
to yield organ-specific ECM. Step 2: Organ-specific ECM were patterned on the nitrocellulose slide using a repeater 
pipette. On-chip immunofluorescence characterization of ECM proteins was performed followed by slide scanning 
with LI-COR imager. (B) Representative SDS-PAGE gel of P-ECM, L-ECM and H-ECM protein extracts contain 
abundant low molecular weight proteins (<100 KD) that are absent in collagen I and Matrigel. (C) Total protein 
content quantification for P-ECM, L-ECM and H-ECM by BCA assay. (D) Sircol collagen assay showed collagen 
content from P-ECM, L-ECM and H-ECM extracts. (E) sGAG content quantification for P-ECM, L-ECM and H-
ECM by Blyscan assay. (Error bars indicate ± SEM and n=3 independent experiments, ** P<0.01). 
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5.3.2 Fabrication of organ-derived ECM array 
Having extracted the ECM from individual native organs, we next fabricated the 
patterning substrates, presenting the organ-derived ECM as individual microspots. We first 
coated glass slides with a thin nitrocellulose layer to immobilize the ECM proteins. 
Nitrocellulose coating rendered the surfaces more hydrophobic and resulted in water contact 
angles of 53.3º ± 0.2º, significantly higher than uncoated glass surface (36.9º ±1.1º, n=3, P<0.01; 
Figure 5.2A). This method allows adequate protein adsorption while providing sufficient optical 
clarity for microscopy and scanning applications [245]. To verify the efficiency of protein 
deposition, we coated matrigel on tissue culture plastic (TCP) pre-treated with nitrocellulose and 
compared with non-treated TCP for 5 min and 60 min. Immunostaining by Lectin peanut 
agglutinin (PNA) detected significantly higher fluorescence intensity on surfaces pre-coated with 
nitrocellulose (137500 ± 2210 versus 58900 ± 3370 for 5 min coating; 240000 ± 20405 versus 
110050 ±  28520 for 60 min coating, P<0.01, n=3; Figure 5.2B-C), indicating efficient 
deposition of ECM-associated carbohydrate structures on nitrocellulose surface. After 
confirming the efficient adsorption of matrigel, we then evaluated our organ-derived ECM by 
microspotting them onto nitrocellulose-coated glass slide. All organ-derived ECMs (P-, L- and 
H-ECM) and control ECM (matrigel) were spotted at the same concentration of 100 µg/ml. 
Atomic force microscopy (AFM) evaluation of microspotted organ-derived ECM extracts 
showed significant higher surface roughness - root mean square (RMS) than nitrocellulose only 
surface (P<0.01, n=5; Figure 5.2D, Supplemental Figure A.10), confirming their immobilization 
onto the nitrocellulose coated surface. Furthermore, the RMS value were about the same for all 
the organ-derived ECM extracts and matrigel control, indicating similar amount of proteins were 
immobilized. In order to reproducibly pattern protein microspots of similar amount of protein, 
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we used a repeater pipette that dispenses constant volumes of ECM protein solution. We used 
matrigel as our testing ECM solution here. Matrigel measured in 1 - 3µl volume were spotted 
with a diameter ranging from 1500 μm – 2300 μm to yield spatially separated ECM microspots 
(Figure 5.2E). Each array contains up to 24 microspots for a glass slide (Figure 5.3A) or 25 
microspots for a well in 6 well plate (Figure 5.6A). To render the glass surface in between the 
patterns resistant to unspecific protein and cell attachment, the remaining nitrocellulose layer can 
be easily blocked with BSA. Slide scanning images of PNA lectin staining showed that each 
volume of microspot had similar diameter (<5% difference) and the diameter correlated linearly 
(R2 = 0.95) with increasing volume (Figure 2F). The same trend was observed with LI-COR 
quantification of near-infrared (680 nm) PNA stain – it correlated linearly with increasing 
volume and there was narrow variability of RFU for each volume (Figure 5.2G), confirming the 
reproducible spotting quality that can be achieved by the repeater pipette dispersion. Taken 
together, these data suggest that this spotting technique is reproducible, and the platform is 
efficiently pattern-able with organ-derived ECM proteins to generate an organ-specific ECM 
array. 
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Figure 5.2 Surface coating and immobilization of ECM proteins to generate 2D ECM array.  
(A) Water contact angles measurement showed increased hydrophobicity in nitrocellulose coated surface. 
(B) PNA lectin staining of adsorbed matrigel protein on tissue culture plastic (TCP) surface versus TCP surface 
coated with nitrocellulose after 5 and 60 min of matrigel coating time. (C) Corresponding quantification of PNA 
lectin fluorescence intensity showed higher amount of ECM proteins were immobilized on nitrocellulose coated 
surface. (D) AFM measurement of local root mean square (RMS) for surface roughness evaluation. Significant 
higher RMS value in microspotted organ-derived ECM than nitrocellulose only surface indicate organ-specific 
ECMs were immobilized onto the nitrocellulose coated surface. No significant difference was detected among 
different organs, indicating similar amount of proteins were immobilized. (E) PNA lectin stain visualized 
microspotted 2D ECM array with 1 µl, 2 µl and 3 µl of matrigel (triplicates). (F) Correlation plot shows the varying 
size of microspot can be achieved by varying the volume of matrigel droplets. (G) Quantification of PNA lectin stain 
shows the fluorescence intensity as a function of increasing volume of matrigel droplets. (Error bars indicate ± SEM 
and n=3 independent experiments, ** P<0.01). 
5.3.3 ECM array combined with quantitative imaging permits analysis of ECM 
composition of organ-derived ECMs 
Next, we characterized the individual matrix protein components of the organ-derived ECM 
spotted on the array by on-chip, immunofluorescence staining with IR-dye, and fluorescence 
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quantification by LI-COR Odyssey imager (Figure 5.3A). As a validation for this assay, we 
micro-spotted matrigel to study the sensitivity and the detection range for for Laminin and 
Collagen IV proteins. LI-COR image analysis detected increasing fluorescence intensity for both 
Laminin and Collagen IV staining with increasing concentration of spotted matrigel. The protein 
fluorescence intensity correlated linearly (R2 > 0.97; Supplemental Figure A.11) with matrigel 
concentration for both proteins over a range of dilution factors (1:4 to 1:16). Having validated 
our array platform, we next used it to characterize the ECM composition in P-, L-, and H-ECM, 
testing for a range of ECM proteins including Collagen I, Collagen IV, Fibronectin and Laminin. 
These ECM molecules were chosen because they are known to be critical in determining stem 
cell fate [232] and are primary components in various organs, including the pancreas [15, 267]. 
We quantitatively determined the levels of individual ECM proteins and compared to matrigel, 
rat tail collagen I (positive controls) and gelatin (negative control) (Figure 5.3B-E). As expected, 
the on-chip immunofluorescence assay was able to detect the ECM protein profiles on both the 
positive ECM controls (high laminin and collagen IV for matrigel; high collagen I for rat tail 
collagen; Figure 5.3B-C). Negative ECM control - gelatin is a denatured form of collagen and 
resulted in lower collagen I fluorescence intensity (Figure 5.3B). Interestingly, despite the 
identical ECM preparation protocols and amount of protein being microspotted, the composition 
of the organ-derived ECM varied dramatically, illustrating the complex and different ECM 
compositional profiles among the three organs. There was no significant difference detected for 
Collagen I and Collagen IV ECM protein levels among the three organs (P>0.05, n=3; Figure 
3B-C), consistent with the previous assessment by Sircol collagen assay (Figure 5.1D). However, 
laminin level was detected at much higher level in H-ECM (363.2 ± 15.8) than P- and L-ECM 
(84.9 ± 7.9; 153.5 ± 22.1 respectively, P<0.05, n=3; Figure 5.3D). In addition, fibronectin level 
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was also detected to be significantly higher in L-ECM (16.9 ± 3.4) than P- and H-ECM (2.9 ± 
1.2, 4.2 ± 1.2 respectively; P<0.01, n=3; Figure 5.3E). These data indicate that the ECM array 
combined with immunostaining and LI-COR analysis allows sensitive quantitative evaluation of 
different organ-derived ECM. 
 
 
Figure 5.3 On-chip, near IR Dye, immunofluorescence staining and LI-COR quantification.  
(A) Representative LI-COR image of stained 2D organ-specific ECM array. Matrigel, Gelatin and Rat tail 
collagen I were microspotted as controls. (B-E) Quantification of ECM proteins, Collagen I (B), Collagen IV (C), 
Laminin (D) and Fibronectin (E) and normalized to rat tail collagen I. Specific composition of matrigel, rat tail 
collagen I and gelatin (denatured collagen I) were detected consistent with reported literature composition, suggests 
the sensitivity and validation of the assay to semi-quantify the ECM composition of organ-derived ECMs. 
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5.3.4 Organ-derived ECM array to probe cell–ECM adhesion 
Cell adhesion to the ECM is essential for a coordinated morphogenesis and growth of functional 
tissue [268, 269]. To measure the adhesive properties of the organ derived ECM, we used 
pancreatic progenitor (PP) cells derived from hPSC as described in our previous published 
studies [70, 71], and seeded them onto the organ-derived ECM array. As depicted in step 1 of 
schematic in Figure 5.4A, we first generated definitive endoderm from human embryonic stem 
cells (hESCs) using activin A (100 ng/ml) and wnt3a (25 ng/ml) for 4 days (day 0-4). We then 
induced pancreatic progenitor cell fate by sonic hedgehog inhibition (KAAD Cyclopamine, 
0.2µM) for 4 days (day 4-8) and retinoic acid from day 6-8. With this reported protocol, we were 
able to efficiently generate up to 60% of PP cells [69, 71, 236] expressing the transcription factor 
pancreatic and duodenal homeobox1 (Pdx1), which is the master regulator giving rise to all 
pancreatic lineage cells [184]. The pre-differentiated PP cells were then seeded onto the arrays in 
serum-free media and allowed to adhere for 2 h at 37 °C (step 2 of schematic Figure 5.4A). To 
ensure uniform seeding, the slides were agitated every 15 min. We first tested this approach with 
matrigel spotted arrays. The PP cells adhered preferentially to matrigel spotted regions and did 
not attach to the nitrocellulose coated regions lacking ECM proteins. The cell patterning was 
robust over the array surface (3 x 3 ECM microspots), yielding near confluent cellular 
microspots as shown in Figure 5.4B. To quantify cells bound to each spot, cell nuclei were 
stained with DraQ5 DNA stain, a DNA-binding dye that fluoresce in the infrared spectrum and 
the slides were scanned and quantified with LI-COR to detect the fluorescent intensity of DraQ5. 
As shown in Figure 5.4C, the cell density correlated strongly with the cell seeding density of the 
hPSC-PP cells, which confirms both the quantification technique and compatibility of the array 
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with hPSC derived cell types. Live/dead images of the adhered cells demonstrated good viability 
24 hours after cell seeding, indicating cytocompability of the ECM array (Figure 5.4D). 
Using the same methodology, we next seeded the hPSC-PP cells on organ-derived ECM 
(P-, L- and H-ECM) spotted arrays and evaluated their adhesion (Figure 5.4E). Live/dead images 
after 24 hours showed most adhered cells were viable but there were considerable differences in 
cell adhesion between the three organ ECMs (Figure 5.4F). This was further confirmed by 
quantification using LI-COR analysis of DRAQ5 DNA stain. Adhesion of the hPSC-PP cells to 
L-ECM was the highest among the three organ-derived ECMs, while H-ECM exhibited the 
lowest hPSC-PP cell adhesion (P<0.01). Interestingly, in spite of having pancreatic tissue origin, 
P-ECM exhibited significantly lower adhesion of hPSC-PP cells as compared to L-ECM 
(P<0.05; Figure 5.4G). These results clearly suggest that adhesion of hPSC-PP cells was 
responsive to the composition differences between organ-derived ECMs. 
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Figure 5.4 hPSC-derived PP cells on 2D ECM array to investigate Cell-ECM adherence.  
(A) Schematic representation of cell-ECM adherence assay on fabricated organ-specific ECM array. Step 
1: differentiation protocol of hPSC to pancreatic progenitor cells. Step 2: Cell seeding of harvest hPSC-PP onto 
ECM array. (B) Different cell seeding densities were tested to seed PP cells on matrigel microspotted surface. (C) 
Corresponding DNA DraqQ5 quantification showed detection of fluorescence intensity increase linearly with 
increased cell seeding density. We determined 1 x 106 million cells/ml to be the optimal density as it gave rise to a 
uniform confluent cellular microspot under matrigel condition (positive control). (D) Live/dead staining of one of 
the confluent cellular microspot showed high viable cells indicating the cytocompatibility of the platform. (E) 
Phase-contrast images of short term cell seeding (5 min) on different organ-derived ECM on the 2D ECM array. 
Each organ ECM showed different cell adherence profiles. (F) Live/dead staining of washed 2D ECM array after 
long term cell seeding (24 hours). Similar adherence profile was observed with the short term cell seeding. (G) 
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Quantification of DraQ5 stained 2D ECM array after cell seeding. L-ECM showed the highest PP cells adherence, 
followed by P-ECM and H-ECM. (n = 4-5, * P<0.05) 
5.3.5 Fabrication and characterization of 3D organ-derived ECM array 
While the ECM array is a useful tool to interrogate cell-ECM interaction under adherent culture, 
the increasing appreciation of the importance of three-dimensional (3D) spatial organization of 
cells has prompted the development of 3D cellular arrays [248, 249, 251, 252, 270] which better 
mimics the complexity of the native microenvironment. In addition, many ECM proteins don’t 
have an adhesive role but are still critical for stem cell growth, survival, differentiation and 
morphogenesis [231, 232, 271]. Hence, it is important to develop a 3D system to globally present 
the ECM proteins while supporting 3D culture of hPSCs. Alginate is a suitable hydrogel matrix 
which adequately supports hPSC growth and differentiation while being inert to cell adhesion 
[69, 272]. Further, alginate hydrogels have been previously developed into a 3D cell on-a-chip 
array for mouse embryonic stem cell [248] and human neural stem cell [249] differentiation. 
Here, we modified the technique to incorporate our organ-derived ECM into alginate, while 
encapsulating pre-differentiated hPSC cells. Instead of using poly (styrene-co-maleic anhydride) 
(PS-MA)-treated surface, we used nitrocellulose coated surface, which has been shown to have a 
higher protein binding capacity than PSMA-treated surface (80-100 µg/cm2  [273] versus 68.2 
µg/cm2 [274, 275]). After pretreating the glass slides with nitrocellulose, mixture of poly-L-
lysine (PLL) and BaCl2 were microspotted onto predetermined positions using the same repeater 
pipette microspotting technique as described above. Alginate was pre-mixed with specific organ-
derived ECM. hPSC-PP cells were harvested and suspended within the alginate-ECM matrix 
material before micro-spotting onto the predetermined positions on nitrocellulose-coated glass 
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slides. 3D cell-laden gel were formed by the deposition of the pre-mixed alginate and ECM 
solution containing hPSC-PP cells on top of the PLL/BaCl2 bottom layer as shown in schematic 
Figure 5.5A. Under these conditions, the positively charged PLL serves as a substrate to bind 
Ba2+ ions and assist the attachment of the negatively charged alginate. The divalent Ba2+ ions 
bind preferentially to the G-blocks in the alginate and cause instantaneous gelation of the 
alginate chains to give rise to 3D cell-laden microspots (1µl) with a height and diameter of 250 
µm and 1600 µm respectively (Figure 5.6B). 
With the platform now being 3D, we wanted to test the sensitivity of LI-COR imaging 
platform in detecting the protein expression throughout the thickness of the 3D gel microspots 
with the same on-chip, immunofluorescence staining method. Previous studies have shown that 
LI-COR was able to detect near infrared and infrared fluorescence signals of up to 2 mm 
thickness [276, 277], which is within the thickness range of our 3D gel microspots (250 µm). In 
addition, we wanted to ensure that the ECM proteins were stably incorporated into the 3D gel 
microspots throughout the culture period (up to 10 days). To validate this, we microspotted 
premixed matrigel and alginate (cell free) at various concentration (0 µg/ml – 200 µg/ml) onto 
the PLL/BaCl2 pre-spotted array and maintained it in maturation media for 10 days at 37 °C 
culture incubator. The range of matrigel concentration on the 3D gel array were stained with 
PNA lectin and quantified by LI-COR Odyssey imager at day 0 and day 10 (Figure 5.5B). We 
observed good linearity among the range of matrigel evaluated (Day 0, R2 = 0.94; Day 10, R2 = 
0.98; Figure 5.5C), indicating sensitivity of the immunostaining and LI-COR imaging under 3D 
configuration. Furthermore, majority of the matrigel was retained within the alginate throughout 
the 10 day culture period with less than 20% loss of ECM protein at higher matrigel 
concentration (i.e. 100 µg/ml and 200 µg/ml; Figure 5.5D). Specific ECM antibody staining also 
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detected similar protein levels (Supplemental Figure A.12) compared to the quantitative 
evaluation by 2D ECM array as described above (Figure 5.3), indicating retained ECM after 
inclusion into alginate gel array, as would be expected. 
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Figure 5.5 Fabrication and characterization of 3D organ-specific ECM array.  
(A) Schematic representation of alginate microspots with cells and ECM extracts on nitrocellulose glass 
slide pre-spotted with PLL/BaCl2. (B) PNA lectin staining on matrigel alginate microspots (without cells) on 3D 
ECM array on day 0 and day 10 on a range of matrigel quantification (0-200 µg/ml) (C) Corresponding correlation 
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plot of PNA lectin fluorescence signals at day 0 and day 10 showed good correlation of fluorescence intensity 
(RFU) over the range of matrigel concentration evaluated, indicating the good linearity and sensitivity of the assay. 
(D) Comparison of PNA lectin stain fluorescence signal at day 0 and day 10 over a range of different incorporated 
matrigel concentration. The incorporated matrigel after 10 days in culture showed less than 20% decrease in 
fluorescence signals, indicating released or degraded ECM components was nominal. At higher concentration of 
matrigel (100-200 µg/ml), the difference between day 0 and day 10 was smaller and insignificant (P>0.05). (Error 
bars indicate ± SEM and n=3 independent experiments, * P<0.05). 
5.3.6 Differentiation of hPSC-PP is responsive to organ-specific ECM, as detected in the 
3D array 
Next, we used this miniaturized 3D alginate-ECM array to study the differentiation of 
encapsulated hPSC-PP cells. The pre-differentiated hPSC-PP cells were harvested with 
enzymatic digestion to yield single cell suspension (cell density of 2.5 x 106 cells/ml) and mix 
with specific organ ECM-alginate solutions. Arrays of 25 alginate microspots (Figure 5.6A) (n=5 
for each ECM condition) were prepared and cultured in maturation media with notch inhibition, 
a known inducer of beta cell phenotype [57, 69, 71] for 9 days.  During this period, the cells 
remained confined within the microspots, with no spot breakage (Figure 5.6C) and no visible gel 
detachment from the slide, indicating the microspots were structurally stable. Confocal 
microscopy images also indicated that the encapsulated cells were evenly distributed inside the 
alginate-ECM microspots (Figure 5.6B). However, live/dead staining showed significant cell 
death (up to 80%) in the 3D cell-laden alginate-ECM microspots (Figure 5.6D-E). This is most 
likely due to cell-cell contact inhibition while harvesting the hPSCs, which is known to activate 
the apoptotic pathway in hPSCs [222]. While we added Rho-associated protein kinase (ROCK) 
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inhibitor (i.e. Y-27632), which has been illustrated to boost cell survival in this process [221, 
222], we still observed significant cell death.   
In order to retain high viability of hPSC-PP cells in our 3D ECM array platform, we 
chose to encapsulate cell clusters instead of single cell hPSC-PPs. We hypothesize that the 
preserved cell-cell contact in the clusters will not activate apoptotic pathway and hence will 
retain high viability. In our previous study we have reported the excellent potential of alginate 
capsules as a platform for pancreatic differentiation of stem cells[69]. The encapsulated single 
cells form small colonies within the alginate capsule that subsequently differentiate into 
pancreatic progenitor cells upon induction. These hPSC-PP aggregates can be easily harvested 
by mild treatment of EDTA to dissolve away the alginate capsules. Schematic in Figure 5.6F 
illustrates the differentiation protocol to generate 3D hPSC-PP aggregates and encapsulate into 
the 3D ECM gel array (Figure 5.6G). To ensure relatively homogenous-sized aggregates were 
encapsulated, we passed the hPSC-PP aggregates through a cell strainer (100 µm mesh size) to 
avoid inclusion of cell clusters larger than the microspot gel size. This will avoid cellular 
overgrowth and protrusion out of the alginate microspots as shown in our Supplemental Figure 
A.13. After culturing for 9 days in different organ ECM gel array, live/dead staining of 
encapsulated hPSC-PP aggregates showed excellent viability (>90%, Figure 5.6H-I) much higher 
than what was experienced with the encapsulated single cell hPSC-PPs. In comparing across 
different organ-derived ECM, no significant difference was observed in the viability of PP 
aggregates (P>0.05, Figure 5.6I).  
Having achieved high viability, we next investigated the differentiation outcome of 
hPSC-PP aggregates exposed to different organ-derived ECM in the 3D alginate microspots. We 
cultured the encapsulated hPSC-PP aggregates in different organ-derived ECM alginate 
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microspots (n=5 for each organ) for 9 days in the presence of notch inhibition (DAPT). Parallel 
cultures on alginate with and without matrigel were used as controls. Immunostaining and LI-
COR imaging was performed to assess pancreatic maturation using pancreatic and islet-specific 
transcription factors such as Pdx1, Nkx6.1, and insulin protein marker, Cpeptide. The result 
showed that higher PDX1 expression was detected in all the alginate-ECM microspots compared 
to alginate only controls (Figure 5.6J-K). NKX6.1 did not show any differences between P-
ECM, H-ECM, matrigel and the alginate only control. However, L-ECM elicited a substantial 
increase of all PP markers, including C-peptide protein expression (Figure 5.6K). Interestingly, 
P-ECM only showed a modest increase in C-peptide level but did not show significant increase 
of PP markers or C-peptide when compared to H-ECM or controls (P>0.05, Figure 5.6K). 
Confocal sectioning also corroborated this finding and detected higher expression of C-peptide 
staining in L-ECM alginate microspots (Figure 5.6L). To ensure that this observation was 
attributed to the ECM-specific differences and not any physical parameters of the gel, like 
stiffness, we performed AFM stiffness measurement of the alginate microspots after 
incorporation of ECM proteins. Our result revealed no stiffness differences between the alginate 
microspots alone and alginate microspots incorporated with ECM proteins (Supplemental Figure 
A.14). Collectively, these data suggest that the hPSC-PP aggregates were responsive to organ-
derived ECM differences and further matured into insulin-expressing cells, with highest 
differentiation phenotype observed in L-ECM matrix. Furthermore, such stem cell differentiation 
phenomena can be studied in a miniaturized 3D alginate-ECM array. 
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Figure 5.6 hESC-derived PP cells on 3D ECM array to investigate differentiation.  
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(A) Photograph of the organ-specific 3D ECM array, 25 microspots were generated in each well (6 well 
plate) (n=5 for each ECM). (B) Confocal images showing the three-dimensional distribution of hESC-PP cells after 
encapsulated onto the 3D ECM array. Shown in each panel is the top view and side view of the microspot, from a z-
stack of 5 µm sections. Each spot is 1 µl resulting in a diameter of 1600 µ and a height of 250 µm. (C) 
Corresponding phase-contrast image showing one of the 3D microspot encapsulated with PP cells. (D) 
Representative live/dead images of hESC-derived PP cells encapsulated in organ-ECM microspots on the 3D array. 
High number of dead cells were detected. (E) Live/dead quantification confirmed high percentage of dead cells 
across all the ECM conditions. However, there was no significant difference observed between each ECM condition. 
(F) Step-wise differentiation protocol in alginate capsules to generate PP aggregates. After decapsulation with 
treatment of 100 mM EDTA, PP aggregates were filtered through 100 µm mesh-sized cell strainer to avoid larger 
clumps inclusion in the 3D ECM array. Right panel showed the phase contrast image of relatively smaller and more 
homogenous sized PP aggregates used in the 3D ECM array. (G) Representative phase contrast image of PP 
aggregates inside the 3D alginate-ECM microspot. (H) After cultured inside 3D ECM array for 9 days, live/dead 
images showed good viability in all the organ ECM conditions. (I) Quantification of live/dead images confirmed the 
viability >90% in all ECM conditions including the controls (matrigel and alginate only). (J) LI-COR image showed 
the immunostaining characterization of the differentiation of PP cells in 3D ECM array. PP aggregates were 
encapsulated in organ-specific 3D ECM array and cultured in maturation medium with notch inhibition for 9 days, 
fixed and stained for analysis on the LI-COR Odyssey instrument. DraQ5 (red) was used as a counter stain for cell 
number and the Pdx1, Nkx6.1 and C-peptide (green) antibodies followed by an IRDye-800CW secondary antibody 
for quantitation of pancreatic maturation. (K) The PP aggregates were responsive to different organ ECM and gave 
rise to different levels of Pdx1, Nkx6.1 (pancreatic progenitors) and C-peptide (insulin) markers. (L) Representative 
stacked confocal images showed the specific C-peptide staining on the PP aggregates and consistent with the 
expression level found with LI-COR. L-ECM microspots demonstrated the highest number of insulin-expressing 
cells. (Error bars indicate ± SEM, 5 microspots for ECM condition, n=3 independent experiments, * P<0.05). 
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5.4 DISCUSSION 
Extracellular matrix (ECM) components are important physiological regulators of stem cell 
function and fate [232, 244, 278]. In order to facilitate the high throughput analysis of cell-ECM 
interaction to dictate stem cell fate and function, several groups have developed combinatorial 
ECM array platform using single purified proteins in 2D adherent [100, 244] and 3D hydrogel 
[250-252] configurations. However, recapitulating the native ECM microenvironment niche with 
single purified proteins has proved to be inadequate [100, 254], hence more complex ECM has 
also been investigated using cell-derived matrix in-vitro [144, 255] or decellularized tissue or 
organ [50, 101]. Herein, we have developed an ECM array using native-mimicry ECM from 
decellularized organs (namely pancreas, liver and heart). The system is compatible with 
quantitative imaging, and permits rapid evaluation of the matrix protein profiles of different 
organ-derived ECM, along with the sensitive measurement of the cell-ECM interaction both in 
2D adherent cultures as well as 3D non-adherent culture. In this report, we evaluated the effect of 
ECM specifically on pancreatic differentiation of hPSCs, but the developed platform is versatile 
to be applied to characterize any lineage specific differentiation. 
To generate organ-specific ECM components, we employed a protocol combining 
decellularization, lyophilization, pulverization, and protein extraction to create organ ECM-
derived solutions from pancreas, liver and heart. It is important to note that chaotropic agent 
extraction process does not completely solubilize the ECM. The residual ECM pellet is likely to 
contain mostly collagen as reported by Lin et al. [266]. When compared to the ECM extracted by 
urea (a chaotropic agent), they found that the SDS-PAGE profile of the collagenous ECM pellet 
was similar to that of purified collagen, and it did not exhibit high potency to support 
mesenchymal stem cell (MSC) function. In contrast, ECM extracted by urea contained multiple 
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bioactive ECM components that accelerated MSC proliferation, attachment, spreading, migration 
and multi-lineage differentiation. Hence it was likely to contain majority of the bioactive ECM 
component. In addition, Matrigel is also extracted with urea from Engelbreth-Holm-Swarm 
(EHS) tumors. It contains multiple ECM components such as laminin, collagen IV and entactins, 
and is commonly used as a bioactive culture substrate to promote cell differentiation and 
function [279]. Hence we expect that by using chaotropic agent extraction method, we were able 
to extract the bioactive portion of organ-specific ECMs. Consistent with Lin et al.’s finding 
[266], our result from immunostaining, SDS-PAGE and biochemical characterization of the 
organ-derived ECM extracts revealed retention of multi-components ECM, distinctly different 
than purified rat tail collagen I (Figure 5.1F and Figure 5.3A-E). Even though we are preserving 
multi-component ECM, it is likely that we are not capturing the full spectrum of ECM proteins 
from native organs, and losing some fraction from the harsh treatments of decellularization and 
ECM extraction. Nevertheless, we have previously demonstrated the effectiveness of this ECM 
processing approach, and the resulting ECM has been shown to recapitulate essential 
components of native ECM from different tissues including retina [265, 280], embryoid bodies 
[144] and pancreas [50]. 
Quantitative comparisons of cell-ECM interaction require reproducible substrate 
preparation and sensitive detection assay. Using a nitrocellulose-coated surface in combination 
with repeater pipette microspotting, we were able to generate arrays of microspots with highly 
reproducible protein content. There are several advantages of using nitrocellulose-coated surface 
for patterning ECM proteins. First, nitrocellulose coating is clear and permits excellent optical 
observation of the cells. Secondly, it is inert and doesn’t appear toxic to cells. When blocked 
only with BSA, nitrocellulose is a very poor substrate for cell attachment [262]. Lastly, 
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nitrocellulose coating is well suited to bind a broad range of different ECM proteins via a 
combination of intermolecular forces, dominated by hydrophobic and van der Waals [281], 
without compromising the protein structure of the immobilized ECM extracts. The protein 
binding capacity of the nitrocellulose coating is instantaneous, nearly irreversible, and 
quantitative to 80–100 µg/cm2 [273], much higher than poly(styrene-co-maleic anhydride) (PS-
MA) coating (another common surface coating for protein immobilization), which shows only 
68.2ug/cm2 of protein binding capacity [274, 275]. Several alternate substrate preparation have 
been developed for patterning protein microarrays [244, 251, 282], but the optimal substrate for 
patterning ECM proteins remains to be investigated. To develop an array platform for 
quantitative characterization, we utilized an on-chip, near IR-dye, immunofluorescence staining 
method with LI-COR Odyssey scanner. This method provides a robust high-throughput method 
for the quantitation of immunofluorescent staining and has advantages over microscopy-based 
screening approaches with regard to throughput and sensitivity. Acquisition and quantification of 
our generated arrays with 25 microspots can be accomplished in less than 10 min on the LI-COR 
odyssey scanner. This is in contrast to other reported studies involving hours-long acquisition 
time on a high-throughput microscope in the visible spectrum [244, 248, 249, 283]. In addition, 
the high sensitivity of the LI-COR scanner and the near-IR dyes provided robust signals at lower 
antibody dilutions than were possible using a microscopy-based system and dyes in the visible 
spectrum. With the increased sensitivity, however, there is an enhanced probability of artifact 
from unspecific antibody background staining. Hence, appropriate controls need to be included 
in the experimental plan to adequately remove the effect of background from acquired data. 
The fabricated ECM array was first applied to characterize the cell-ECM interaction for 
cell attachment, and its specificity to organ-derived ECM. Analysis of the decellularized extracts 
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for individual ECM proteins revealed that pancreas, liver and heart each has differing levels of 
ECM proteins such as collagen I, collagen IV, laminin and fibronectin (Figure 5.3). When seeded 
with hPSC-PP cells, we observed differential adhesion profile responding to different organ-
specific ECM with the L-ECM resulted in highest PP cells adhesion. Pancreatic progenitor (PP) 
cells display αvβ3 and αvβ5 integrins to mediate adhesion and migration both in vitro and in vivo 
model of pancreatic islet development [284]. These integrins are among the receptors that have 
been shown poised to receive signals from ECM components including fibronectin, collagen IV 
and vitronectin [285, 286]. Hence it can be postulated that the favorable adhesion of hPSC-PP 
cells to L-ECM can be attributed to the significantly higher fibronectin content found in L-ECM 
over P- and H-ECM.  
While the 2D ECM array was efficient in analyzing the composition and adhesive 
properties of the ECM, it restricts us to analyze cell-ECM interactions for adherent cells only. 
However, ECM proteins are known to contribute beyond just adhesive function to dictate cell 
fate commitment [231, 232]. Hence to explore the cell-ECM interactions under non-adhesive 
cultures, we devised an encapsulation system in an inert hydrogel, which allows cell growth 
without adhering to the hydrogel. In our earlier work we have reported culture and differentiation 
of hESCs into islet-like cells in alginate capsules [69]. In addition to providing means for 
adhesion-free culture, it also provides a 3D environment to the cells, which is gaining increasing 
appreciation as a vital component of cell microenvironment, more so for human pluripotent stem 
cells [287]. While our previous report was in free suspension culture of encapsulated hPSCs, 
Fernandes et al. [248] have reported an alginate-based matrix array immobilized on glass slide to 
facilitate toxicity and drug screening applications [249]. With this immobilization technique, it is 
now possible to distribute nanoliter volumes of different samples in a spatially addressable 
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footprint for high throughput applications. They applied this platform for screening of human 
neural stem cells toxicity [249] and mouse embryonic stem cells differentiation [248]. In this 
study, we adopted the alginate immobilization platform and modified it to introduce the organ-
derived ECM to the encapsulated hPSCs. The incorporation of ECM was stable with near-
complete retention of the ECM throughout the culture period (Figure 5.5D).The negligible ECM 
loss from the array spots further rules out the concern of possible influence from adjacent array 
spots.  Inclusion of ECM also did not modify the alginate stiffness thus confirming the observed 
effect is not from likely physical hydrogel parameters (Supplemental figure A.14).  
Our alginate-ECM array is a versatile platform. It allows the feasibility of simultaneous 
multi-parametric modulation. In our study we modified the ECM composition of the array spot 
while keeping the physical gel parameters unchanged. It is possible to simultaneously change gel 
physical parameters, for example the array stiffness, by micro-spotting different divalent cation 
(e.g. Ca2+ or Sr2+) or different concentration of BaCl2 cationic solutions onto the nitrocellulose 
surface, which will give rise to different stiffness upon alginate gelation. In our study, we 
microspotted only one concentration of BaCl2 solution (10mM), which led to identical low 
stiffness (1kPA) across the different ECM conditions tested. This low stiffness was chosen 
mainly to be within the “soft” tissue range of native pancreatic tissue, which has been identified 
to be another critical parameter to modulate cell fate [162, 288]. In addition, the platform is also 
versatile enough to allow the encapsulation of single cells or cell aggregates. Encapsulation of 
single cells and its propagation into colonies under encapsulation is the most common practice 
for most of the cell lines. Hence we demonstrated the feasibility of microspotting single cells of 
MIN6 beta cells and maintaining viable culture in the 3D alginate gel array for 10 days 
(supplemental figure A.15). However such single cell encapsulation tends to be restrictive for 
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hPSCs because hPSCs are prone to cell death after being made single cell. While there was 
significant survival of the single-cell encapsulated hPSC-PP in our array platform, the 
dissociation process still led to significant cell death, as expected. These dead cells remained 
entrapped in the alginate matrix which is an undesirable culture condition. While we observed 
good viability of hPSC-PP cells in the 2D cell-ECM adhesion assay, likely only viable cells were 
capable of integrin-ECM mediated adhesion. Loosely attached dead cells were expected to be 
washed away during the staining process. In contrast, the 3D cell-laden ECM array involved the 
encapsulation of all dissociated cells, which likely include the entrapment of significant dead 
cells. Hence we developed a methodology to generate hPSC-PP aggregates and encapsulate these 
aggregates without dissociation. The preserved cell-cell contact in the aggregates protect the 
cells from apoptosis, and furthermore, it results in stronger differentiated phenotype, as 
demonstrated by our previous study [69] and reports from other groups [72, 75, 78, 214].  
Recent studies have shown the manifestation of enhanced stem cell functions and 
intricate tissue formation when organ-specific ECM scaffolds were employed [196, 289]. The 
ECM scaffolds were shown to have the capacity to direct tissue-specific stem cell lineage 
commitment and maintain the phenotype of mature cell populations. However, the organ specific 
effect observed from these studies cannot be solely attributed to the ECM composition difference 
as these studies employed decellularized whole-organ scaffolds that are complex and vastly 
different beyond biochemical ECM properties (e.g. difference in growth factors, biophysical 
properties such as stiffness and topology etc.). In our studies, we implemented a more level 
comparison between different organs by extracting only the bioactive ECM components devoid 
of any confounding biophysical factors. Despite the identical extraction protocol, organ-specific 
differences were detected in all three organs in terms of their ECM compositional profiles. These 
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differences in turn led to different maturation outcome in the hPSC-PP cells, when 
complemented with chemical induction. Surprisingly, P-ECM, in spite of its pancreas origin, was 
not the most suitable in promoting the differentiation of hPSC-PP cells into insulin-expressing 
cells. In contrast, the liver derived ECM had the best performance among the organs compared in 
this study. It is noteworthy that majority of the pancreas is composed of exocrine tissue with only 
2% made up of islet cells. While the differences in the ECM composition between endocrine and 
exocrine pancreas is not obvious, it is still non-specific to the pancreatic endocrine cell 
population, which is of interest in this study. On the other hand, liver is developmentally close to 
pancreas (i.e. both from endoderm germ layer) with previous successful reports of hepatocytes 
trans-differentiation into insulin-producing cells [290]. Liver has also been successfully used as a 
favorable transplant site to support islet insulin function during islet transplantation. In addition, 
liver has a very high density of vasculature and there is a substantial amount of interaction 
between islets and the ECM associated with vasculature. It has also been proposed that the 
vasculature basement membrane could be a favorable niche for promoting insulin gene 
expression and β cell proliferation [291]. It should also be noted that there is likely a beneficial 
effect that can be attributed to the variety of matrix-bound growth factors and cytokines retained 
in the ECM extracts, which have been demonstrated effective for inducing differentiation and 
maintaining cellular phenotypes [238, 289, 292]. Collectively, our results strongly suggest that 
hPSC-PP cell maturation was responsive to the different organ-derived ECM, as judged by the 
analysis in our 3D cell-laden alginate-ECM array. Our developed array is conducive for hPSC 
studies, in particular pre-differentiated hPSCs. While our focus here was on pancreatic 
differentiation, it can be directly applied to any other lineage-specific differentiation of hPSC. 
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5.5 CONCLUSION 
In conclusion, we developed an ECM array platform that allows culture of cells under 
both adherent 2D configuration and non-adherent 3D aggregate configuration. Our array system 
enables rapid and sensitive measurement of the differential effect of organ-specific ECM towards 
stem cell differentiation, in a miniaturized and parallel fashion. While studies have demonstrated 
the conception that tissue differentiation using decellularized ECM requires matching on a ‘like-
for-like’ basis [154, 196], interestingly, our ECM array analysis showed the positive effect of 
liver ECM to induce pancreatic differentiation of hPSC over pancreas ECM and heart ECM. Our 
platform is easily applicable to other lineage-specific differentiation of hPSC, and versatile to 
create organ-specific matrices from any organ of interest. The developed platform will allow 
rational design of engineered stem cell niches and support the rapidly developing field of stem 
cell biology, tissue engineering and regenerative medicine. 
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6.0  OVERALL CONCLUSIONS AND FUTURE WORK 
The studies presented in this dissertation merges together advancements in stem cell and tissue 
engineering towards engineering a regenerative pancreas. We accomplished this by (1) 
engineering a 3D scaffold derived from native organ by perfusion-decellularization technique, 
(2) repopulating the scaffold with differentiating hPSCs and (3) cultured with an in-house 
designed bioreactor. Exposure to the native ECM microenvironment is expected to provide 
inductive cues to the population of differentiating hPSCs.  Lastly, we investigated the matrix-
specificity by developing miniaturized arrays to investigate cell-ECM interaction during hPSC 
differentiation. 
6.1 TO DECELLULARIZE AN INTACT WHOLE PANCREAS AND 
CHARACTERIZE THE POTENTIAL OF THE NATURAL 3D SCAFFOLD TO 
SUPPORT PANCREATIC TISSUE AND WHOLE ORGAN ENGINEERING 
The production of an intact acellular organ such as the pancreas by perfusion-decellularization 
offers a promising alternate approach for pancreatic tissue engineering and functional organ 
replacement. In chapter 2, we demonstrated that perfusion-decellularization of whole pancreas 
results in the generation of a natural pancreas ECM scaffold with a perfusable vascular tree, 
ductal network and intact 3D architecture, which acts as a suitable template for pancreatic tissue 
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engineering and whole organ regeneration. Comprehensive characterization of the decellularized 
pancreatic matrix showed the preservation of complex multi-faceted ECM proteins, 3D spatial 
orientation and microstructure, and relative stiffness of native pancreas. Decellularized 
pancreatic matrix was non-cytotoxic and promoted angiogenesis when subcutaneously implanted 
in a mouse model. Repopulation of decellularized pancreas with pancreatic cells showed the 
cytocompatibility of the scaffold. The recellularized constructs maintained their respective 
phenotypic expression (β-cells: C-peptide; acinar cells: Amylase) after 5 days of culture. Finally, 
we demonstrated that the decellularized pancreas matrix is supportive of β-cell function, as 
evidenced by the strong up-regulation of insulin gene expression. Such native organ derived 
scaffold is likely to have a great impact in pancreatic tissue engineering, by providing a niche 
microenvironment for pancreatic cell types and even stem/progenitor cells. 
For future work related to this aim, it will be critical to examine the efficiency of 
decellularization protocols to remove cells. In this study, we used ionic detergent SDS, which 
has shown to be very effective to solubilize cells and cleave proteins but also potentially harmful 
if not properly removed from the resulting 3D scaffolds. It is noteworthy that any 
decellularization protocol will cause changes in the retained ECM; the objective of 
decellularization is to remove cells and cell remnants with minimum disruption of the important 
ECM proteins. If the detergent used is too disruptive, important biochemical properties from the 
native organs may be lost and hinder the functionality of the engrafted cells. Other milder 
detergent such CHAPS (Zwitterionic detergent) or non-ionic detergent Triton-X 100 have been 
successfully used in other organs such as lungs [111], liver [117] and heart [133], but yet to be 
demonstrated its efficiency in pancreas. There is a delicate balance between complete 
decellularization and preservation of biological activities. In addition, it remains to be 
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investigated whether islet-specific ECM can be preserved with this decellularization technique. 
A minimal 2% of the entire pancreas consists of endocrine islets, while the rest is exocrine, 
making is challenging to isolate and preserve islet-specific ECM particularly challenging. 
6.2 TO REPOPULATE THE DECELLULARIZED PANCREAS WITH HESCS AND 
MATURE INTO INSULIN-EXPRESSING CELL IN WHOLE ORGAN BIOREACTOR 
CULTURE 
Whole organ engineering has emerged as a promising alternative avenue to fill the gap of donor 
organ shortage in organ transplantation. Recent breakthroughs in the decellularization of solid 
organs and repopulation with desired cell populations have generated neo-organ constructs with 
promising functional outcomes. The realization of this goal requires engineering advancement in 
the perfusion-based bioreactors to (i) efficiently deliver decellularization agents, followed by (ii) 
its reconstruction with relevant cell types and (iii) maintenance of viability and function of the 
reconstructed organ. In Chapter 3, we presented the development and assembly of a perfusion 
bioreactor to enable regenerative reconstruction of pancreas. The assembled bioreactor is 
versatile to efficiently decellularize multiple organs, as demonstrated by complete 
decellularization of pancreas, liver and heart in the same set-up.  Further, the same system is 
amenable to support organ reconstruction with diverse cell types. Using our in-house bioreactor 
system, we demonstrated pancreas reconstruction with both immortalized MIN-6 beta cells and 
differentiating human pluripotent stem cells. Importantly, we show the significant advantage of 
perfusion culture over static culture in enhancing cell engraftment, viability and phenotypic 
maintenance of the reconstructed pancreas. In addition, this study is a significant step forward for 
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whole organ engineering as it allows cost-effective and easy assembly of perfusion bioreactors to 
enable rapid advancement in regenerative organ reconstruction. 
After establishing the bioreactor system to support organ reconstruction, we next sought a 
cell source suitable for repopulating the decellularized pancreas scaffold and regenerate a 
bioengineered pancreas in Chapter 4. Early organ engineering studies seeded decellularized 
organ scaffolds with primary cells and immortalized cell lines [108, 111, 136]. While these 
studies present a promising new avenue for organ regeneration, the lack of abundant functionally 
mature cells is a major limitation to the clinical application of engineered organs. Human 
pluripotent stem cells (i.e. ES and iPS cells) represent an attractive source of cells owing to its 
virtually unlimited replicative capacity and the potential to differentiate into a variety of cell 
types. By recapitulating embryonic and fetal developmental stages using external growth factors 
or small molecule inhibitors, recent PSC differentiation protocol has enabled the generation of 
pancreatic β cells in vitro with high efficiency [78, 79]. In this chapter, we evaluated the 
possibility of repopulating decellularized organ scaffolds (e.g. pancreas and liver) with 
pancreatic progenitor cells derived from hPSC. We have previously reported efficient 
differentiation of pancreatic progenitor cells from hPSCs on adherent cultures [70, 71], which we 
used to repopulate our decellularized pancreas. More recently, we reported an efficient derivation 
of PP aggregates by alginate encapsulation of hPSCs and subsequent differentiation under 
encapsulation [69]. The differentiated hPSC-PP aggregates not only express enhancement of 
pancreatic differentiation than the parallel adherent cultures, but also retain cell-cell contact 
which makes them more amenable to organ repopulation. However, engraftment of these hPSC-
PP aggregates required a more extensive vascular support, which was found to be superior in 
decellularized liver over the decellularized pancreas scaffold. Decellularized liver repopulated 
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with hPSC-PP aggregates resulted in extensive and uniform cellular engraftment and viability 
throughout the thickness of the scaffold. More importantly, the seeded hPSC-PP aggregates 
matured into mono-hormonal C-peptide positive cells after 9 days of bioreactor culture. This is 
the first demonstration, to the best of our knowledge, of the feasibility of repopulating 
decellularized organ scaffolds with hPSC derived pancreatic progenitor cells, paving the way for 
diabetes therapy, organ engineering and drug discovery applications. 
For future work, the bioreactor design can further benefit from a few continued design 
improvements. For instance, the importance of monitoring organ growth and development using 
noninvasive imaging detection is not to be overlooked. Current data metrics from whole organ 
culture typically involves end-point analysis to assess cell survival, proliferation and function of 
the engineered organ. New, noninvasive methods to evaluate organ and cell growth such as near-
infrared (IR) imaging allows for deep tissue imaging with limited tissue scattering and auto-
fluorescence [197]. Another area of improvement is to fit the bioreactor with specific sensors to 
ensure a controlled environment. Biomimetic physical, electrical, or chemical stimuli could also 
be built-in to improve and promote organ function. For example, mechanical stretching of heart 
tissue has been found to promote cell alignment [199] while electrical stimulation causes the 
coordinated beating of heart cells [200]. 
For whole organ reconstruction, there is a need for integrating other stromal cell 
population to reconstitute the overall supporting microenvironment for organ regeneration. 
Seeding of supporting cell types such as fibroblast, endothelial and mesenchymal stem cells has 
shown to enhance the attachment, viability and matrix remodeling of the recellularized organs 
such as recellularized lung [121], kidney [118] and liver [233-235]. The derivation of these cells 
from patient-specific iPS cells opens door for personalized medicine and build customized organ 
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avoiding the need of immune suppression. In addition, extended bioreactor culture (e.g., 14 or 21 
days) would likely allow the seeded cells to further expand within the matrix and adopt more 
mature phenotypes. Implantation into the host animal for an extended “in vivo culture” period 
may also be advantageous for further regeneration. Complete recapitulation of cellular 
components and functional beta cells would likely be aided by the recipient’s endogenous 
environment and repair program [67]. 
6.3 TO EVALUATE THE MATRIX-SPECIFICITY OF ORGAN-DERIVED ECM IN 
HUMAN EMBRYONIC STEM CELL DIFFERENTIATION 
The process of stem cell differentiation is regulated by multi-parametric cues from the 
surrounding microenvironment  including extracellular matrix (ECM), soluble factors, matrix 
stiffness, substrate topography and adjacent cell-cell interactions [293]. Stem cells interacts with 
the ECM, which is a complex tissue-specific structure via several different cell surface receptors, 
of which the largest family is integrins [294]. The cell-ECM interaction allows cells to sense 
mechanical and biochemical cues and respond directly by inducing downstream cellular 
signaling, modulating the response of other integrins and influencing organ-specific lineage 
commitment [278, 292, 295, 296]. Hence it is of interest to quantify the contribution of organ-
specific ECM, alone and in synergy with the other microenvironmental factors, in modulating 
stem cell fate.  
In this final chapter, we developed an ECM array system that enables rapid and sensitive 
measurement of the differential effect of organ-specific ECM toward stem cell differentiation 
under both adherent 2D and non-adherent 3D culture configuration. We generated organ-specific 
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ECM by decellularizing whole organs (e.g. pancreas, liver and heart) and extracting ECM using 
chaotropic agents (e.g. Urea and GuHCl). Other ECM digestion methods such as enzymatic 
pepsin digestion could also be implemented yet the optimal ECM digestion protocol remains to 
be investigated. Despite the identical extraction protocol, biochemical and SDS-PAGE 
characterization revealed considerable differences in ECM compositional profiles between the 
three organs. By micro-spotting organ-derived ECM onto nitrocellulose-coated surface, we were 
able to pattern them into ECM islands and generated organ-specific ECM arrays. The effect of 
cell-ECM adhesion of stem cell fate was evaluated by seeding pre-differentiated hPSC-PP cells 
on the array. Interestingly, the hPSC-PP cells were responsive to different organ-derived ECM 
and expressed different adherence profiles, further confirming the matrix-specificity of each 
organ. In the 3D ECM array with non-adherent PP aggregate culture, our platform showed 
excellent compatibility with enhanced maturation into insulin expressing cells in organ-derived 
ECMs compared to matrigel. Interestingly, P-ECM being the origin of the tissue did not show 
higher insulin expression than L-ECM. Overall, this method allows the investigation of cell-
ECM interaction during stem cell differentiation in a miniaturized and parallel fashion. 
Furthermore, our method of ECM array fabrication is easily applicable to other organ types, 
allowing versatile characterization of organ-specific matrices and characterize any lineage 
specific differentiation of stem cells. The developed platform will allow rational design of 
engineered stem cell niches and support the rapidly developing field of stem cell biology, tissue 
engineering and regenerative medicine. 
For future work, it is critical to evaluate the potential retention of matrix-bound growth 
factors and cytokines retained in the ECM extracts, which have been demonstrated effective for 
inducing differentiation and maintaining cellular phenotypes [238, 289, 292]. In our study, we 
  171 
evaluated four major ECM proteins (i.e. Collagen I, Collagen IV, Laminin and Fibronectin) 
preserved in the organ-ECM extracts; however there is likely other ECM proteins that have an 
effect on pancreatic differentiation of stem cells, but was not investigated in this study. More 
comprehensive characterization such as mass spec or growth factor analysis is required to truly 
understand the precise contribution of each of these factors. Another area for future investigation 
is the parallel investigation of stiffness’ effect with ECM incorporated in the array. Since our 
array is versatile to allow simultaneous multi-parametric modulation, it will be interesting to 
investigate the combinatorial effect of stiffness and ECM in this miniaturized platform. The 
stiffness within a tissue environment is another critical parameter to modulate cell fate [162, 
288]. Studies have shown that stiffer matrix will promote the differentiation of MSC to bone 
lineage whereas softer matrix to adipose lineage [162]. When organs ECMs are coupled with 
their corresponding tissue stiffness, it is likely to give rise to a synergistic promotion of organ-
specific differentiation. For example, it is intuitive to think that the combination of H-ECM with 
a stiffer gel could result in the promotion of cardiac differentiation whereas the P-ECM with a 
softer gel may result in promotion of pancreatic differentiation. In contrast, the mismatch of 
stiffness and ECM would likely result in less favorable lineage specific differentiation. This 
remains an interesting hypothesis to be tested, whether organ-specific ECM effect will act in 
synergy or be overridden by the stiffness modulation. 
Overall, the findings described in this dissertation present an alternative therapeutic 
solution to diabetes by generating a bioengineered pancreas from native organ scaffolds and 
renewable hPSCs. Specifically, we demonstrated that MIN-6 β-cell and hPSC-derived PP cells 
cultured in 3D organ scaffolds exhibit improved insulin expression over other commercially 
available ECM proteins (e.g. matrigel and other individual ECM proteins). These findings 
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strongly point toward the importance of 3D native complex ECM in supporting β-cell 
differentiation and function. However, preclinical testing will be required to determine whether 
the significant improvement in functionality observed in vitro can extend to in vivo settings and 
for how long. While not a focus of this dissertation, the protection of insulin-producing cells 
from immune attack will also need to be addressed to limit the need for immunosuppressive 
drugs. 
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APPENDIX A 
SUPPLEMENARY TABLES AND FIGURES 
 
Figure A.1 Decellularization of bovine pancreas.  
Panel images show progressive decellularization of bovine pancreas over the course of 65 hours. 
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Table 6.1 Supplemental table for ECM proteins detected with mass spec analysis 




Peptides Σ# PSMs MW [kDa] 
P11087 Collagen alpha-1(I) chain OS=Musmusculus GN=Col1a1 PE=1 SV=4 - 
[CO1A1_MOUSE] 
18.58 2 17 19 3240 137.9 
Q01149 Collagen alpha-2(I) chain OS=Musmusculus GN=Col1a2 PE=2 SV=2 - 
[CO1A2_MOUSE] 
32.22 2 28 28 2972 129.5 
P08122 Collagen alpha-2(IV) chain OS=Musmusculus GN=Col4a2 PE=2 SV=4 - 
[CO4A2_MOUSE] 
15.70 2 18 18 2632 167.2 
P08121 Collagen alpha-1(III) chain OS=Musmusculus GN=Col3a1 PE=2 SV=4 - 
[CO3A1_MOUSE] 
16.80 1 17 17 1121 138.9 
Q3U962 Collagen alpha-2(V) chain OS=Musmusculus GN=Col5a2 PE=1 SV=1 - 
[CO5A2_MOUSE] 
12.69 1 10 13 851 144.9 
Q9JLI2 Collagen type V alpha 3 chain OS=Musmusculus GN=Col5a3 PE=2 
SV=1 - [Q9JLI2_MOUSE] 
7.53 1 8 8 533 171.9 
P02463 Collagen alpha-1(IV) chain OS=Musmusculus GN=Col4a1 PE=2 SV=4 - 
[CO4A1_MOUSE] 
4.31 2 3 5 479 160.6 
P02535-3 Isoform 3 of Keratin, type I cytoskeletal 10 OS=Musmusculus GN=Krt10 
- [K1C10_MOUSE] 
18.61 6 1 11 346 49.5 
J3QQ16 Protein Col6a3 OS=Musmusculus GN=Col6a3 PE=4 SV=1 - 
[J3QQ16_MOUSE] 
13.30 3 29 29 328 288.5 
E9PZ16 Endorepellin OS=Musmusculus GN=Hspg2 PE=4 SV=1 - 
[E9PZ16_MOUSE] 
10.95 3 37 37 289 469.5 
P11679 Keratin, type II cytoskeletal 8 OS=Musmusculus GN=Krt8 PE=1 SV=4 - 
[K2C8_MOUSE] 
9.59 3 1 8 240 54.5 
O88207 Collagen alpha-1(V) chain OS=Musmusculus GN=Col5a1 PE=2 SV=2 - 
[CO5A1_MOUSE] 
4.73 9 8 8 217 183.6 
Q04857 Collagen alpha-1(VI) chain OS=Musmusculus GN=Col6a1 PE=2 SV=1 - 
[CO6A1_MOUSE] 
15.22 1 12 12 211 108.4 
Q61292 Laminin subunit beta-2 OS=Musmusculus GN=Lamb2 PE=2 SV=2 - 
[LAMB2_MOUSE] 
15.51 1 22 22 206 196.5 
F8VQJ3 Laminin subunit gamma-1 OS=Musmusculus GN=Lamc1 PE=4 SV=1 - 
[F8VQJ3_MOUSE] 
8.71 3 13 13 200 177.1 
Q02788 Collagen alpha-2(VI) chain OS=Musmusculus GN=Col6a2 PE=2 SV=3 - 
[CO6A2_MOUSE] 
13.83 2 14 14 191 110.3 
Q61001 Laminin subunit alpha-5 OS=Musmusculus GN=Lama5 PE=1 SV=4 - 
[LAMA5_MOUSE] 
7.15 1 20 20 166 403.8 
E9Q1Z0 Protein 4732456N10Rik OS=Musmusculus GN=4732456N10Rik PE=3 
SV=1 - [E9Q1Z0_MOUSE] 
15.61 6 1 11 116 58.2 
A2AQ53 Fibrillin 1 OS=Musmusculus GN=Fbn1 PE=4 SV=1 - [A2AQ53_MOUSE] 6.51 2 15 17 115 312.1 
F8VQ43 Laminin subunit alpha-2 OS=Musmusculus GN=Lama2 PE=4 SV=1 - 
[F8VQ43_MOUSE] 
5.36 2 14 14 91 343.6 
E9Q557 Desmoplakin OS=Musmusculus GN=Dsp PE=3 SV=1 - [DESP_MOUSE] 9.57 2 24 24 87 332.7 
E9Q6A6 Collagen alpha-6(VI) chain OS=Musmusculus GN=Col6a6 PE=4 SV=2 - 
[E9Q6A6_MOUSE] 
5.34 3 11 11 73 246.3 
  175 
Table 6.1 (continued) 
P11276 Fibronectin OS=Musmusculus GN=Fn1 PE=1 SV=4 - [FINC_MOUSE] 5.33 1 11 11 57 272.4 
E9Q3W4 Plectin OS=Musmusculus GN=Plec PE=4 SV=1 - [E9Q3W4_MOUSE] 3.83 28 18 18 57 498.8 
E9QPE7 Myosin-11 OS=Musmusculus GN=Myh11 PE=4 SV=1 - 
[E9QPE7_MOUSE] 
5.16 2 2 8 48 223.2 
E9Q2T3 Protein Tnxb OS=Musmusculus GN=Tnxb PE=4 SV=1 - 
[E9Q2T3_MOUSE] 
4.45 2 12 12 48 339.7 
O08638 Myosin-11 OS=Musmusculus GN=Myh11 PE=1 SV=1 - 
[MYH11_MOUSE] 
4.26 2 1 7 47 226.9 
Q792Z1 MCG140784 OS=Musmusculus GN=Try10 PE=2 SV=1 - 
[Q792Z1_MOUSE] 
8.13 1 2 2 45 26.2 
Q02257 Junction plakoglobin OS=Musmusculus GN=Jup PE=1 SV=3 - 
[PLAK_MOUSE] 
16.24 3 11 11 43 81.7 
Q63ZW6 Col4a5 protein OS=Musmusculus GN=Col4a5 PE=2 SV=1 - 
[Q63ZW6_MOUSE] 
3.67 2 2 4 41 161.7 
Q80X19-2 Isoform 2 of Collagen alpha-1(XIV) chain OS=Musmusculus 
GN=Col14a1 - [COEA1_MOUSE] 
7.30 5 9 9 41 191.2 
P02469 Laminin subunit beta-1 OS=Musmusculus GN=Lamb1 PE=1 SV=3 - 
[LAMB1_MOUSE] 
3.64 3 6 6 40 197.0 
Q9CPN9 Protein 2210010C04Rik OS=Musmusculus GN=2210010C04Rik PE=2 
SV=1 - [Q9CPN9_MOUSE] 
8.10 1 2 2 39 26.4 
B1AVK5 Procollagen type IV alpha 6 OS=Musmusculus GN=Col4a6 PE=4 SV=1 - 
[B1AVK5_MOUSE] 
2.25 1 3 3 38 163.9 
P07356 Annexin A2 OS=Musmusculus GN=Anxa2 PE=1 SV=2 - 
[ANXA2_MOUSE] 
26.25 4 7 7 32 38.7 
Q6IFZ8 MCG1050941 OS=Musmusculus GN=Gm5414 PE=2 SV=1 - 
[Q6IFZ8_MOUSE] 
8.88 2 1 5 31 60.2 
A6H584 Collagen alpha-5(VI) chain OS=Musmusculus GN=Col6a5 PE=1 SV=2 - 
[CO6A5_MOUSE] 
1.63 2 3 3 30 289.4 
P10493 Nidogen-1 OS=Musmusculus GN=Nid1 PE=1 SV=2 - [NID1_MOUSE] 2.65 1 3 3 26 136.5 
Q63870 Collagen alpha-1(VII) chain OS=Musmusculus GN=Col7a1 PE=2 SV=3 - 
[CO7A1_MOUSE] 
1.53 1 3 4 25 295.1 
Q78PY7 Staphylococcal nuclease domain-containing protein 1 OS=Musmusculus 
GN=Snd1 PE=1 SV=1 - [SND1_MOUSE] 
7.58 2 5 5 25 102.0 
P16546-2 Isoform 2 of Spectrin alpha chain, non-erythrocytic 1 OS=Musmusculus 
GN=Sptan1 - [SPTN1_MOUSE] 
4.12 8 10 10 25 282.2 
E9Q1F2 Actin, cytoplasmic 1, N-terminally processed OS=Musmusculus GN=Actb 
PE=3 SV=1 - [E9Q1F2_MOUSE] 
17.97 16 1 5 22 32.5 
Q8VDD5 Myosin-9 OS=Musmusculus GN=Myh9 PE=1 SV=4 - [MYH9_MOUSE] 4.13 1 6 7 22 226.2 
Q9QZR9 Collagen alpha-4(IV) chain OS=Musmusculus GN=Col4a4 PE=2 SV=1 - 
[CO4A4_MOUSE] 
4.93 1 6 6 21 164.0 
P21981 Protein-glutamine gamma-glutamyltransferase 2 OS=Musmusculus 
GN=Tgm2 PE=1 SV=4 - [TGM2_MOUSE] 
4.66 2 3 3 21 77.0 
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Q61495 Desmoglein-1-alpha OS=Musmusculus GN=Dsg1a PE=2 SV=2 - 
[DSG1A_MOUSE] 
4.73 4 5 5 21 114.5 
A1BN54 Alpha actinin 1a OS=Musmusculus GN=Actn1 PE=2 SV=1 - 
[A1BN54_MOUSE] 
4.85 4 4 4 20 102.7 
P63268 Actin, gamma-enteric smooth muscle OS=Musmusculus GN=Actg2 
PE=2 SV=1 - [ACTH_MOUSE] 
14.10 16 1 5 18 41.8 
O88322 Nidogen-2 OS=Musmusculus GN=Nid2 PE=1 SV=2 - [NID2_MOUSE] 2.21 1 3 3 18 153.8 
P62806 Histone H4 OS=Musmusculus GN=Hist1h4a PE=1 SV=2 - [H4_MOUSE] 29.13 1 3 3 17 11.4 
P68373 Tubulin alpha-1C chain OS=Musmusculus GN=Tuba1c PE=1 SV=1 - 
[TBA1C_MOUSE] 
5.35 3 2 2 17 49.9 
A2AJY2 Collagen alpha-1(XV) chain OS=Musmusculus GN=Col15a1 PE=4 SV=1 
- [A2AJY2_MOUSE] 
2.30 4 3 3 17 138.2 
P00688 Pancreatic alpha-amylase OS=Musmusculus GN=Amy2 PE=1 SV=2 - 
[AMYP_MOUSE] 
10.04 5 5 5 15 57.3 
E9Q5F6 Ubiquitin-related 2 (Fragment) OS=Musmusculus GN=Ubc PE=4 SV=1 - 
[E9Q5F6_MOUSE] 
32.84 12 2 2 15 22.6 
P07901 Heat shock protein HSP 90-alpha OS=Musmusculus GN=Hsp90aa1 
PE=1 SV=4 - [HS90A_MOUSE] 
4.09 2 2 3 15 84.7 
P97927 Laminin subunit alpha-4 OS=Musmusculus GN=Lama4 PE=1 SV=2 - 
[LAMA4_MOUSE] 
1.54 10 3 3 14 201.7 
Q9Z1Z0-3 Isoform 3 of General vesicular transport factor p115 OS=Musmusculus 
GN=Uso1 - [USO1_MOUSE] 
6.25 3 3 3 14 54.7 
Q61879 Myosin-10 OS=Musmusculus GN=Myh10 PE=1 SV=2 - 
[MYH10_MOUSE] 
1.92 3 2 4 13 228.9 
Q9JIF7 Coatomer subunit beta OS=Musmusculus GN=Copb1 PE=1 SV=1 - 
[COPB_MOUSE] 
3.36 1 3 3 13 107.0 
P14148 60S ribosomal protein L7 OS=Musmusculus GN=Rpl7 PE=2 SV=2 - 
[RL7_MOUSE] 
6.30 2 1 2 12 31.4 
Q61753 D-3-phosphoglycerate dehydrogenase OS=Musmusculus GN=Phgdh 
PE=1 SV=3 - [SERA_MOUSE] 
3.56 1 2 2 12 56.5 
Q8BU30 Isoleucine--tRNA ligase, cytoplasmic OS=Musmusculus GN=Iars PE=2 
SV=2 - [SYIC_MOUSE] 
2.14 1 3 3 12 144.2 
P17897 Lysozyme C-1 OS=Musmusculus GN=Lyz1 PE=1 SV=1 - [LYZ1_MOUSE] 12.16 2 2 2 11 16.8 
Q9WTI7-4 Isoform 4 of Unconventional myosin-Ic OS=Musmusculus GN=Myo1c - 
[MYO1C_MOUSE] 
1.87 4 2 2 11 111.2 
P46978 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 
STT3A OS=Musmusculus GN=Stt3a PE=1 SV=1 - [STT3A_MOUSE] 
1.84 4 2 2 11 80.5 
E9PVA8 Protein Gcn1l1 OS=Musmusculus GN=Gcn1l1 PE=4 SV=1 - 
[E9PVA8_MOUSE] 
1.57 2 4 4 11 292.8 
B7FAV1 Filamin, alpha (Fragment) OS=Musmusculus GN=Flna PE=4 SV=1 - 
[B7FAV1_MOUSE] 
1.16 5 3 3 11 274.5 
F8VQ40 Laminin subunit alpha-1 OS=Musmusculus GN=Lama1 PE=4 SV=1 - 
[F8VQ40_MOUSE] 
1.27 2 4 4 11 337.9 
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Q9EST1 Gasdermin-A OS=Musmusculus GN=Gsdma PE=2 SV=1 - 
[GSDMA_MOUSE] 
6.73 4 3 3 11 49.6 
E9Q3D6 Heat shock protein HSP 90-beta (Fragment) OS=Musmusculus 
GN=Hsp90ab1 PE=4 SV=1 - [E9Q3D6_MOUSE] 
11.11 3 1 2 11 22.5 
P10126 Elongation factor 1-alpha 1 OS=Musmusculus GN=Eef1a1 PE=1 SV=3 - 
[EF1A1_MOUSE] 
4.11 2 2 2 11 50.1 
P17809 Solute carrier family 2, facilitated glucose transporter member 1 
OS=Musmusculus GN=Slc2a1 PE=1 SV=4 - [GTR1_MOUSE] 
2.85 1 2 2 10 53.9 
Q8VDN2 Sodium/potassium-transporting ATPase subunit alpha-1 
OS=Musmusculus GN=Atp1a1 PE=1 SV=1 - [AT1A1_MOUSE] 
1.96 1 2 2 10 112.9 
P99024 Tubulin beta-5 chain OS=Musmusculus GN=Tubb5 PE=1 SV=1 - 
[TBB5_MOUSE] 
7.66 7 1 3 10 49.6 
B7ZN27 Cad protein OS=Musmusculus GN=Cad PE=2 SV=1 - [B7ZN27_MOUSE] 2.00 5 4 4 9 235.7 
P22892 AP-1 complex subunit gamma-1 OS=Musmusculus GN=Ap1g1 PE=1 
SV=3 - [AP1G1_MOUSE] 
2.31 2 2 2 9 91.3 
P10852 4F2 cell-surface antigen heavy chain OS=Musmusculus GN=Slc3a2 
PE=1 SV=1 - [4F2_MOUSE] 
3.42 2 2 2 8 58.3 
Q61555 Fibrillin-2 OS=Musmusculus GN=Fbn2 PE=1 SV=2 - [FBN2_MOUSE] 0.86 1 1 3 8 313.6 
P58252 Elongation factor 2 OS=Musmusculus GN=Eef2 PE=1 SV=2 - 
[EF2_MOUSE] 
2.21 5 2 2 8 95.3 
Q9D6F9 Tubulin beta-4A chain OS=Musmusculus GN=Tubb4a PE=1 SV=3 - 
[TBB4A_MOUSE] 
7.66 5 1 3 8 49.6 
Q76MZ3 Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A 
alpha isoform OS=Musmusculus GN=Ppp2r1a PE=1 SV=3 - 
[2AAA_MOUSE] 
3.40 1 2 2 8 65.3 
Q9QZS0 Collagen alpha-3(IV) chain OS=Musmusculus GN=Col4a3 PE=1 SV=2 - 
[CO4A3_MOUSE] 
5.51 2 5 5 7 161.6 
P70168 Importin subunit beta-1 OS=Musmusculus GN=Kpnb1 PE=1 SV=2 - 
[IMB1_MOUSE] 
3.08 1 2 2 7 97.1 
Q922D8 C-1-tetrahydrofolate synthase, cytoplasmic OS=Musmusculus 
GN=Mthfd1 PE=1 SV=4 - [C1TC_MOUSE] 
8.88 1 6 6 6 101.1 
Q68FD5 Clathrin heavy chain 1 OS=Musmusculus GN=Cltc PE=1 SV=3 - 
[CLH_MOUSE] 
1.43 2 2 2 6 191.4 
Q02053 Ubiquitin-like modifier-activating enzyme 1 OS=Musmusculus GN=Uba1 
PE=1 SV=1 - [UBA1_MOUSE] 
4.16 1 3 3 6 117.7 
Q8BMJ2 Leucine--tRNA ligase, cytoplasmic OS=Musmusculus GN=Lars PE=2 
SV=2 - [SYLC_MOUSE] 
2.72 1 3 3 5 134.1 
P32037 Solute carrier family 2, facilitated glucose transporter member 3 
OS=Musmusculus GN=Slc2a3 PE=1 SV=1 - [GTR3_MOUSE] 
3.25 1 2 2 5 53.4 
Q9D0R2 Threonine--tRNA ligase, cytoplasmic OS=Musmusculus GN=Tars PE=1 
SV=2 - [SYTC_MOUSE] 
3.60 1 2 2 5 83.3 
D3YXT0 NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial 
OS=Musmusculus GN=Ndufs2 PE=3 SV=1 - [D3YXT0_MOUSE] 
6.41 3 3 3 5 49.5 
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P28481-2 Isoform 3 of Collagen alpha-1(II) chain OS=Musmusculus GN=Col2a1 - 
[CO2A1_MOUSE] 
4.17 7 1 3 4 131.8 
Q3UQ28 Peroxidasin homolog OS=Musmusculus GN=Pxdn PE=2 SV=2 - 
[PXDN_MOUSE] 
1.56 1 2 2 4 165.0 
F8WIT2 Annexin OS=Musmusculus GN=Anxa6 PE=3 SV=1 - [F8WIT2_MOUSE] 2.85 2 2 2 4 75.2 
Q504P4 Heat shock cognate 71 kDa protein OS=Musmusculus GN=Hspa8 PE=2 
SV=1 - [Q504P4_MOUSE] 
3.35 9 2 2 4 68.7 
B9EJ54 MCG21756, isoform CRA_b OS=Musmusculus GN=Nup205 PE=2 SV=1 - 
[B9EJ54_MOUSE] 
0.85 1 2 2 4 227.3 
O70133 ATP-dependent RNA helicase A OS=Musmusculus GN=Dhx9 PE=1 SV=2 
- [DHX9_MOUSE] 
2.17 4 3 3 4 149.4 
Q3V3R1 Monofunctional C1-tetrahydrofolate synthase, mitochondrial 
OS=Musmusculus GN=Mthfd1l PE=1 SV=2 - [C1TM_MOUSE] 
3.89 1 3 3 4 105.7 
P52480-2 Isoform M1 of Pyruvate kinase isozymes M1/M2 OS=Musmusculus 
GN=Pkm - [KPYM_MOUSE] 
3.20 2 2 2 4 57.9 
P52431 DNA polymerase delta catalytic subunit OS=Musmusculus GN=Pold1 
PE=1 SV=2 - [DPOD1_MOUSE] 
1.99 2 2 2 4 123.7 
Q3TXS7 26S proteasome non-ATPase regulatory subunit 1 OS=Musmusculus 
GN=Psmd1 PE=1 SV=1 - [PSMD1_MOUSE] 
3.46 1 3 3 4 105.7 
D3YWT0 Signal peptidase complex catalytic subunit SEC11A OS=Musmusculus 
GN=Sec11a PE=4 SV=1 - [D3YWT0_MOUSE] 
10.00 4 2 2 4 19.6 
Q8BP47 Asparagine--tRNA ligase, cytoplasmic OS=Musmusculus GN=Nars PE=1 
SV=2 - [SYNC_MOUSE] 
3.40 1 2 2 4 64.2 
P39061-2 Isoform 3 of Collagen alpha-1(XVIII) chain OS=Musmusculus 
GN=Col18a1 - [COIA1_MOUSE] 
1.75 4 2 2 3 134.1 
Q9JHU4 Cytoplasmic dynein 1 heavy chain 1 OS=Musmusculus GN=Dync1h1 
PE=1 SV=2 - [DYHC1_MOUSE] 
0.34 1 2 2 3 531.7 
F8WJL5 Glyceraldehyde-3-phosphate dehydrogenase OS=Musmusculus 
GN=Gapdh PE=3 SV=1 - [F8WJL5_MOUSE] 
6.95 7 2 2 3 32.5 
Q6URW6-2 Isoform 2 of Myosin-14 OS=Musmusculus GN=Myh14 - 
[MYH14_MOUSE] 
0.80 3 1 2 3 227.6 
O54734 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa 
subunit OS=Musmusculus GN=Ddost PE=1 SV=2 - [OST48_MOUSE] 
4.99 1 2 2 3 49.0 
P09405 Nucleolin OS=Musmusculus GN=Ncl PE=1 SV=2 - [NUCL_MOUSE] 3.82 1 3 3 3 76.7 
A2AVJ7 Ribosome binding protein 1 OS=Musmusculus GN=Rrbp1 PE=4 SV=1 - 
[A2AVJ7_MOUSE] 
1.23 2 2 2 2 158.3 
Q9JLI8-2 Isoform 2 of Squamous cell carcinoma antigen recognized by T-cells 3 
OS=Musmusculus GN=Sart3 - [SART3_MOUSE] 
4.49 2 2 2 2 45.3 
Q7TMB8-2 Isoform 2 of Cytoplasmic FMR1-interacting protein 1 OS=Musmusculus 
GN=Cyfip1 - [CYFP1_MOUSE] 
1.68 4 2 2 2 144.9 
Q9EPL8 Importin-7 OS=Musmusculus GN=Ipo7 PE=1 SV=2 - [IPO7_MOUSE] 2.02 1 2 2 2 119.4 
P10107 Annexin A1 OS=Musmusculus GN=Anxa1 PE=1 SV=2 - 
[ANXA1_MOUSE] 
6.94 1 2 2 2 38.7 
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Figure A.2 ProE schematic drawing of perfusion-decellularization set-up 
 
Figure A.3 Perfusion system is compatible for scaling up 
The photograph shows the capability of peristaltic pump to accommodate two pump head and drive the 
perfusion of additional lines for decellularization for a proof-of-concept for scale up. Inset with higher magnification 
of two hearts being decellularized. 
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Figure A.4 Microbiological testing for bioreactor culture 
The microbiological evaluation showed no microbiological contamination. Negative control (left): Culture 
medium before exposure to bioreactor culture, positive control (right): culture medium added with E-Coli bacteria. 
A.1.1 Mathematical modeling of oxygen diffusion across oxygenator in in-house 
bioreactor 
Silicone tubing used in the bioreactor acts as a medium for exchange of gases between 
the aqueous media and the environment. This tubing has a high oxygen permeability ( ) of 
 [Cole-Parmer tubing reference]. While travelling the length of the tube, 
the media will get oxygenated continuously until oxygen concentration reaches equilibrium with 
the surrounding ambient air in contact with the tubing. The minimum theoretical length of the 
tubing required for maximum oxygenation of the media can be calculated using a steady state 
mass balance equation. In the following paragraphs, salient features of a mathematical model 
used to determine this length are given. 
The fundamental balance equation across a cylindrical control volume (Figure A.5) can 
be written as: 
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: molar flux of oxygen at z  
: molar flux of oxygen at z + dz 
: cross-sectional area of flow channel 
: molar flux across the tube surface 
 
Figure A.5 Cylindrical control volume used for the mass balance equation 
Here, the aqueous media is assumed to be an incompressible fluid flowing at constant 
temperature. The oxygen concentration of the media entering the silicone tubing is very low and 
therefore, assumed to be zero. Any presence of oxygen at the tube inlet will only slightly 
overestimate the minimum length. It is assumed that each type of gas from the ambient or the 
media is diffusing through the thickness of the tube independently of each other and the ambient 
air inside the incubator is assumed to be an ideal gas. Hence, a balance equation for oxygen can 
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be written independently of other gases like N2, CO2 etc. The flux of oxygen transfer is related to 





: permeability of oxygen through the pipe tubing 
: molar volume of oxygen (2.45 x 10-7 m3/mol, calculated using Ideal Gas 
approximation at 37 oC and 1 atm pressure) 
: thickness of the tube 
: Drop in oxygen partial pressure across the thickness of the tube = 
 
Here, P denotes the absolute pressure and y denotes mole fraction of oxygen 
 
Once oxygen has entered the inner surface of the tube, it is immediately dissolved into 
the aqueous medium. Once dissolved, the diffusion of oxygen in the radial direction is 
instantaneous and therefore, an average oxygen concentration in the aqueous medium can be 
tracked along the axial ‘z’ direction with no change in the radial direction. The solubility of 
oxygen transferred through the tube wall into the aqueous flow is governed by Henry’s law for 
dilute solutions at STP, given by: 
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The Henry’s law can be used to relate the partial pressure of oxygen at the inner surface 
of the tubing to the average concentration in the aqueous media. The solubility constant ( ) for 
oxygen at STP is 77942 Pa m3 / mol. 
 
Volumetric flow rate ( ) through the pipe can be related to the average flow velocity ( ) 
through the relation,  
 
Using Equations (1-4), the rate of change of oxygen concentration across the length of 




Figure A.6 shows the model predicted concentration of oxygen along the length of the 
tube. The oxygen concentration rises gradually and reaches a steady value from 0.8 to 1 m. A 
final length of 1 m is chosen in the final design. 
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Figure A.6 Average axial oxygen concentration. 
The curve shows the mean concentration as predicted by Equation 5. Geometric constants for the tubing 
are: Inner Diameter = 3.1 mm, Outer Diameter = 6.1 mm. Flow rate is kept constant at 1 ml/min. 
 
Figure A.7 Decellularization of adult mouse pancreas.  
(A) H&E staining of cadaveric pancreas. (B) H&E staining image shows complete removal of cells (left) 
and SEM image shows the intact matrix of architecture of decellularized pancreas. 
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Figure A.8 Matrigel culture of 3D PP aggregates as control.  
(A) Phase image of 3D PP aggregates cultured on matrigel. (B) Immunostaining shows low expression of 
Pdx1 and Nkx6.1 indicating inability of matrigel to promote differentiation of 3D PP aggregates. 
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Figure A.9 Co-seeding of endothelial and PP cells into decellularized liver.  
(A) Immunostaining shows the presence of pancreatic transcription factor, Pdx1 (green) and endothelial 
marker, vWF (red) on the engrafted cells. 
 
Figure A.10 AFM images showing the surface roughness of 2D ECM array.  
Different organ-ECM were immobilized onto nitrocellulose coated glass and showed higher RMS value 
than nitrocellulose only surface. 
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Figure A.11 Sensitivity analysis of the on-chip IR Dye immunofluorescence staining with LI-COR 
scanner.  
(A) LI-COR images 2D ECM array showed stained matrigel microspots with laminin and collagen IV 
antibodies. Three different lots of matrigel were evaluated. (B) Correlation plot of fluorescence intensity from 
laminin staining showed good linearity across different dilutions of matrigel. (C) Correlation plot of fluorescence 
intensity from collagen IV staining showed good linearity across different dilutions of matrigel. 
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Figure A.12 LICOR sensitivity for 2D and 3D analysis  
Collagen IV staining of matrigel on 2D spotted matrigel and 3D alginate-matrigel mixture. Analysis shows 
similar RFU intensity detected in both configurations indicating the sensitivity of the LICOR detection and scalable 
to 3D configuration. 
 
Figure A.13 Spot breakage was observed when larger PP aggregates were cultured inside the 3D 
alginate microspots.  
(A) Day 5 phase contrast image of the PP aggregates inside 3D alginate microspot. (B) Live/dead image of 
the PP aggregates inside 3D alginate microspot. (C) Merged phase contrast and live/dead image of the PP aggregates 
inside 3D alginate microspot. 
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Figure A.14 AFM stiffness measurement of the 3D ECM array.  
The AFM stiffness measurement showed no significant change in young modulus after incorporation of 
organ-derived ECM or matrigel. (n=5, P>0.05) 
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Figure A.15 Single cells of MIN-6 beta cells exhibited good viability throughout 10 days culture 
inside 3D alginate microspots with and without matrigel.  
(A) Phase contrast images of the cell-laden 3D alginate microspots on day 1, day 4, and day 10. (B) 
Live/dead images of viable MIN-6 beta cells in 3D alginate microspots on day 1, day 4, and day 10. (C) 
Quantification of percentage live/dead of the MIN-6 beta cells in 3D alginate microspots on day 10. No significant 
difference were found between matrigel and without matrigel incorporated alginate microspots. (n=5, P>0.05) 
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